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3Abstract
The majority of CATH domain structure superfamilies have small populations and are
conserved in sequence and function. However, previous studies have shown that ∼ 4% are
highly populated and functionally diverse. Previous analyses of some of these showed that
relatives with different functions tend to exploit different functional sites to perform their
function. In this work, functional site diversity was explored with a much larger dataset
of superfamilies, by examining residues involved in protein interfaces and catalytic sites.
This was done using a novel protocol to map sites across each superfamily. Functional site
locations were shown to be least diverse for catalytic sites and most diverse for protein-
protein binding sites. However, although protein interaction sites can vary considerably,
in 79% of superfamilies analysed there is a common protein interface site, used by at least
80% of the functionally diverse relatives.
By contrast with protein interactions, enzyme superfamilies tend to use the same
active site in functionally diverse relatives. However, sometimes the nature and location
of catalytic residues vary. We examined changes in catalytic machinery over one hundred
enzyme superfamilies by considering physicochemical properties and sequence/structure
positions. Reaction mechanisms were also compared to explore how enzyme chemistry
has evolved between functionally diverse relatives and how changes in chemistry relate to
changes in catalytic residues. A complex relationship was found and several examples are
discussed to illustrate the different trends identified.
In the final chapter, we assigned metagenome sequences to functional families in CATH
and used KEGG pathway annotations to identify differences in the functional abilities of
two metagenome environments, the human tongue and gut. Bacteroidetes, Firmicutes, and
Proteobacteria phyla dominate both microbiomes. Enriched functional terms in the tongue
and gut environments suggested an enrichment of bacterial cell wall building proteins in
the mouth and an enrichment of denitrifying enzymes in the gut.
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Chapter 1
Introduction
Proteins have evolved to perform thousands of different functions. To understand
this process of evolution we can study their amino acid sequences and their structures
(where available) to find clues on their evolutionary relationships. Furthermore,
once we understand the link between a protein’s structure and sequence, and the
function it performs, we can use this knowledge to predict the protein function of new
uncharacterised proteins which are related to the ones studied. With the exponential
rise of sequence data through fields such as metagenomics, the prediction of function
is a highly important and valuable tool.
In this thesis, work is presented which describes the evolution of functions in
many different protein families in the CATH classification of domain families. We
then use in-house function annotation tools to predict the functional repertoires in
the diverse microbial communities found in the human mouth and gut.
1.1 Expansion of protein sequence data
As previously mentioned, sequenced DNA provides a wealth of information
needed to build an understanding of what an organism can do. The latest pub-
lication from the genomes online database (GOLD) (Pagani et al., 2012) reported
6,908 complete genome sequencing projects and 12,972 incomplete projects. These
are projects that are publicly available. With the evolution of sequencing tech-
nologies and the fall in the price of sequencing, the amount of sequence data is
rising exponentially. The GOLD statistics for 2014 show that bacteria are the
most sequenced kingdom of life with 36,413 genome projects, compared to 8,574
eukaryotic, 5,035 metagenomic, 4,381 viral, and 906 archaeal genome projects (see
https://gold.jgi-psf.org/statistics).
Much of the protein sequence data is available from the Universal Protein Re-
source Knowledge Base (UniProtKB). UniProtKB/SwissProt (discussed in more de-
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tail in Section 1.5) comprises 546,000 (in release 2014 07) manually-curated protein
sequences and has doubled in size since ∼ 2008. UniProt/TrEMBL, representing
the unreviewed section of UniProtKB, is growing even more rapidly and is currently
at 79,824,243 sequences (in release 2014 07). TrEMBL has seen an extremely large
increase in sequence data, doubling in size in less than every two years (The UniProt
Consortium, 2014).
The National Centre for Biotechnology Information (NCBI) hosts two sequence
databases, GenBank (Benson et al., 2013) and RefSeq (Pruitt et al., 2005). GenBank
and RefSeq comprise protein and nucleotide sequence data, as compared to UniProt
which contains only protein sequence data. The latest release of Genbank (version
203, August 2014) comprises 174,108,750 un-curated and redundant nucleotide se-
quences. Sequences from large-scale sequencing projects have also been added since
April 2002. GenBank exchanges data daily with partners worldwide, the European
Molecular Biology Laboratory Nucleotide Sequence Database (EMBL-Bank) which
is part of the European Nucleotide Archive (ENA) (Leinonen et al., 2011) and the
DNA Data Bank of Japan (DDBJ) (Kaminuma et al., 2011), to provide a collection
of comprehensive sequence data. RefSeq is a curated, non-redundant collection of
nucleotide and protein sequences. Its entries are curated from redundant sequences
in GenBank and it is currently limited to organisms with completely sequenced
genomes.
1.2 Expansion of protein structure data
Solved three-dimensional protein structures obtained by Electron Microscopy,
NMR, and X-ray crystallography methods are deposited in the Protein Data Bank
(PDB) (Bernstein et al., 1977). Bernstein et al. (1977) reports that the first struc-
tures were deposited in 1976. Subsequently, tens to hundreds of structures were
deposited each year until the 1990s which saw the start of the NIH-funded Protein
Structural Initiative (PSI) projects and a large increase in the amount of structural
data published (see Figure 1.1). Thousands of structures were deposited from the
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mid-1990s through to tens of thousands from 1999 onwards. As of 2014, the number
of total protein structures in the PDB has passed the 100,000 mark.
Figure 1.1: The yearly growth of the PDB from 1970 to 2014.
1.3 The organisation of sequence and structural
data
Protein sequence and structure data has been organised into evolutionary fam-
ilies by a number of resources. Most notably, the CATH-Gene3D (Sillitoe et al.,
2013; Lees et al., 2014) resource, and the SCOP (Andreeva et al., 2014) and SU-
PERFAMILY (Wilson et al., 2009) resources. Protein structures from the PDB are
classified into evolutionary related groups, or superfamilies, in the CATH and SCOP
resources, and protein sequence data are added to these superfamilies through the
Gene3D and SUPERFAMILY resources.
Proteins that share the same common ancestor are known as homologues. This
differs from anatomical homology which can describe the evolutionary relationship
between two or more structures e.g. limbs, or even species. Homologous proteins can
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be further described as orthologous or paralogous. Two proteins are orthologues,
or are orthologous, if they are found in different species and have descended from a
single gene in their last common ancestor. Paralogues on the other hand occur within
a genome and are genes resulting from the duplication of a single gene (Sonnhammer
and Koonin, 2002).
Protein domains are independently-folding functional and evolutionary units of a
protein sequence that form the building blocks of the protein structure. The CATH
database (established in 1997, Orengo et al. (1997)) is a hierarchical classification of
protein domain structures. To classify protein domains in CATH, protein structures
from the PDB are first split into separate chains. Domain boundaries are automat-
ically inferred if there is enough similarity to existing domains, based on a sequence
or structure similarity to already classified domains in CATH. The structural com-
parison program, CATHEDRAL (Greene et al., 2007) is used to detect structure
similarity. If there is not enough similarity, domain boundaries are manually de-
fined, i.e. the protein chain sequence is cut at the identified domain boundaries.
To detect sequence similarity, sequences of new PDB chains are scanned against a
library of hidden Markov models (HMMs) from each CATH superfamily. The scores
obtained from the CATHEDRAL and HMM scans are used to determine whether
the domains identified in a new PDB chain are homologous to any domains clas-
sified in CATH. If there is enough evidence they are automatically classified into
a superfamily. If not they are manually classified, for example, domains that are
remote homologues typically have to be manually classified (Greene et al., 2007).
At the top level of the CATH hierarchy, the Class (or C-level) is used to classify
domains based upon their secondary structure content (see Figure 1.2). Class 1
domain structures are mostly alpha-helical, Class 2 domain structures are mostly
beta-sheet, Class 3 domain structures have significant amounts of alpha-helical and
beta-sheet structural elements, and Class 4 domains have very little secondary struc-
ture (Sillitoe et al., 2013).
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Figure 1.2: The first three levels of the CATH classification. Taken from Orengo et
al. (1997).
The second level of the hierarchy is the Architecture (A-level), which represents
similarities in how the secondary structures are arranged in 3D space. The third level
is the topology or fold groups (T-level), which captures both the 3D arrangement
and the connections between the secondary structures. Finally, the fourth level, the
homologous superfamilies (H-level) contains domain structures that have > 35%
sequence identity, as well as sufficient structural and functional similarity. The
latest version of CATH, v4.0, consists of 277,687 structural domains from 69,058
PDBs classified into 2738 homologous superfamilies (Sillitoe et al., 2013).
The Structural Classification Of Proteins (SCOP) database (established in 1995),
like CATH, classifies protein domains using structural and evolutionary relationship
information. The top level, Class, also classifies by secondary structure content.
The second level groups domains by their structural folds, which is more similar
to the T-level in CATH. The third level of SCOP represents the classification into
homologous superfamilies (comparable to the H-level in CATH). Although SCOP is
largely based on manual curation, unlike CATH, the curators do use some automatic
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methods e.g. DALI, Pfam, BLAST to check for homology (Andreeva et al., 2014).
As the PDB has grown and more remote evolutionary relationships detected,
the relationships between domain structures, in some fold groups and homologous
superfamilies, have been found to be more complex than previously thought. A
SCOP2 prototype has therefore been developed which still organises protein domains
according to their structural and evolutionary relationships, but instead forms a
network from these relationships rather than a simple hierarchy (Andreeva et al.,
2014).
The Gene3D resource (Lees et al., 2014) adds protein sequences to CATH from
UniProt and ENSEMBL for proteins with no structural data. These sequences are
predicted to belong to CATH domain superfamilies by scanning them against the
HMM libraries built for each superfamily. CATH is expanded many hundreds-fold
by this approach and some of the sequences have experimental characterisation,
which increases the functional information for each CATH superfamily. The latest
version of Gene3D (version 12.0) consists of 25,615,754 CATH version 4.0 protein
domain assignments from > 6000 cellular genes from ENSEMBL and > 20 million
unique protein sequences from UniProtKB. This was a 45% increase in sequence data
compared to the previous release. Pfam and SUPERFAMILY domain annotations
have also been added to the resource in the latest release to expand domain sequence
coverage (Lees et al., 2014).
The SUPERFAMILY resource (Gough et al., 2001; Wilson et al., 2009) is similar
to Gene3D as it uses structural domain classifications to identify domains within
UniProt sequence data, however these classifications are from SCOP rather than
CATH. HMMs based upon the SCOP domain classifications are used to identify
domains and structurally annotate the sequence data. The latest publication of
SUPERFAMILY reported protein domain assignments for > 900 genomes (Wilson
et al., 2009).
By contrast, the Pfam resource (Finn et al., 2014) is a domain family resource in
which evolutionary relationships are captured mainly using sequence data. In Pfam,
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each protein family is represented by two multiple sequence alignments (MSAs) and
a profile HMM for the identification of Pfam domains in new sequences. One of the
MSAs is the seed alignment, i.e. all the protein sequences used to define the family,
which contains a small number of family representative members. The other MSA
contains the full sequence alignment, comprising sequences for all family members.
The sequences for the full alignment are taken from UniProtKB. Curated families
are known as Pfam-A families. There are also automatically generated families to
improve sequence coverage, known as Pfam-B families. As mentioned, Pfam families
have largely been generated using sequence data, however new families added to the
latest release (version 27.0) have been identified by also using structural data in
the PDB and CATH. For example, where a CATH domain does not match a Pfam
family, the CATH domain sequence is used to iteratively search Pfam sequence
database to extract sequences for a new Pfam family seed alignment (Finn et al.,
2014).
Gene3D, SUPERFAMILY, and Pfam are part of the InterPro consortium, which
comprises 11 databases (Hunter et al., 2012). In addition to those described al-
ready, InterPro also contains the protein family resources PANTHER (Mi et al.,
2010), PIRSF (Nikolskayaw et al., 2006), TIGRFAMs (Selengut et al., 2007), and
HAMAP (Lima et al., 2009), and the protein domain family resources PROSITE (Sigrist
et al., 2010), PRINTS (Attwood et al., 2003), ProDom (Bru et al., 2005), and
SMART (Letunic et al., 2009).
These databases provide diverse information about protein families, domains,
functional site data, and conservation data. Each database is manually integrated
into InterPro so that each non-redundant protein family has a combination of mod-
els based upon the different sources. The accuracy of each family is also manually
checked by exploring the functional annotations such as GO terms, family HMMs
or other types of representative model produced, and family names. One can scan
a sequence of interest against all members of InterPro using the online tool or stan-
dalone program, InterProScan (Jones et al., 2014) to obtain domain and functional
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annotations.
1.4 The definition of protein function
It is difficult to define function as it is a term that only makes sense in context.
Furthermore, although a lot of research has been conducted into the function of pro-
teins, the functions of other entities, e.g. non-coding RNA and organelles (Bork et
al., 1998) are generally less well characterised. However, we shall focus on proteins
as these play a large role in defining the functions of phenotypes for a particular
organism. There are numerous areas with which function can be associated, ranging
from biochemical function (e.g. catalytic activity) to biological processes and path-
ways (e.g. metabolic pathways, signal cascades), through to organ and organism
function (e.g. physiology, behaviour). When annotating protein function it is there-
fore possible to describe function at any one of these levels. This can make it hard
to compare function between different proteins as they may be annotated at differ-
ent levels. The terms used can differ between researchers and unless the protein’s
functional annotation, or a close homologue, has been experimentally confirmed it
may be difficult to trust.
For many years, most functional annotations were written as free text in the
public literature and they contained a wide range of terminology and synonyms.
Recent years have seen the improvement of natural language processing and the
extraction of information from the literature, however a much bigger step has been
the creation of standards in defining function (Lee et al., 2007). One of the first
standards was the Enzyme Commission (EC) numbering scheme, which is used to
classify enzyme function (Barrett, 1992). There are many other important resources
that provide standardised functional categories. For example, the Clusters of Or-
thologous Groups of proteins (COGs) (Tatusov et al., 2003); ENZYME (Bairoch,
2000) which, uses EC numbers in its annotations; the manually-curated Swiss-Prot
database (Wu et al., 2006); the Functional Catalogue (FunCat) from the Munich
Information Centre for Protein Sequences (Ruepp et al., 2004); the Kyoto Encyclo-
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pedia of Genes and Genomes (KEGG) (Kanehisa et al., 2014), a biological systems
database that integrates molecular biology with systemic information; and Meta-
Cyc (Caspi et al., 2010), a database of over 900 experimentally-confirmed metabolic
pathways. Controlled vocabularies have also been developed, for example the Gene
Ontology (GO) (Ashburner et al., 2000) schema (described more below), which is a
relatively recent standard that is open source and provides the user with three types
of structured controlled vocabulary with which to annotate protein sequences.
1.5 Protein function data resources
This section describes in more details the different resources used to provide
protein function information. Those resources that focus only on enzyme data will
be discussed in Section 1.5.1.
The GO is the most comprehensive resource providing information on protein
functions. It provides a standardised set of functional terms for annotating protein
sequence data which comprises three functional term ontologies: biological processes
(BP), molecular function (MF), and cellular compartment (CC). The BP ontology
consists of terms that refers to a protein’s biological objective or the pathway or
process that it is involved in. The MF ontology comprises terms related to the
molecular function of the protein and is intended to capture conceptual protein
function categories. One or more ordered assemblies of MF terms can be used to
describe a biological process. The CC ontology consists of terms related to the
cellular location of the protein when it is performing its function (Ashburner et al.,
2000). GO terms in these ontologies are connected as nodes in a directed acyclic
graph where one term can have a relationship with one or more other terms. This
allows the ontology networks to be easily updated as more information is gathered.
It also means that the ontology networks can be flexible in reflecting the different
ways in which different organisms perform a given function, for example the nucleus
is re-arranged in different ways by different organisms during mitosis (Ashburner et
al., 2000).
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GO categories have been linked to sequence data in numerous resources to pro-
vide standardised protein function annotations. These resources include: CATH,
SCOP, Pfam, ENZYME, FunCat, and SwissProt (Ashburner et al., 2000).
The SwissProt resource represents the reviewed section of UniProtKB which
contains manually annotated protein entries. Information is extracted from the
literature and computational analysis, and the curators aim to annotate protein
family representatives across a diverse range of taxonomic groups. While there are
many data extracted from the literature, those related to function include: the
protein function, catalytic activity, pathway information, and functional site residue
data (The UniProt Consortium, 2014).
The FunCat database (Ruepp et al., 2004) is a hierarchically structured clas-
sification and also uses its own controlled vocabulary. It was first developed to
describe the biology of yeast but has since been extended to the plant Arabidopsis,
prokaryotes, and animals. Functional classification is based on seven main cate-
gories: metabolism, information pathways, transport, perception and response to
stimuli, developmental processes, localisation, and experimentally uncharacterised
proteins (Ruepp et al., 2004).
1.5.1 Enzyme function data resources
There are thousands of different enzyme functions, which are typically classified
using their chemical reaction information through the hierarchical Enzyme Com-
mission (EC) numbering system (Barrett, 1992).
EC numbers are manually assigned to enzymes using published experimental
data by the Joint Commission on Biochemical Nomenclature (JCBN) of the Interna-
tional Union of Biochemistry and Molecular Biology (IUBMB) and the International
Union of Pure and Applied Chemistry (IUPAC) (Kotera et al., 2004). There are
four (numbered) hierarchical levels to an EC number: the first level represents the
class of the catalysed reaction, which comprises six categories (see Table 1.1); the
second level (the sub-class) represents the bonds the reaction acts on; the third level
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(the subsub-class) represents the chemical functional group acted on; the fourth
and final level represents the substrate for the enzyme-catalysed reaction. There
are currently 5445 active EC entries (09-Jul-14 release) in the ExPASy ENZYME
database (Bairoch, 2000).
EC Class
Number
Name Description
EC 1 Oxidoreductases Enzymes that catalyse the transfer of elec-
trons from one molecule (the reductant, or
the electron donor) to another molecule
(the oxidant, or the electron acceptor)
EC 2 Transferases Enzymes that transfer a functional group
from one compound (the donor) to an-
other (the acceptor)
EC 3 Hydrolases Enzymes that catalyse the hydrolysis of
various bonds
EC 4 Lyases Enzymes that cleave bonds in ways other
than hydrolysis or oxidation. Two sub-
strates are usually involved in one reaction
direction, however only one in the other
direction
EC 5 Isomerases Enzymes that catalyse the conversion of
one isomer to another
EC 6 Ligases Enzymes that catalyse the joining of two
molecules through the formation of a new
chemical bond
Table 1.1: Description of each Enzyme Commission (EC) class (Barrett, 1992).
Enzyme-related data are also available from a number of online database re-
sources. For example, the BRaunschweig ENzyme DAtabase (BRENDA) enzyme
portal (Schomburg et al., 2013) contains functional biochemical and molecular en-
zyme data and currently consists of 2.7 million semi-curated entries detailing enzyme
occurrence, function, kinetics, and molecular properties (Schomburg et al., 2013).
BRENDA is a large resource that also includes enzyme-related information from
automatic text mining and from analysing relationships between EC number and
disease.
The KEGG ENZYME database (Kanehisa et al., 2014) is based upon the Ex-
plorEnz database (McDonald et al., 2009), which uses the IUBMB EC nomenclature
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to define enzyme function.
The integrated relational enzyme database, IntEnz (Fleischmann et al., 2004) is
the official version of the Enzyme Nomenclature and contains the most recent version
of the EC number list, decided by the Nomenclature Committee of the IUBMB. The
aim of this database is to create a single relational enzyme database linking three
data sources: 1) the Enzyme (EC) List; 2) the Enzyme Nomenclature database,
ENZYME; and 3) the enzyme function database, BRENDA.
1.5.1.1 Reaction mechanism data
The Mechanism, Annotation and Classification in Enzymes (MACiE) database (Hol-
liday et al., 2011) consists of entries describing enzyme reaction mechanisms and
contains information on similarity of reaction pairs. Each reaction mechanism en-
try includes the chemical reaction diagram, a walk-through of each reaction step,
and the catalytic residues involved. In the comparison of reaction mechanisms, the
similarity of a reaction pair depends on the similarity of the reaction steps in each
mechanism (O’Boyle et al., 2007).
There is a tool available in MACiE for the comparison of reaction mechanism
entries, which calculates the similarity of reaction mechanisms for enzyme A and
B using a similarity score calculated using the Tanimoto coefficient (Equation 1.1).
Reaction information is stored in bitmaps, where each bit represents a modelled
characteristic. In an enzyme object a characteristic can either be present, i.e. 1,
or not present, i.e. 0. The variable c represents the total number of common bits
between A and B that have a value of one. The variables a and b represent the total
number of bits that have a value of one in each A and B, respectively. This method is
used to calculate similarity in catalytic machinery and reaction mechanism (O’Boyle
et al., 2007).
T (A,B) =
c
a+ b− c (1.1)
SABIO-RK (Wittig et al., 2012) is a manually-curated database that takes in-
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formation from the literature, storing standardised biochemical information and
corresponding kinetic properties. It is a quantitative reaction-orientated source of
information, which includes rate equations, kinetic parameters, and the experimen-
tal and environmental conditions used to calculate the kinetics.
The KEGG REACTION resource contains all reactions from KEGG ENZYME
and additional reactions from the metabolic pathways in KEGG PATHWAY (Kane-
hisa et al., 2014) (see below for more details on this).
1.5.1.2 Metabolic pathway data
The Reactome resource is an open-source database that focusses on human biological
metabolic pathways. Croft et al. (2014) reported functional information for 7088
human proteins (34% of the predicted human proteome) which take part in 6744
reactions and 1481 metabolic pathways.
The MetaCyc database (Caspi et al., 2010) contains experimentally determined
metabolic pathways that are curated from the literature, and enzyme data. There
are more than 1800 pathways from more than 30,000 publications, which make it
the largest collection of metabolic pathways available to date.
KEGG PATHWAY contains interactive maps of manually-drawn pathways that
contain information on molecular interactions and chemical reactions. There are
hundreds of pathways, which are grouped into seven main categories: metabolism,
genetic information processing, environmental information processing, cellular pro-
cesses, organismal systems, human diseases, and drug development. Each node in a
pathway represents a set of orthologues (KEGG Orthologues, KOs) performing the
same function. Organism-specific metabolic pathway maps have been generated as
well as general overviews for all organisms (Kanehisa et al., 2014).
1.5.1.3 Catalytic residue data
The Catalytic Site Atlas (CSA) (Porter et al., 2004; Furnham et al., 2014) is a re-
source providing catalytic residue annotation for enzymes in the PDB. There are two
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types of data: a manually-curated set of entries taken from enzymes described in the
scientific literature, and an automatically generated data set of catalytic residues
mapped onto homologous structures of the manual entries. Homologues to the man-
ual entries are identified in the PDB and SwissProt using SSEARCH36 (Sierk, 2004)
using a strict statistical significant threshold, E-value, of 1x10−06. In the latest ver-
sion of the CSA there are 968 manually-curated entries/structures, covering ∼ 30%
of the PDB, and 32,216 structures annotated using homology information (Furnham
et al., 2014).
1.6 The evolution of protein functions
1.6.1 Selective evolutionary pressures shaping the evolution
of function
The duplication of genetic material provides the necessary material for sculpting
additional and/or novel functions. For example, whole-genome duplication (poly-
ploidisation) provides duplicate chromosomes, duplicate genes and duplicate regu-
latory regions driving gene expression (Force et al., 1999). The first model of how
products of gene duplication are used in protein function evolution was proposed
by Ohno (1970). Based on the fact that gene duplication provided extra, redun-
dant copies of genes, Ohno founded the classical function evolution model. The
model hypothesises that, whilst one copy of the gene is under selective constraints
to maintain the original function, the other copy of the gene is shielded by the first
and is therefore free to evolve a novel function through amino acid mutations. This
accumulation of mutations would either result in a non-functional pseudo-gene (non-
functionalisation), due to the accumulation of deleterious mutations, or it would lead
to the evolution of a novel function (neo-functionalisation), due to the accumulation
of beneficial mutations (Ohno, 1970).
Lynch et al. (1998) found that deleterious mutations are more common than
beneficial mutations and so the classical model predicts that it is more likely for
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the gene copy to become a pseudo-gene. Force et al. (1999) later proposed a new
model that proposed the function of duplicated genes would be preserved rather
than lost. This model suggested that chromosomes and genes were preserved, i.e.
kept functional, through subfunctionalisation. For example, if different genes on
two duplicate chromosomes became functionally inactive (e.g. through gene inac-
tivation, or loss of regulatory elements), for the organism to remain viable the two
chromosomes must between them retain functional copies of all the genes found in
the ancestral chromosome. In two duplicated genes where different regulatory ele-
ments are inactivated in each copy, it was proposed that the two genes had to be
expressed at the same time to maintain the ancestral function and remain viable.
The model therefore proposes subfunctionalisation as the process whereby duplicate
genetic copies have each lost some functional aspect of the ancestral locus, however
the function provided by the ancestral locus is still required and so both copies must
work together to maintain this function (Force et al., 1999).
While these phenomena have been frequently studied at the whole protein level
in the past, such studies can mask the effects of mutations at the domain-level (Kha-
ladkar and Hannenhalli, 2012). For example, it may be that a single, small domain
within a multi-domain protein is evolving at a faster rate (asymmetric evolution) to
the other domains, however the signal is lost within the signal-to-noise ratio. In cases
of subfunctionalisation where two copies of the gene have domains that are evolving
at different rates, these signals of varying evolutionary rates could cancel each other
out at the whole-protein level. Therefore, studying the evolutionary rates of each
domain allows a more accurate analysis and biological interpretation (Khaladkar
and Hannenhalli, 2012).
Khaladkar and Hannenhalli (2012) demonstrated this with their large-scale study
on duplicate genes in five teleost fishes. They found that previously observed asym-
metry of overall protein evolution is mainly a result of the divergence of specific
protein domains, reflecting the importance of studying evolutionary mutations at
the domain level. Positive selection has also been found to contribute to the diver-
CHAPTER 1. INTRODUCTION 36
gence of function within duplicated genes. This is where the rate of non-synonymous
mutations is greater than the rate of synonymous mutations. A number of studies
(Zhang et al., 1998; Duda and Palumbi, 1999; Hughes et al., 2000) showed that non-
synonymous amino acid mutations, i.e. mutations at the DNA level that lead to a
change in amino acid, are favoured and therefore get fixed at a faster evolutionary
rate than synonymous mutations, i.e. mutations at the DNA level that do not cause
a change in amino acids.
Ohno’s model assumption that the newly duplicated copy of the gene is not
under selective pressure has been a subject of much discussion as duplication is
not observed to be a frequent event (Khersonsky and Tawfik, 2010). Due to the
extra, duplicated, copies of messenger RNA (mRNA) and protein being transcribed
and translated, there is extra stress on the cell to produce more energy, which has
been shown to induce selective pressure to inactivate these extra copies (Cooper
and Lenski, 2000; Dekel and Alon, 2005; Wagner, 2005; Stoebel et al., 2008). Gene
duplication is however, frequently observed to be a positively-selected event when
there are demands for higher amounts of a given protein (McLoughlin and Ollis,
2004; Bergthorsson et al., 2007).
Studies have found that over one-third of the random mutations in a protein
are deleterious (Bershtein et al., 2006; Camps et al., 2007; Tokuriki et al., 2007)
and only ∼ 10−03 of random mutations are thought to be beneficial (Khersonsky
and Tawfik, 2010). In the cases where the duplicated copy is drifting without any
selective pressures, it is orders of magnitude more likely to lose all functionality
due to mutations affecting the protein folding and stability (non-functionalisation)
rather than acquire new functionality (neo-functionalisation) (Bershtein and Tawfik,
2008). This is due to mutations typically affecting the folding and the stability of
the protein (Yue et al., 2005; Tokuriki and Tawfik, 2009).
Khersonsky and Tawfik (2010) therefore offer a number of revisions to Ohno’s
model, including: 1) a gene sharing model, where one gene is recruited for a different,
moonlighting function without any changes in the DNA; 2) new protein functions
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evolve through promiscuous intermediates without the need for prior gene dupli-
cation, gene duplication then allows the different functions of the intermediates to
be optimised (Glasner et al., 2006); 3) gene duplication undergoes positive selective
pressures, increasing functional variability as the secondary functions of promiscu-
ous proteins are selected for when present in high doses (Khersonsky and Tawfik,
2010).
1.7 The prediction of protein function
With the ever-increasing number of new sequences being determined from ex-
perimental efforts such as high-throughput next-generation sequence methods, it
is physically impossible to perform all of the experiments needed to determine the
functionality of each sequence. It is estimated that only ∼ 1%, 7%, 10%, and 20% of
proteins have been experimentally characterised in the model organisms Caenorhab-
ditis elegans, Mus musculus, Drosophila melanogaster, and Homo sapiens (Lee et al.,
2007) and computational methods are constantly being developed and improved to
automatically predict enzyme function. In general, it is hard to predict protein func-
tion due to five main reasons: 1) as mentioned already, function can be defined from
different perspectives and at a range of levels, for example the biochemical events a
protein is involved in, or the role of an enzyme in a pathway; 2) a protein’s function
and its experimental characterisation are context-dependent, therefore there may
not be experimental information for all possible conditions; 3) proteins are often
multifunctional and promiscuous; 4) experimental functional annotations are error-
prone due to experimental misinterpretation and curation issues; and 5) protein
function is currently mapped to gene names, however this is confusing for potential
isoforms of those genes that have different functionality (Radivojac et al., 2013).
A protein’s function is encoded by its amino acid sequence and is dependent on
other factors such as post-translational modifications. Computational methods have
therefore been developed to predict protein function and thereby guide experimental
validation. This can greatly reduce the cost of experimental validation. Over the
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past couple of decades numerous methods have been written to predict protein
function using protein sequence and protein structure information.
1.7.1 Sequence-based methods for protein function predic-
tion
The most common methods used for predicting function from sequence exploit a
sequence’s accession code or text-based searches, related to the gene name for exam-
ple, or sequence-sequence comparison algorithms to match known sequences stored
in a database. Resources for such searches are provided by the National Center
for Biotechnology Information (NCBI) in the USA and by the European Molecular
Biology Laboratory-European Bioinformatics Institute (EMBL-EBI). If searching
for a protein accession code or a gene name, for example, does not obtain a result,
the query sequence can be submitted to the Basic Local Alignment Search Tool
(BLAST) (Altschul et al., 1990). This tool matches a DNA or protein sequence to
a homologous sequence, where possible, in a chosen biological database (Altschul
et al., 1990). Many of the tools available from the NCBI or EMBL-EBI have been
integrated to allow the user to combine multiple tools in the same search. InterPro
(Hunter et al., 2009) from the EMBL-EBI is one such example (discussed in more
detail in Section 1.3).
A threshold is applied to all of these sequence-matching methods for confidence
purposes. For example, various studies have shown that a suitable threshold is
40% pairwise sequence identity when inheriting the first three digits of an EC num-
ber. More than 60% sequence identity is required to inherit all four digits (Rost,
2002; Addou et al., 2009).
The GOtcha method (Martin et al., 2004) uses BLAST and the Gene Ontology
(GO) to predict the function of an unknown gene sequence. GOtcha first compares
a query sequence against seven well-annotated genomes using BLAST. The GO
terms associated with the gene sequences most similar to the query are retrieved.
The method then calculates the probability of each GO term (and their ancestral
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terms) being associated with the unknown sequence. A single probability value is
provided for each GO term, allowing the user to easily assess whether that functional
term could be valid. This approach is valuable as methods such as BLAST provide
multiple outputs that must all be assessed before a match can be assigned.
The Protein Function Prediction (PFP) method (Hawkins et al., 2009) also uses
a sequence-based approach to predict GO functional terms but the method is based
upon the results of Position Specific Iterative (PSI)-BLAST searches rather than
BLAST. PSI-BLAST (Altschul et al., 1997) is a profile-based method that constructs
a profile from an initial BLASTp search and then uses that profile to iteratively
search for increasingly distant homologues. For each sequence that is hit by PSI-
BLAST, its associated GO terms are each scored according to their expectation value
(E-value) (see Equation 1.2). The E-value (E) represents the number of different
sequence alignments, with a score of at least S, that are expected to be found by
chance.
E = Kmn e−λS (1.2)
Where m and n represent the lengths of two random sequences, S represents the
maximal segment pair score (i.e. the segment of the two sequences that provides
the highest similarity score) > S, and K and λ are two parameters used in the
evaluation of the E-value. The GO terms associated with each PSI-BLAST sequence
hit are each scored according to 1) how often a particular GO term is associated
with retrieved hits that are similar in sequence and 2) the sequence identity of the
sequences in 1) with the query (Hawkins et al., 2009).
One key feature of PFP is that it retrieves functional information from highly
divergent sequences hits returned by PSI-BLAST, i.e. those hits with high E-values
(up to 125) that are not considered statistically significant. Such high E-values
however mean that there will be high levels of error, i.e. false positives. Hawkins
et al. (2009) showed that using sequence hits with an E-value > 1, their benchmark
sequence coverage using PFP was double that of the top PSI-BLAST annotations.
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Pairwise methods like BLAST are still very popular as they are the simplest
type of method. However more sensitive profile/pattern-based methods, for example
PROSITE (Sigrist et al., 2002) and PRINTS (Attwood, 2002) are also used to detect
homologues with similar functions.
A more powerful type of profile is the hidden Markov model (HMM), which
is better able to handle residue insertions/deletions (indels) between homologues.
While sequence profiles only report the amino acid frequency at each alignment
position, HMMs also report the probabilities for insertions and deletions. HMMs
also have a higher sensitivity than sequence profiles as they heavily penalise sequence
hits that are matched by chance, in comparison to true positives that frequently have
insertions and deletions at the same alignment positions (So¨ding, 2005).
These are usually constructed from an MSA of homologues sharing similar func-
tions. For example, the widely used Pfam database provides a library of HMM mod-
els for each family. However not all families are functionally coherent (Lee et al.,
2007). InterPro, which has been described previously in Section 1.3, combines func-
tion predictions from PROSITE, PRINTS, Pfam, and eight other resources (Hunter
et al., 2012).
However, it is not always possible to predict function from a protein sequence
because a match in a database may not exist, or the sequence may exist but it may
have no function assigned and simply be described as a ‘hypothetical protein’. An-
other disadvantage of this sequence-based approach is the difficulty in distinguishing
between residues that are structurally conserved and those that are functionally con-
served (Sadowski and Jones, 2009). For example, the patterns of conserved residues
captured by the profile may represent positions important for structural stability or
packing, rather than function.
1.7.1.1 Subclassification of protein domain superfamilies
Homologous superfamilies can sometimes be large and functionally diverse. For ex-
ample, less than 100 (< 4%) superfamilies in CATH are very diverse in sequence,
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structure, and function. These superfamilies also account for a disproportionate
number of domain sequences as they contain more than 40% of domains in CATH
(Dessailly et al., 2009; Cuff et al., 2011). These superfamilies comprise two or more
different EC terms, and up to > 100 different EC terms in some superfamilies (Sil-
litoe et al., 2013). To understand the divergence of function across a superfamily,
a superfamily can be clustered into subfamilies, whereby each subfamily contains
sequences that code for a similar function. As each member of a subfamily has the
same functional properties, the key functional residues should be highly conserved
throughout the subfamily members. By comparing different subfamilies it is possible
to observe how these conserved, key functional residue change in order to provide
different functionalities. For example, the GeMMA protocol (Lee et al., 2010) clus-
ters sequences in a superfamily into families of functionally coherent relatives, or
FunFams, using a hierarchical agglomerative clustering method. This method is
discussed further in Section 2.2.1, page 59.
Abhiman and Sonnhammer (2005a) carried out a large-scale prediction of func-
tional shift in enzyme protein families and benchmarked their methods against
experimentally-annotated data. This was the first study benchmarked on such a
large scale. Enzyme families taken from the Pfam database (Sonnhammer et al.,
1997) were divided into subfamilies using Bayesian Evolutionary Tree Estimation
(BETE) (Sjo¨lander, 1998) and a change in function was identified using two types
of site: Conservation-Shift Sites (CSS), where a sequence position in an MSA is
completely conserved, however the two subfamilies each have a different amino acid
type; and Rate-Shifting Sites (RSS), where the amino acid residues in the different
subfamilies are evolving at different rates. The definition of a change in function in
this analysis was a change in EC number (Abhiman and Sonnhammer, 2005a).
Subfamily Classification In PHYlogenomics uses an algorithm (SCI-PHY) (Brown
et al., 2007) to automatically detect and create subfamilies using functional and evo-
lutionary information. While GeMMA defines a tree of sequence-similarity based
clusters which is then cut into subfamilies, SCI-PHY builds a hierarchical tree using
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sequence information as well as Dirichlet mixture densities and relative entropy mea-
sures. Dirichlet mixture densities are used here to construct subfamily profiles. The
relative entropy measure is used to calculate distances between subfamilies, which
are used to build the tree. HMMs are then derived from the subfamily sequences.
Capra and Singh (2008) developed the method, GroupSim to subclassify a set
of homologous proteins using specificity determining positions (SDPs). SDPs are
alignment positions that determine a subfamily’s functional specificity and they are
therefore used to aid protein function prediction. SDPs allow one to understand the
mechanism of functional diversity within a superfamily and also enable the assign-
ment of specific functions to uncharacterised proteins. To predict SDPs between
subfamilies/specificity groups, GroupSim first compares all pairs of aligned residues
within and between the subfamilies, where all subfamilies are aligned in one MSA.
The average physicochemical similarity of all residue pairs in a group is calculated
for each subfamily in the alignment. The method rewards alignment positions where
a single amino acid residue is conserved in one subfamily but where a different amino
acid is conserved in the other subfamilies, or where it is not conserved in another
subfamily. Such positions are predicted to be SDPs (Capra and Singh, 2008).
1.7.2 Structure-based methods
If there is no detectable sequence similarity to a protein with known function,
structure-based methods can be used to find a functional analogue, e.g. using active
site and/or catalytic residue information. If this is not possible, one can look for
structural features such as pockets on the surface of the protein that are likely to
be active sites. Methods using these techniques are discussed below.
Firstly, as with pairwise sequence comparison, the simplest approach to predict
function from structure is to perform a pairwise structural comparison.
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1.7.2.1 Protein structure comparisons
If two proteins show very high structural similarity along their entire amino-acid
sequence, it is likely that they have the same or a very similar function (Lee et al.,
2007).
There are several publicly-available methods which perform fast pairwise com-
parisons of secondary structure elements. For example, GRATH (Harrison et al.,
2003), which uses graph theory to match a query structure to a structure in the PDB,
and the Secondary Structure Matching (SSM) method (Krissinel and Henrick, 2004)
provided by the PDB. However to obtain an accurate structural alignment, all of the
residues need to be considered. This also means that the methods need to cope with
insertions and deletions (i.e. indels) and various strategies have been developed for
doing this. For example, the STAMP (Structural Alignment of Multiple Proteins)
method (Russell and Barton, 1992) aligns two structures using dynamic program-
ming, as does the STRUCTAL method (Subbiah et al., 1993), and the Combinatorial
Extension (CE) algorithm (Shindyalov and Bourne, 1998). The Sequential Structure
Alignment Program (SSAP) (Taylor and Orengo, 1989; Orengo and Taylor, 1996)
and CATHEDRAL (Greene et al., 2007) use double dynamic programming. Since
SSAP is used in several analyses described in this thesis, the outline of the method
will be given in more detail below.
SSAP uses Needleman-Wunsch dynamic programming algorithms, which have
otherwise been used for sequence alignment. Two levels of dynamic programming
are used. For each structure in a pairwise comparison, a set of vectors connecting
a particular β-carbon atom in a protein structure to all other β-carbon atoms is
described. Then, these vectors are compared for each pair of potentially equivalent
residues between the two proteins, for example, the pairs of residues that have
similar φ and ψ torsion angles, and accessible areas. The first level of dynamic
programming is used at this stage to find the best alignment of the vector sets of
these potentially equivalent pairs of residues. It uses a 2D residue level score matrix
to score the similarity of each residue pair and determines the best path through
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the matrix using dynamic programming. For those pairs of residues with a path
score greater than a threshold, the scores from the optimal path are added to a
2D summary score matrix. All potentially equivalent residue pairs are compared in
this manner and then the second level of dynamic programming is used to find the
best path through the 2D summary score matrix. This defines the aligned residues
between the proteins (Sillitoe and Orengo, 2002).
By contrast with the other residue-based methods above, the DALI method (Holm
and Sander, 1993) uses simulated annealing to handle indels. A two-stage approach
is used to build an alignment of similar hexapeptide backbone fragments between
two protein structures (Koehl, 2006).
When assessing the outcome of these methods, i.e. the significance of the simi-
larity between two structures, the quality of the superposition, and the number of
residues in the alignment are required. The Root Mean Square Deviation (RMSD)
is used as a measure of the superposition quality. It measures the average distance
between the alpha-carbons in superposed proteins (see definition in Equation 1.3,
from Rao and Rossmann (1973) and Maiorov and Crippen (1994)).
D2dis(A,B) = (n(n− 1)/2)−1
n∑
i<j
(dAij − dBij)2 (1.3)
dAij and dBij represent the corresponding distances between the ith atom and
the jth atom.
Whilst studies have suggested a correlation between structural and functional
similarity (e.g. Redfern et al. (2008)), there are no clear thresholds on RMSD be-
tween superposed structures to confirm functional similarity between a pair of pro-
teins. However, when aligning proteins using the SSAP method, a score of 85 out
of 100 is usually associated with similarity in function.
Similarly, although classifying a protein by its structural fold can suggest a func-
tional annotation, there are a number of folds that are highly functionally divergent
(Martin et al., 1998). Furthermore, as mentioned already, many domains in the
CATH database belong to functionally diverse superfamilies. For example, < 4% of
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superfamilies account for > 40% of all domains in CATH and these large superfam-
ilies are very divergent in structure and function (Dessailly et al., 2009).
In the TIM barrel fold, there are 28 different CATH homologous superfamilies,
where the fold supports a different function in each (Lee et al., 2007). Whilst
some approaches take into account the functional clues from a protein’s overall
fold, additional methods that also investigate local structural features are required
(discussed below).
1.7.2.2 Surface structural features
The surface of a protein can provide a number of functional clues, arising from
the location and size of clefts and pockets. Cofactors, substrates and regulatory
elements can bind in surface clefts and most enzymes have their active site in one
of the two largest clefts (Laskowski et al., 1996). There are also cases where several
clefts are involved in binding interactions, for example in homodimer protein-protein
interactions (Laskowski et al., 1996). Laskowski et al. (1996) found that in over 83%
single-chain enzymes, the ligand binds in the largest cleft and that this cleft is usually
much bigger than the others. This makes it relatively easy to identify possible active
sites simply by searching the surface for large clefts. When there is no large cleft
visible however, bound ligands are used to pinpoint the active site.
It is possible to annotate unknown proteins by comparing these clefts against a
library of known active sites. For example, one resource is the electrostatic surface
of functional site (eF-Site) database (Kinoshita and Nakamura, 2004). This resource
contains electrostatic-potential surface information, which can be compared to an
unknown protein model to identify similar regions of charge that are used in binding
and interactions.
Electrostatic potential maps on a protein surface are also used to identify DNA-
binding regions. As DNA is negatively-charged, the protein surfaces that binds the
molecule tend to be the most positively charged on the structure. There are a limited
number of structural motifs that are used to bind DNA, with the helix-turn-helix
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(HTH) motif being the most popular. As many proteins that do not bind DNA also
contain this motif, methods such as eF-Site are used to find true positives (Kinoshita
and Nakamura, 2004).
Another example is the pvSOAR (pocket and void Surface of Amino Acid Residues)
resource, which compares the protein surfaces of geometrically defined pockets and
voids (Binkowski et al., 2005)
1.7.2.3 Using local 3D template methods
Certain proteins, particularly enzymes, have a small number of residues in a lo-
calised 3D area that are key to the function. For example, an enzyme’s catalytic
function is determined by the catalytic residues in its active site. For DNA-binding
proteins, there will be a number of residues on the surface that are required for
the specificity of binding to DNA. Such examples of highly-conserved conformations
can be transformed into 3D residue templates. 3D templates can be constructed
manually through expert knowledge, literature searches, or they can be generated
automatically through sequence comparisons and structural comparisons (Watson
et al., 2005). This type of method can be useful in finding the small changes in
a binding or active site that cause functional alterations, which might be missed
through a global structure-matching method (Lee et al., 2007).
Other template methods ask the user to define residue patterns to search for.
For example, the ASSAM (Spriggs et al., 2003) and the RIGOR/SPASM programs
(Kleywegt, 1999), and the MSDsite database (Golovin et al., 2005), now known as
PDBeMotif, which all run user-defined pattern queries against the PDB (Watson et
al., 2005).
Structural templates have also been created from identified catalytic residues in
the CSA, which are compared to structures of unknown function to potentially infer
an EC number annotation (Porter et al., 2004). The same group later created a
library of structural templates based on the active site areas of non-redundant CSA
families (Torrance et al., 2005). This library was then used to see how catalytic
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sites vary within families having the same enzyme classification. A representative
template was chosen for each family and each family member was superimposed
with the representative template. The degree of difference between this pair was
calculated by RMSD. Sequence identity between the pair was also used to quantify
evolutionary divergence. Catalytic site structure was found to be highly conserved,
even where sequence identity was very low. This is thought to be due to the high
functional constraints placed upon the catalytic residues, which need to be in an
optimal position to be most effective during catalysis (Torrance et al., 2005).
The Comparison of Protein Active Site Structures (CPASS) database (Powers et
al., 2006) stores experimentally-identified ligand-binding sites within PDB structures
to infer active site residues, biological function and to aid drug discovery. CPASS
took the 34,000 protein structures (derived from X-ray crystallography and NMR) in
the PDB in 2006 and stored only protein structures with a ligand bound. The CPASS
program compares any set of ligand-defined active sites and assesses the sequence
and structural similarity, where the sequence does not have to be continuous (Powers
et al., 2006).
1.7.2.4 Using a combination of sequence- and structure-based methods
Although it can be helpful to exploit structural information in the identification of
protein functions, the quality of the structure and the possibility of artifacts needs
to be kept in mind. If non-cognate ligands are used to stabilise the structure for
crystallisation, this could cause a conformational change in the structure, changing
the native structure. In general it is recommended to use multiple approaches to
increase confidence.
Obtaining predictions from multiple sources will increase the likelihood of getting
the correct function prediction for a query protein. The ProFunc (Laskowski et al.,
2005) and ProKnow (Pal and Eisenberg, 2005) servers combine multiple methods and
some of the data sources described above. ProFunc uses BLAST and HMM searches
with fold matching, residue template-based, surface-cleft analysis, and sequence
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similarity scans. ProKnow performs similar analysis and also uses a probability
model to assign GO annotations to the query protein. It also extracts features from
the query structure including fold, sequence motifs and structural motifs (Pal and
Eisenberg, 2005).
1.7.3 Assessment of protein function prediction
The simplest method for validating protein function prediction methods in enzyme
superfamilies is to use EC annotations. One can determine whether the prediction
method has annotated each sequence in a superfamily with the correct EC term,
using the four hierarchical levels in the EC classification.
Another method of validating protein function prediction is to use the Struc-
ture Function Linkage Database (SFLD) (Akiva et al., 2014; Pegg et al., 2006).
There are nine manually-curated functionally diverse superfamilies in the SFLD
that are referred to as a ‘gold standard dataset’, and which have been used to val-
idate a number of function prediction methods. Gold standard families consist of
either experimentally determined functions or sequences that have a high sequence
similarity using BLAST with E-values < 1x10−175 to experimentally characterise
sequences (Pegg et al., 2006). Superfamily members are clustered into subgroups
based upon sequence similarity information. These subgroups are then further clus-
tered in families, which represent enzymes that catalyse the same reaction using a
shared reaction step (Akiva et al., 2014).
A recent community-based protein function validation effort is COMputational
BRidges to EXperiments (COMBREX), based in the USA (Anton et al., 2013).
Its main aim is to provide a traceable link between protein function predictions
made in silico and experiments that validate the protein function. First protein
function predictions are prioritised according to how confident the predictions are
and how many other homologous proteins could be annotated if this protein was
experimentally characterised. The enterprise then funds the experiments needed to
test the function of the top-ranked predictions. The COMBREX database comprises
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approximately 3.3 million proteins from > 1000 complete microbial genome projects
that are associated with approximately 2.5 million function predictions. In the
first year of the project, 140 proteins were tested experimentally. This number
may seem low but a sequence search of these 140 proteins with BLAST and an
E-value 6 1x10−05 reports sequence similarity to over 60,000 proteins, for which
the characterisation could be of use. The 140 proteins also map to 8 domains of
unknown function (DUFs) in Pfam (Anton et al., 2013).
The first large-scale community assessment of protein function annotation (CAFA)
experiment took place in 2011 and highlighted the issues involved in annotation (Radi-
vojac et al., 2013). Fifty-four methods from across the world were submitted, where
each method predicted the protein function of 48,298 target protein sequences from
7 eukaryotic and 11 prokaryotic organisms. As protein function can be described in
many ways, the classification schemes from the Gene Ontology (GO) Consortium
(Ashburner et al., 2000) were used, which provide a controlled vocabulary to anno-
tate protein function related to: 1) biological process, 2) cellular component, and 3)
molecular function.
The methods submitted to the CAFA experiment used a mixture of biological
and computational concepts. The majority of methods used sequence alignment
information, protein structure, protein-protein interactions or gene expression data.
Many methods used machine learning techniques to combine this information and
a few methods used literature mining (Radivojac et al., 2013).
The accuracy of each method was assessed using the maximum F-measure score
(Fmax), which considers the precision and the recall to calculate the score. The
precision (pr) value is the proportion of the positive predictions that are true pos-
itives, as opposed to false positives (see Equation 1.4). The recall (rc) value is the
proportion of positive predictions that are correctly identified (see Equation 1.5).
The Fmax score ranges from zero to one, with one being the best score and zero the
worst (see Equation 1.6, taken from (Radivojac et al., 2013)). Fmax was assessed
using a number of different chosen thresholds, represented by t.
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pr =
TP
TP + FP
(1.4)
rc =
TP
TP + FN
(1.5)
Fmax = max(t)
{
2 · pr(t) · rc(t)
pr(t) + rc(t)
}
(1.6)
All methods were compared against two baseline methods; Basic Local Align-
ment Search Tool (BLAST) hits (Altschul et al., 1997) and a naive method, where
each GO term for each sequence target was scored according to the GO term’s
abundance in the SwissProt database. All methods were also evaluated against
PSI-BLAST predictions, however PSI-BLAST performed no better than BLAST
and so only BLAST was reported. When predicting protein functions in the GO
category of Molecular Function, the Fmax for both BLAST and PSI-BLAST was
0.38. For protein function prediction in the GO category of Biological Process, PSI-
BLAST reached a Fmax score of 0.24 and BLAST a score of 0.26. A total of 26
models performed better than BLAST when predicting function in the Biological
Process category, whereas 33 models performed better than BLAST in the Molecular
Function category.
The ten methods that performed the best overall in the Molecular Function
and the Biological Process ontology categories included the use of: gene expression
data, machine learning techniques, and sequence homology information. The DFX
method, used to generate functional families in CATH, came 7th out of the 56 groups
that took part and was the best domain-based method (see Figure 1.3). The top
method by the Jones group at UCL in both ontology categories combined predictions
based on homology, sequence composition, and gene expression data (Radivojac et
al., 2013).
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Figure 1.3: Plot to the top performing protein function prediction methods in the
first CAFA experiment. Taken from Radivojac et al. (2013).
1.7.4 Outline of thesis
The first work chapter in this thesis explores the extent to which different relatives in
functionally diverse protein domain superfamilies exploit different functional sites.
This was done by examining all known information on functional sites contained
in the CSA and IBIS resources. Subsequently, functional sites, identified in CATH
functional families, were compared to explore whether there was any preference for
different families to use a common functional site.
The second work chapter examines how catalytic machinery can change within
enzyme domain superfamilies. A protocol has been developed to compare catalytic
residues between functional families and score their similarity in physicochemical
properties. Reaction mechanism information has also been used to examine whether
a change in the mechanism can be associated with a change in catalytic machinery.
The third and final work chapter discusses the processing and characterisation
of metagenome data. The CATH functional families have been used to characterise
and compare the functional capabilities of bacteria in the oral and gut metagenome
data.
Chapter 2
Identification and Characterisation of Func-
tional Diversity in Protein Domain Super-
families
2.1 Introduction
2.1.1 Identifying functional site residues
There are a number of manually curated resources providing information on func-
tionally important residues in proteins. For example, the Catalytic Site Atlas (CSA)
and the NCBI Inferred Biomolecular Interactions Server (IBIS). These resources re-
port experimentally determined key functional residues involved in catalytic reac-
tions and interaction binding interfaces, respectively. However not all known protein
sequences have experimentally determined functional residue annotations. A num-
ber of algorithms have therefore been established to predict functional residues.
Detecting functional residues within a superfamily is a difficult task. Many ap-
proaches aim to identify conserved residue sites in a multiple sequence alignment on
the assumption that functionally important sites are likely to be conserved. How-
ever, the multiple sequence alignment (MSA) that one uses to detect these residues
must contain relatives that are functionally similar. Some superfamilies however
contain a large numbers of relatives that are structurally and functionally diverse.
In these cases, subclassification into functional subfamilies can be performed to pro-
duce good quality sequence alignments.
However, the majority (∼ 96%) of superfamilies in the CATH database are small
and since their members often carry out the same general biological function, the
amino acid residues responsible for carrying out this function are expected to be
conserved throughout evolution, i.e. they are conserved across all sequences in a
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superfamily alignment. For example, the members of the serine protease superfamily
are well known for the preservation of their catalytic triad in the active site where 3
residue positions are completely conserved across all members (Drenth et al., 1972;
Kraut, 1977).
If one can identify the conserved residue positions in a protein superfamily se-
quence alignment then it is likely that these positions could play a structural and/or
functional role in the protein. Positions with a structural role for example may be
important in maintaining the stability of the protein or important in folding. As
mentioned already, positions with a functional role may be catalytic residues, or
may be involved in interface interactions such as ligand binding, protein-protein
interactions, and protein-DNA binding.
2.1.1.1 Identifying conserved residues
Many different types of algorithms have been developed to study the evolution of
homologous protein sequences and identify conserved sites, ranging from simple ma-
jority fraction (Wu and Kabat, 1970), to entropy or mutual information-based algo-
rithms ( Shannon and Weaver, 1949; Wu and Kabat, 1970; Mihalek et al., 2004), and
statistical estimations of residue mutability with methods such as Rate4Site (Pupko
et al., 2002). By identifying all of the conserved residues, these methods can be used
to identify residues that are preserved throughout evolution, for example residues
in enzyme active sites.
Methods based on physicochemical properties Livingstone and Barton (1993)
developed the program, Analysis of Multiply Aligned Sequences (AMAS), which
calculates a conservation score based on the physicochemical properties observed at
each sequence position of a MSA. At each MSA position in a pre-defined subfam-
ily, the general physicochemical properties of each amino acid are defined according
to Taylor (1986) and Zvelebil et al. (1987). Two different methods are subsequently
applied, the first (similar to Zvelebil et al. (1987)) scores an alignment position as be-
ing ‘positively’ conserved if the amino acids all have the same physicochemical prop-
CHAPTER 2. IDENTIFICATION AND CHARACTERISATION OF
FUNCTIONAL DIVERSITY IN PROTEIN DOMAIN SUPERFAMILIES 54
erties and ‘negatively’ conserved if the amino acids have different properties. The
second method within AMAS only calculates conservation of the positions whose
amino acids have the same physicochemical properties (Livingstone and Barton,
1993).
Methods based on entropy Scorecons is another approach, which was devel-
oped by Valdar (2002) to quantify the conservation of each residue position in a
protein sequence alignment. Each position is assigned an evolutionary conservation
score between 0 and 1, where 0 indicates zero conservation at that position, through
to 1 where the residue at that position is completely conserved. Amino acid di-
versity at each position is calculated using amino acid similarity information from
a Dayhoff-like mutation data matrix (Jones et al., 1992). The overall score sums
up the contributions from each individual sequence, and sequences are weighted in-
versely with their redundancy in the alignment (Valdar, 2002). This method was
reviewed along with 13 other methods in Manning et al. (2008) and was reported
to consistently score in third place.
Phylogenetic tree-based approaches In addition to Lichtarge et al. (1996), a
number of other groups also use a phylogenetic tree-based approach. Consurf (Glaser
et al., 2003; Ashkenazy et al., 2010; Celniker et al., 2013) calculates the evolutionary
rate of each position in an MSA to determine which positions are highly variable
throughout evolution (i.e. not conserved), and those that evolve slowly and are
therefore highly conserved. The evolutionary rate is calculated through an empir-
ical Bayesian method or a maximum likelihood method, and the phylogenetic tree
is used to display the evolutionary relationships between MSA sequences. Conser-
vation scores are mapped onto the 3D structure of a family member to display any
clusters of highly conserved residues on the protein surface, which are inferred to
be functionally important residues. The MINER algorithm (La and Livesay (2005))
uses evolutionary information from an MSA to calculate the phylogenetic similar-
ity between a local (sliding window) region of the MSA and the whole alignment.
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From this, phylogenetic motifs (PMs) are identified, which are shown to structurally
cluster around key functional residues.
2.1.2 Identifying specificity determining positions in func-
tionally diverse superfamilies
As conserved residues can relate to either structural or functional roles, algorithms
have been developed to distinguish between these two roles. Within a functionally
diverse superfamily, functional residues may be conserved throughout the super-
family however the physicochemical property of the residue may change between
subfamilies performing different functions, for example they may be associated with
changes in substrate specificity. Such residues are described as specificity determin-
ing positions (SDPs).
An SDP can be identified as an MSA position that is highly conserved across
two subfamilies in the same homologous superfamily but the conserved amino acid
residue in each subfamily is different. By examining these different specificities, the
degree of functional diversity can be examined within a given protein family. Where
functions are known for the different subfamilies, the SDP information can then be
used to assign specific functions to query sequences (Capra and Singh, 2008). The
first approaches to the identification of SDPs were published in the mid-1990s from
the groups of Sander (Casari et al. (1995)), who used principal component analysis
to identify the functional residues from an MSA of homologues, and Lichtarge et al.
(1996), who developed the Evolutionary Trace (ET) method, which uses conserved
sequence patterns in homologous proteins as well as residue mutation information
from the evolutionary relationships to detect changes in function.
Since then, a variety of algorithms have been produced to identify functional
residues.
Entropy and mutual information-based algorithms The Funshift database
(Abhiman and Sonnhammer (2005a,b)) identifies SDPs using a method described
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by Sjo¨lander (1998) where the amino acid distribution of each MSA position is
calculated and the relative entropy between two subfamilies computed. The relative
entropy across the MSA positions is accumulated and converted into a Z-score, which
would be high (above 0.5) if the amino acid distributions between two subfamilies
were very different (Abhiman and Sonnhammer (2005a)). Alignment positions that
are not conserved between subfamilies and evolved at different evolutionary rates
are identified using the maximum likelihood ratio-based (LRT) method by Sjo¨lander
(1998) and Knudsen and Miyamoto (2001).
Hannenhalli and Russell (2000) present a method that, given a protein family
MSA and a set of protein sequences grouped into subfamilies (e.g. by EC number),
identifies SDPs through the comparison of subfamily-specific sequence profiles and
also through the analysis of entropy at each alignment position. Alignment positions
with significantly high relative entropy were found to correlate with SDP positions
known to be involved in defining subfamilies for enzymes including protein kinases
and trypsin-like serine proteases.
Mirny and Gelfand (2002) used an entropy and mutual information-based ap-
proach to identify SDPs between subgroups of paralogues and orthologues. Orthol-
ogous proteins generally have the same biochemical function, however paralogous
proteins usually have different specificities as they recognise and bind to different
substrates. Orthologous proteins tend to have the same specificity in different or-
ganisms as they bind the same substrate. The method first identifies paralogues
in a group of homologous proteins and for each of these paralogues, its orthologues
are identified in related organisms and an MSA constructed. Mutual information
is computed for each alignment position and the likelihood of a position being a
SDP is calculated. Kalinina et al. (2004) used this method to develop the web-tool
SDPpred for users to submit their own MSAs as well as their subfamily definitions
to predict SDPs.
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2.1.3 Characterising functional site diversity in a large pro-
tein domain superfamily
Dessailly et al. (2010) performed a detailed analysis of the large, functionally and
structurally diverse HUPs domain superfamily. The name “HUP” is derived from
different members of the superfamily, which include “High signature” proteins, the
“Universal stress protein A”, and “PP-ATPase” (Aravind et al., 2002). As men-
tioned already, the majority of homologous superfamilies have relatively small pop-
ulations and the relatives perform the same, or very similar function. Less than
4% of superfamilies (accounting for more than 50% of domains in CATH) contain
many relatives which are very functionally diverse (Cuff et al., 2011). To under-
stand functional divergence better in these large superfamilies, the members of the
HUP domain superfamily were studied in some detail. Relatives were subclassified
into functional groups if they performed similar reactions but had different sub-
strate specificities. Functionally important residues were found to be more conserved
within these subgroups than between subgroups. Catalytic residues were found to
be more conserved than ligand-binding residues. They also found that some func-
tional groups used different protein interfaces to bind with different protein domain
partners (Dessailly et al., 2010).
2.1.4 Aims and objectives
This chapter follows on from the analysis of the HUPs superfamily by Dessailly et al.
(2010) by examining functional site diversity across all functionally diverse CATH
superfamilies.
Functionally diverse superfamilies are identified based on the number of EC and
GO terms they have and the number of diverse functional families within them.
Variations in functional site residue locations across a superfamily are identified
by mapping all known sites for a superfamily onto a representative structure.
Two different methods are used for identifying the functional families within a
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superfamily. The functional purity of the families produced by these methods are
assessed and the most coherent functional family dataset was then used to identify
common and unique functional sites within a superfamily.
Finally, examples of superfamilies with highly conserved and highly variable
functional sites will be discussed.
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2.2 Methods
In this work, data from CATH (version 3.5) and Gene3D (version 11.0) (Cuff et
al., 2011) have been used to analyse functional diversity within CATH superfamilies,
and the extent to which superfamily relatives share the same functional site residues.
The first part of the work involved mapping all of the functional site data available
for a given superfamily onto a structural representative for that superfamily. This
part of the project was done in collaboration with Benoit Dessailly, who had been
involved in the initial design of the project before taking up a Fellowship in Japan.
As well as examining the variation in location of functional sites across domain
superfamilies, we wanted to examine whether some sites were commonly used by
relatives having different functions. For this analysis we used a functional subclassi-
fication of CATH (functional families, or FunFams). FunFams were generated by a
small team of researchers in the Orengo Group. My contribution was to assess the
functional and structural purity (also referred to as coherence) of different functional
subclassifications.
Work from this chapter has been published in Dessailly, Dawson, Mizuguchi, and
Orengo (2013).
2.2.1 Domain superfamily data
CATH functional families Functional families were introduced to the CATH-
Gene3D classification in 2012 (Lees et al., 2012) using a two-step approach. First,
all superfamily sequences are compared to generate a hierarchical tree. Second,
similarities between sequences at each node of the tree are analysed to determine
where to cut the tree to produce functionally coherent sequence clusters.
In the first step, the GeMMA algorithm (Lee et al., 2010) clusters relatives in a
superfamily using a hierarchical agglomerative clustering algorithm to produce a tree
of clusters built from the leaf nodes to the root node. This iterative approach first
clusters close homologues, i.e. sequences with at least 90% sequence identity, using
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the program CD-HIT (Li and Godzik, 2006). For each of these clusters, MSAs are
constructed using MAFFT (Katoh et al., 2005). In the second iteration, clusters are
compared using a profile-profile approach that exploits the COmparison of Multiple
Protein Alignments with Assessment of Statistical Significance (COMPASS) set of
tools (Sadreyev and Grishin, 2003). COMPASS takes two MSAs as input and from
these builds two position-specific scoring matrix (PSSM) profiles for comparison
purposes and reports the similarity of profile pairs. GeMMA then identifies the
profiles with the highest similarity which are then merged. This continues until one
cluster remains. The results of clustering can be visualised as a tree of clusters for
the superfamily.
The final tree of clusters is partitioned by cutting the tree. In the original 2012
approach used to generate functional families, the nodes are merged if their similar-
ity value has an E-value less than 1x10−10, otherwise they are kept separate. This
approach is referred to as the ‘unsupervised’, or Funfamer, method (Lee et al., 2010).
Functional families generated by this method will be described as FunFamSEQ func-
tional families (Figure A.1). The FunFamSEQ functional families have been previ-
ously benchmarked against the Structure Function Linkage Database (SFLD) (Pegg
et al., 2006).
A more recent approach to generating the functional families was developed
using a ‘supervised’ protocol (Rentzsch and Orengo, 2012). This approach (DFX)
detects and accounts for functional ‘chaining’ within the tree of clusters. ‘Chaining’
refers to instances of protein domain sequences in a superfamily that cluster in an
unexpected way. In DFX, GO annotation data is used to ensure functional coherence
in each functional family, and clusters are only merged if they contain coherent
GO terms. However, in some superfamilies the sequence similarity reflected in the
COMPASS scores appears to contradict GO term similarity so that domain relatives
apparently having different functions are preferentially merged in the hierarchy. This
phenomenon usually arises because in these superfamilies, domains have a generic
functional role that remains unchanged despite the different functional contexts
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(reflected in different GO terms for their parent proteins) in which the relatives
appear. The DFX method is described in more detail in Rentzsch and Orengo
(2012) and the functional families produced by this method will be referred to as
FunFamGOs (Figure A.1).
FunFamGOs were shown to perform well in predicting functions for uncharac-
terised sequences. The DFX method came 7th out of 56 groups in the CAFA inde-
pendent assessment of function prediction (Radivojac et al., 2013).
Characterising superfamily diversity by the number of s60 clusters “s60
clusters” are groups of domain sequences clustered at 60% sequence identity (Fig-
ure A.1). Whereas some superfamily relatives cannot be grouped into functional
families because they lack GO functional terms or they do not match the HMMs
generated for a given functional family, all relatives can be clustered into s60s. The
number of s60 clusters was used to provide a measure of superfamily diversity. This
analysis used the 1,456 superfamilies that have two or more s60 clusters.
2.2.2 Assessment of functional purity within functional fam-
ilies
Functional families are generated as clusters of sequences that code for protein do-
mains carrying out a highly similar, if not the same, biological function. The same
functional residues are expected to be present in the same sequence position through-
out, i.e. the functional residues are expected to be completely conserved.
We first assessed and compared the functional purity of FunFamSEQ and FunFamGO
functional families to determine which were most functionally coherent. These would
then be used for the analysis of common functional sites. The FunFams were assessed
by examining whether conserved residues, i.e. a position in an MSA where the amino
acid residues are the same throughout all relatives, were enriched in known catalytic
and binding functional residues. Catalytic residues with literature-based evidence
were taken from the Catalytic Site Atlas (CSA) (Porter et al., 2004). Residues
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involved in binding interfaces were taken from the Inferred Biological Interactions
Server (IBIS) resource (Shoemaker et al., 2012). The binding interfaces included
ligand information for protein-protein, protein-nucleic acid, and protein-small lig-
and interactions. Small ligands encompass the small organic compounds, peptides
and ions. All available literature-based functional site information was used for all
residues found in structural domains and the data was not limited to either buried
or surface residues.
Residues in a multiple alignment position were considered conserved if assigned
a score of least 0.7 by the in-house Scorecons program (Valdar, 2002) (described in
Introduction, page 53). This value has been previously been determined as identi-
fying a high proportion of known catalytic residues from the CSA (Dessailly et al.,
2010).
Enrichment tests were adapted from Rausell et al. (2010) and performed to find
out whether conserved residues in functional family alignments were significantly
enriched in known functional residues. The enrichment (E) value for each functional
family was calculated as the proportion of conserved residues that were functional
(Pc), minus the proportion of all residues in the protein domains that were functional
(Pa) (see Equation 2.1).
E = Pc− Pa (2.1)
E values were averaged for each superfamily. An unpaired, one-sided Wilcoxon
Rank-Sum test (Kruskal, 1957) was run on all averaged enrichment values using the
wilcox.test function in R (R Core Team, 2012). This test assessed a P-value for the
null hypothesis that the median enrichment value was zero. An enrichment value of
zero indicates that the proportion of unconserved functional residues is the same of
the proportion of conserved functional residues. The alternative hypothesis assumed
that the median enrichment value was greater than zero, i.e. a positive E value,
which reflected a greater proportion of conserved functional residues in comparison
to unconserved functional residues.
CHAPTER 2. IDENTIFICATION AND CHARACTERISATION OF
FUNCTIONAL DIVERSITY IN PROTEIN DOMAIN SUPERFAMILIES 63
A functional family may contain sequences that do not always represent a com-
plete protein domain, i.e. sequence fragments. This is due to a number of reasons:
1) the correct start and/or end gene positions may not have been correctly defined
in UniProt, 2) there are only partial annotations for some genes in a number of com-
pleted genomes, or 3) there is no close homologue available to define a gene. Due
to such issues there are sometimes protein domain fragments within the domain se-
quence clusters. These sequence fragments could affect the quality of the functional
family MSA, e.g. there may be many gaps caused by aligning the fragments to full-
length protein domain sequences. To overcome this issue, sequence fragments were
removed from functional family data. Any sequences less than 80% of the average
family sequence length were removed.
Once the sequence fragments had been removed, functional family sequences were
re-aligned with MAFFT (Katoh and Toh, 2008) and residue conservation scores were
calculated with Scorecons (Valdar, 2002). Enrichment tests were then performed for
these data as previously described.
2.2.3 Assessment of structural coherence in functional fam-
ilies
To assess the structural coherence of a set of relatives, the relatives were pairwise
compared using SSAP (Taylor and Orengo, 1989) and the mean RMSD calculated.
Since running SSAP is computationally expensive, structural coherence was only
measured for each FunFamSEQ, FunFamGO, and superfamily within the top 50 most
structurally diverse superfamilies. We assumed that if the functional family rela-
tives were found to have high structural similarity in these 50 superfamilies, then
functional families in all other less structurally diverse superfamilies would also be
structurally coherent. A structurally diverse superfamily here refers to a superfamily
with at least five structurally similar groups (SSGs). An SSG is a group of relatives
that can be pairwise superposed with each other within a given RMSD threshold.
Here we use a cutoff of 5 A˚ to produce ‘SSG5s’.
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An unpaired, two-sided Wilcoxon Rank-Sum test was used to determine whether
there was a significant difference between the means in the distribution of average
RMSD values in the FunFamSEQs and FunFamGOs.
2.2.4 Protocol to identify functional site coverage across
each superfamily
We first wanted to examine the number of different functional sites (i.e. the coverage
of the structure by functional sites) used by relatives across each functionally diverse
superfamily using all known functional site data for that superfamily.
Functional site residues were extracted for superfamily members from the CSA (Porter
et al., 2004) and IBIS (Shoemaker et al., 2012) resources.
Pairs of superfamily members were aligned using the SSAP algorithm (Taylor
and Orengo, 1989) in an all-against-all protocol. The SSAP score calculated from
the pairwise comparison was assigned to each domain in the pair. For each domain,
all of its assigned SSAP scores were summed and the domain with the highest cumu-
lative SSAP score was chosen as the superfamily representative. The domains with
functional site residue information were aligned to the superfamily representative
and the functional site residue information was mapped onto the equivalent residues
in the superfamily representative.
Functional site coverage for each superfamily representative was calculated as the
number of functional site positions mapped onto a representative sequence, divided
by the total number of residue positions in the representative.
2.2.5 Protocol to identify common functional sites across
each superfamily
Following the examination of functional site coverage, we then wanted to explore
whether there were any common sites in the superfamily i.e. sites used by more
than one FunFam.
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Figure 2.1 describes the steps taken in the identification of common functional
sites. Each of these stages will now be discussed.
Figure 2.1: Flowchart showing the steps taken to identify common and unique
functional sites.
Extracting functional residue site information Functional residues were ex-
tracted from the CSA and IBIS for all FunFamSEQ functional family structural
domains as described in Section 2.2.4.
Identifying functional family representatives and mapping functional site
information onto this representative Pairs of functional family members were
aligned using the SSAP algorithm (Taylor and Orengo, 1989) in an all-against-all
protocol. The domain with the highest cumulative SSAP score was chosen as the
functional family representative. The members with functional site residues were
aligned to the functional family representative and the functional site residue infor-
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mation mapped onto the equivalent residues in the functional family representative
(Figure 2.2). This pairwise mapping was done using an in-house program previously
written by Benoit Dessailly for his analysis of the HUPs superfamily.
Figure 2.2: Examples of structural domains annotated with functional site residue
information from the CSA (in orange) and IBIS (in green). Functional residue
information was then inherited onto the functional family representative.
Identifying superfamily representatives and mapping functional site in-
formation onto this representative Pairs of functional family representatives
were aligned using the SSAP algorithm (Taylor and Orengo, 1989) in an all-against-
all protocol. The domain with the highest cumulative SSAP score was chosen as the
superfamily representative.
For each functional family, functional site data of CSA and IBIS residues were in-
herited from each family representative domain onto the superfamily representative
domain (Figure 2.3).
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Figure 2.3: Functional residue information was inherited onto the superfamily repre-
sentative from functional family representatives. Examples of functional site residues
from the CSA are shown as orange diamonds and from IBIS as green diamonds.
Identifying common functional sites and characterising functional site
diversity The proportion of functional family representatives contributing to each
mapped functional site residue on the superfamily representative was calculated.
This protocol was used to identify the sites common to functionally diverse relatives,
i.e. in FunFams, and to get an idea of the distribution of common and unique sites
across the representative domain structure.
Figure 2.4 illustrates the accumulation of catalytic functional site residues from
functional families representatives onto the superfamily representative structure. A
colour-coding system was used to indicate the proportion of the functional family
representatives mapped to each functional site residue on the superfamily represen-
tative. For example, if only one of the three example functional families contributed
to a mapped position on the superfamily representative, the residue was coloured
green (bottom-right structural domain). Meanwhile, if all three functional families
within a superfamily mapped to the same functional site residue on the superfamily
representative, this residue was coloured red.
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Figure 2.4: Catalytic functional residues mapped onto functional family and super-
family representatives. The top three domains show catalytic functional residues (in
black) mapped onto functional family representative domains. These sites were then
accumulated onto the superfamily representative (in black, bottom-left structural
domain). Each site on the superfamily representative structure was colour-coded to
indicate the proportion of functional families with sites that map to that position
(bottom-left structural domain).
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2.2.6 Post-processing of functional families for the CATH
website
A pipeline was written for the processing of all functional families in all CATH
superfamilies to make the functional family information available online. The func-
tional families have been available on the CATH website since version 3.5, which was
established in 2012 (Sillitoe et al., 2013). For each functional family, the information
available included the representative structure with mapped functional site residues
highlighted, and the MSA of the family with conserved position marked.
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2.3 Results
Domains in some superfamilies are very small and the sites take up a large
proportion of the domain. To overcome these issues, superfamilies were only included
in the analysis where: 1) the superfamily representative domain was at least 100
amino acids in length, 2) each contributing member of functional site data had a
functional coverage of less than 50%. Superfamilies were also only included in the
analysis if the superfamily representative had a functional site coverage value above
zero.
2.3.1 Exploring functional site coverage
Table 2.1 shows the number of superfamilies used in, and excluded from, the analysis
after the two filters described above were applied and the superfamily representative
domains with no functional site coverage were identified.
Site Type # Superfamilies
used
# Superfamilies
filtered out
# Superfamilies
with no coverage
Catalytic Sites 328 53 1,075
Protein-Protein
Interfaces
645 433 378
Nucleic Acid
Binding Sites
116 107 1,233
Small Ligand
Binding Sites
659 274 523
Table 2.1: Number of superfamilies considered in, and excluded from, the dataset
for each type of functional site, after applying the two filters and in light of the
number of superfamily representative domains with zero functional site coverage.
Figure 2.5 shows the functional site coverage calculated for each superfamily
analysed, plotted against the diversity of the superfamily measured by the number
of s60 clusters in the superfamily. The coverage of the superfamily representative
by functional sites is a simple measure of functional site diversity. Superfamilies
with a high coverage of functional sites will be those in which the functional sites of
relatives occur at many different structural locations.
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(a) Catalytic Sites (b) Small Ligand Binding Sites
(c) Nucleic Acid Binding Sites (d) Protein-Protein Binding Sites
Figure 2.5: Functional site coverage and sequence diversity of domain superfamilies.
Each plot shows the data for a specific type of functional site. Each superfamily
is represented as a dot in these plots. Each dot is partially transparent to enable
visualisation of the data points overlapping. Functional site coverage on the Y-
axis is measured as the proportion of residues in the representative that map to
a functional site in superfamily members. Superfamily diversity on the X-axis is
measured as the number of sequence clusters grouped at 60% sequence identity
within each superfamily.
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Catalytic residue sites are observed to have the lowest functional site coverage
(Figure 2.5a), where at most only 20% of superfamily representative positions have
catalytic residues mapped from different family members. Small ligand and protein-
protein binding sites (Figures 2.5b and 2.5d) are seen to have the highest levels of
functional site coverage. In general, we observe that the more diverse superfamilies
frequently have the larger coverage values.
The restriction in catalytic site location could be explained by the relatively
small size of an active site, by the limited number of catalytic residues that can be
involved in a given catalytic reaction, and by the preference for the same site by
superfamily relatives.
For nucleic acid binding sites a maximum of ∼ 65% coverage is observed, with
most of the superfamilies having a coverage of 6 30% (see Figure 2.5c). This max-
imum coverage is higher than the maximum coverage observed for catalytic sites.
Many superfamilies do not have the ability to bind either DNA or RNA, reflected by
a large number of superfamilies (1233 out of 1456, ∼ 85%) having a representative
coverage of zero for this functional type (see Table 2.1).
For small ligand binding sites, a small number of superfamilies have coverage
values over 80% but the majority of superfamilies have less than 40% coverage (see
Figure 2.5b). As the ligands being bound are small, fewer residues are required for
binding than are needed for binding macromolecules. It may be that high coverage
in some of these superfamilies is an artifact of the protein domain binding to different
artificial ligands prior to crystallisation and therefore the solved structure contains
these bound ligands.
Protein-protein interface binding sites have the highest levels of functional site
coverage with up to 100% coverage. For the majority of diverse superfamilies (i.e.
those with at least 20 s60 clusters), more than 60% of residue sites on the superfam-
ily representative are mapped by protein-protein interface residues from different
superfamily members (See Figure 2.5d).
CHAPTER 2. IDENTIFICATION AND CHARACTERISATION OF
FUNCTIONAL DIVERSITY IN PROTEIN DOMAIN SUPERFAMILIES 73
2.3.2 Assessment of functional purity in functional families
For the next part of the study we wanted to explore the proportion of functional
families mapping to a particular site on the superfamily representative. For this
we needed to use functionally coherent families. We therefore compared the func-
tional purity of the two families, FunFamSEQ and FunFamGO, described in Methods
Section 2.2.1.
Functional families ideally represent groups of homologous sequences that carry
out related biological functions and for this reason the relatives within them are
expected to consist of highly similar or identical functional residues, in both spatial
and physicochemical terms.
Residue enrichment analyses were used to assess the functional purity of the
FunFamSEQ and FunFamGO functional families generated using the FunFamer and
DFX protocols, respectively. Enrichment scores were calculated using both CSA and
IBIS functional site data. Figure 2.6 shows that more FunFamSEQs than FunFamGOs
have a higher percentage of conserved catalytic residues, before and after the removal
of partial domain sequences from family sequence alignments.
In the removal of partial domain sequences, also referred to as fragments, a total
of 393,430 sequences (out of 4,149,361, 9.5%) were removed from the FunFamSEQs
and 521,349 sequences (out of 4,113,867, 12.7%) were removed from the FunFamGOs.
Following fragment removal there are still approximately 100 FunFams with no
conserved catalytic residue positions.
CHAPTER 2. IDENTIFICATION AND CHARACTERISATION OF
FUNCTIONAL DIVERSITY IN PROTEIN DOMAIN SUPERFAMILIES 74
Figure 2.6: The number of functional families with conserved catalytic residues,
before and after the removal of partial domain sequences.
The proportion of conserved IBIS functional residues is also higher in FunFamSEQs
than FunFamGOs, before and after partial sequence fragment removal (see Table
2.2). The proportions are however lower for IBIS residues than for conserved cat-
alytic residues. This is because catalytic residues are more highly conserved and
are restricted in their spatial position to a greater degree, as previously shown in
Figure 2.5a. Regardless of whether FunFamSEQs or FunFamGOs are analysed, the
removal of partial sequence fragments shows an increase in the proportion of con-
served functional residues, indicating that the family alignment quality has been
increased.
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Family Type CSA IBIS Nucleic
Acid Binding
IBIS Protein-
Protein Interface
IBIS Small
Ligand Bind-
ing
FunFamGOs
(+ fragments)
57.82% 26.15% 21.50% 31.63%
FunFamGOs (-
fragments)
76.05% 37.32% 33.76% 47.41%
FunFamSEQs
(+ fragments)
58.43% 34.70% 24.34% 35.02%
FunFamSEQs
(- fragments)
78.33% 47.73% 39.28% 52.03%
Table 2.2: The proportion of CSA and IBIS functional residues that are conserved.
Using the residue enrichment analysis described in Methods, we examined whether
the FunFamGO and FunFamSEQ alignments contained conserved residues that were
significantly enriched in known functional residues. Wilcoxon Rank-Sum tests re-
ported significant p-values for all functional site types, except for the IBIS protein-
protein interface residues which are only significantly enriched in the FunFamSEQ
families (Table 2.3).
Family Type CSA IBIS Nucleic
Acid Binding
IBIS Protein-
Protein Inter-
face
IBIS Small
Ligand Bind-
ing
FunFamGOs
(+ fragments)
<2.2 x 10−16 5.9 x 10−06 0.55 <2.2 x 10−16
FunFamGOs (-
fragments)
<2.2 x 10−16 3.6 x 10−07 0.35 <2.2 x 10−16
FunFamSEQs
(+ fragments)
<2.2 x 10−16 7.0 x 10−09 0.0095 <2.2 x 10−16
FunFamSEQs
(- fragments)
<2.2 x 10−16 2.2 x 10−06 0.00068 <2.2 x 10−16
Table 2.3: P-values reported from Wilcoxon Rank-Sum tests performed on
FunFamGO and FunFamSEQ functional family alignments to observe whether con-
served residues were enriched in functional residues.
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2.3.3 Assessment of structural coherence in functional fam-
ilies
Figure 2.7 shows that FunFamSEQ functional family relatives superpose with lower
RMSD values than relatives within FunFamGOs and relatives within superfamilies.
As analyses have shown that relatives with significant similarities in structure are
more likely to have similar functional roles and protein interactions (Redfern et al.,
2008), the FunFamSEQs were considered to be more functionally coherent on the
basis of their structural coherence, and therefore selected for further analysis.
Figure 2.7: Mean RMSD distributions of the top 50 most structurally diverse CATH
superfamilies, and the FunFamGOs and FunFamSEQs within these superfamilies.
Using a Wilcoxon Rank-Sum test, the FunFamGO and FunFamSEQ distributions
were found to be significantly different with a p-value < 0.0002253.
2.3.4 Identifying common functional sites in superfamilies
In the previous sections we showed that functional site coverage can be quite high
in some superfamilies, i.e. a large proportion of residues are functional site residues,
and also for some types of functional sites, e.g. protein-protein interfaces. Here, we
examine whether some functional sites on a domain are more frequently used than
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others. To do this we examined the proportion of functional families mapped to
each functional site residue on the superfamily representative and we identify sites
common to multiple functional families. This analysis also revealed sites unique to
particular functional families.
An example of a superfamily with high sequence diversity and diverse use of
functional sites is shown in Figure 2.8. This figure illustrates the Aldolase Class
I superfamily (CATH code 3.20.20.70), whose functional families use different cat-
alytic residue sites. In total, 34 catalytic functional site residues have been mapped
onto the superfamily representative.
Figure 2.8: Catalytic functional site residues mapped onto the superfamily represen-
tative domain 3f4wA00 for the Aldolase Class I superfamily (CATH code 3.20.20.70).
Mapped residues are colour-coded according to the proportion of functional families
contributing catalytic site data to a given site.
To ensure that our functional family dataset gave similar insights into functional
site coverage, we repeated the previous study of functional site coverage as reported
in Section 2.3.1. Figure 2.9 shows the functional site coverage for each superfam-
ily, against the functional diversity of the superfamily measured by the number of
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FunFamSEQ functional families.
As seen previously in Figure 2.5a, catalytic residue sites have the lowest super-
family representative coverage values. In the previous analysis, a maximum coverage
of 20% was observed and now a similarly low maximum coverage of 13% is reported
(see Figure 2.9a). The coverage values calculated from nucleic acid binding site data
still show more than half of the superfamilies have 6 30% coverage.
Small ligand binding site data shows coverage values that are below 25% for half
of the superfamilies, which is slightly lower than the previous results that showed a
large proportion of the superfamilies had less than 40% coverage.
The lower coverage values for catalytic and small ligand binding sites may be
due to the fact that FunFams must have at least one experimentally characterised
GO term. Therefore not all CATH domain structures with site data are included in
the FunFam dataset, i.e. some of the PDB structures are not mapped to FunFams.
Finally, protein-protein interface data also shows the highest levels of superfamily
representative coverage, as previously in Figure 2.5d. Again, the majority of the
superfamilies have at least 60% of the representative residues mapped to protein-
protein interface residues (see Figure 2.9d).
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(a) Catalytic Sites (b) Small Ligand Binding Sites
(c) Nucleic Acid Binding Sites (d) Protein-Protein Binding Sites
Figure 2.9: Functional site coverage and sequence diversity of domain superfamilies.
Each plot shows the data for a specific type of functional site. Each superfamily
is represented as a black dot in these plots. Each dot is partially transparent to
enable visualisation of the data points overlapping. Functional site coverage on the
Y-axis is measured as the proportion of residues in the representative that map to
a functional site in one or more superfamily members. Superfamily diversity on the
X-axis is measured as the number of FunFamSEQ functional families within each
superfamily.
Whilst protein-protein interface binding sites are found in numerous locations
across the structure for many superfamilies in the data set, we decided to examine
whether there was a preference for a particular site within each superfamily. The
red box in Figure 2.10 shows that in 364 (out of 463, ∼ 79%) of superfamilies,
there is one site (the most common protein-protein interface functional site residue)
which is mapped to by 80-100% of their functionally diverse functional families.
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The remaining 99 (out of 463, ∼ 21%) of superfamilies have common sites which are
mapped to by 40-79% of their functionally diverse functional families. This shows
that whilst multiple sites can be used, there are preferential sites for interfaces within
some superfamilies.
The large coverage observed for protein interfaces is likely to be due to differences
in domain and protein partners for functionally different relatives. This has been
suggested by previous studies (Todd et al., 2001; Dessailly et al., 2010; Reid et al.,
2010). The fact that we observe some overlap between the sites suggests that there
may be a part of the surface that has features more suited to forming an interface
and that is therefore more frequently exploited.
Figure 2.10: The number of superfamilies against the percentage of their func-
tional families mapping to the most common protein-protein interface functional
site residue. The red box highlights the 364 (∼ 79%) superfamilies each with 80-
100% of their functional families contributing to the most commonly mapped PPI
functional site residue.
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Some further examples of superfamilies with high or low functional site coverage
for protein-protein interfaces and high or low sequence diversity are discussed below.
2.3.4.1 Selected examples
The coverage plots obtained using either s60 or FunFam diversity have shown the
range of coverages observed for different superfamilies. Some examples will now be
presented from different parts of the coverage plot for interfaces to illustrate some
of the varying phenomena observed.
Example of a functionally coherent superfamily with common functional
sites The bacterial GTPase-activating protein (GAP) superfamily (CATH code
1.20.120.260) has low functional site coverage (20%) of protein-protein interface
binding sites and low sequence diversity with only 3 s60 clusters for 111 bacterial
species (see red dot in the bottom left-hand corner of Figure 2.11, which is adapted
from Figure 2.5d).
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Figure 2.11: The bacterial GAP domain superfamily (CATH code 1.20.120.260)
is highlighted in red to show its position amongst all superfamilies in terms of
functional site coverage and sequence diversity. This superfamily has low functional
site coverage and low sequence diversity. The position of the superfamily in the plot
is highlighted in red.
Bacterial type III secretion systems inject GAPs into an eukaryotic host cell
where host cell’s Rho-family GTPases are targeted to disrupt their maintenance of
the host cytoskeleton (Litvak and Selinger, 2003).
The protein-protein interface shown in Figures 2.12a and 2.12b is the same in all
relatives. The two relatives illustrated are from different species and have less than
35% sequence identity however they use the same interface binding residues. This
similarity in interface is likely to be due to relatives binding to the same protein
partner. For example, both relatives bind the human Rac protein (see Figures 2.12a
and 2.12b). Litvak and Selinger (2003) constructed a multiple sequence alignment
of ten bacterial GAPs and discovered two short highly-conserved motifs across the
different species. These two motifs are used in protein-protein interactions across
all superfamily members with known structure (see residues highlighted in red in
Figure 2.12c). The interactions are with the GTPase phosphate-binding loop (p-
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loop), the GTPase switch regions, and the bound nucleotide.
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(a) Pseudomonas aeruginosa Exos toxin in complex with human Rac.
(b) Salmonella enterica subsp. enterica, serovar Typhimurium LT2 Tyrosine Phosphatase
SPTP in complex with human Rac.
(c) GAP domain superfamily representative with mapped interface residues from different
functional families.
Figure 2.12: Example of a small superfamily with limited coverage of protein-protein
interfaces, the Bacterial GTP-ase Activating Protein (GAP) domain superfamily
(CATH code 1.20.120.260). The GAP domain is displayed in grey cartoon and in
the same orientation. Interacting domains are shown in other colours. In Subfigures
2.12a and 2.12b, the protein-protein interface residues on the GAP domain are
coloured black. Subfigures 2.12a and 2.12b display PDB entries 1he1 and 1g4u,
respectively. Subfigure 2.12c displays the superfamily representative in grey cartoon
and inherited protein-protein interaction sites, which are coloured according to the
percentage of functional families that have an interface residue at a given position,
using the following colour scale: 0 in grey, 1-20% in blue, 20-40% in green, 40-60%
in yellow, 60-80% in orange and 80-100% in red).
CHAPTER 2. IDENTIFICATION AND CHARACTERISATION OF
FUNCTIONAL DIVERSITY IN PROTEIN DOMAIN SUPERFAMILIES 85
Example of a functionally diverse superfamily with common functional
sites The “Two Dinucleotide Binding Domains” Flavoproteins (tDBDF) super-
family (CATH code 3.50.50.60) is a very large and diverse superfamily with 127
s60 clusters and 22 SSG5 clusters. The superfamily representative however has low
functional site coverage as only 37% of residues are mapped to protein-protein inter-
face binding sites, where each mapped position comes from one or more functional
families. Figure 2.13 highlights the position of this superfamily relative to others in
terms of functional site coverage and sequence diversity.
Figure 2.13: The “Two Dinucleotide Binding Domains” Flavoproteins domain su-
perfamily (CATH code 3.50.50.60) is a large superfamily with low functional site
coverage and high sequence diversity. The position of the superfamily in the plot is
highlighted in red.
Members of this domain superfamily are known to catalyse multiple types of ox-
idation/reduction reactions in energy metabolism, apoptosis, maintenance of redox
homeostasis and cellular signalling (Ojha et al., 2007). A variety of small molecules
and proteins are used as substrates. The superfamily gets this name as relatives
belong to proteins using two dinucleotide binding Rossmann-fold domains. The
N-terminal domain, termed the FAD domain, typically binds a flavin dinucleotide
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(FAD) and the C-terminal domain is known as the NADPH domain, which binds
a pyrimidine nucleotide. Both of these domains have a modified nucleotide-binding
fold (Bieger and Essen, 2001).
The examples in Figure 2.14 show these two domains in the context of ho-
modimeric enzymes. Members of the tDBDF superfamily contain disulphide ox-
idoreductase enzymes which include glutathione reductase, thioredoxin reductase,
adenylylsulphate reductase (Subfigure 2.14a), and quinol-fumarate reductase (Sub-
figure 2.14b). Each of these enzymes are made up of two identical monomers, which
each have four domains. In some of the figures, the crystallised structures lack some
of the domains.
The FAD cofactor is positioned between the FAD and the NADPH domains and
the main contacts between the domains are via the isoalloxazine ring system of the
FAD cofactor (Bieger and Essen, 2001). The superfamily representative structure is
therefore colour-coded grey in this region due to the lack of protein-protein interface
residues.
The superfamily representative domain represents the FAD domain and the yel-
low and green regions shown on its alpha-helices (Figure 2.14c) correspond to in-
terfaces between the monomers in the homodimer. Figure 2.15 illustrates the basic
structure of the homodimer using the protein structure from which the superfamily
representative was taken. This PDB structure (1FL2) only consists of two domains
from a monomer. The majority of interfaces were reported to occur between the two
FAD domains, hence the frequently used yellow region in Subfigure 2.14c. These
interactions are reported to stabilise the dimers formed by relatives in this super-
family (Bieger and Essen, 2001).
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(a) tDBDF domain from the subunit A of Adenylylsulfate reductase from Archaeoglobus
fulgidus in complex with subunit B.
(b) tDBDF domain from the flavoprotein subunit of Quinol-fumarate reductase, from
Escherichia coli, in complex with other subunits.
(c) tDBDF superfamily representative with mapped interface residues from different func-
tional families.
Figure 2.14: Example of a large and diverse superfamily with limited coverage of
protein-protein interfaces. This is the “Two-Dinucleotide Binding Domains” Flavo-
protein (tDBDF) superfamily (CATH code 3.50.50.60). The tDBDF domain is dis-
played in grey cartoon and the same orientation. The interacting partners are rep-
resented as coloured cartoon tubes in Sub-figures 2.14a (PDB entry 1jnr) and 2.14b
(PDB entry 1kf6). Interface residues on the tDBDF domain are coloured black.
Subfigure 2.14c follows the same colour scheme as described in Figure 2.12.
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Figure 2.15: The basic structure of the homodimer formed by the two domains in the
“Two-Dinucleotide Binding Domains” Flavoprotein (tDBDF) superfamily (CATH
code 3.50.50.60) (adapted from Bieger and Essen (2001)). The FAD domain is high-
lighted in pink and the NADPH domain in blue. The FAD cofactor is highlighted
in black.
Example of a functionally diverse superfamily with diverse functional
sites The NAD(P)-binding Rossmann superfamily (CATH code 3.40.50.720) is
extremely diverse with high functional site coverage, ∼ 97% protein-protein interface
coverage, and high sequence diversity, 402 s60 clusters. It also shows high structural
diversity with 52 SSG5 clusters. This superfamily is highlighted as a large red dot
in the top right-hand corner of Figure 2.16.
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Figure 2.16: The NAD(P)-binding Rossmann domain superfamily (CATH code
3.40.50.720) is highlighted in red to show its position within all superfamilies in
terms of functional site coverage and sequence diversity. This superfamily has high
functional site coverage and high sequence diversity.
As suggested by their name, these domains bind the coenzyme nicotinamide
adenine dinucleotide (NAD) and they also bind a large selection of catalytic domains,
assigned to multiple CATH superfamilies (Bashton and Chothia, 2002). It is the
bound catalytic domain that determines substrate specificity and the enzymatic
reaction. Bashton and Chothia (2002) describe four patterns of connectivity, which
are observed in some of our examples. The catalytic domain can be fused to the
NAD(P)-binding Rossmann domain at the N- or C-terminus, or in the middle of
the Rossmann domain sequence (Figures 2.17c and 2.17e). The NAD(P)-binding
Rossmann domain can also be fused in the middle of the catalytic domain sequence
(Figure 2.17a). Many of the examples in Bashton and Chothia (2002) show the
catalytic domain positioned close to the yellow region in Figure 2.17f. The yellow
region corresponds to interfaces with other chains in the protein complex.
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(a) Human S-adenosylhomocysteine hy-
drolase homodimer.
(b) Rat brain 3-hydroxyacyl-CoA dehy-
drogenase homodimer.
(c) Human NEDD8-activating enzyme E1
regulatory subunit in complex with the
catalytic subunit.
(d) Sulfur carrier protein ThiF adeny-
lyltransferase in a heterotetrameric com-
plex with Sulfur carrier protein ThiS,
from Escherichia coli.
(e) Homotetramer of GDP-D-mannose de-
hydratase from Aquifex aeolicus VF5.
(f) Rossmann superfamily representative
with mapped interface residues from dif-
ferent functional families.
Figure 2.17: Example of a large and diverse superfamily with large coverage of
protein-protein interfaces. This is the NAD(P)-binding Rossmann superfamily
(CATH code 3.40.50.720). The Rossmann domain is displayed in grey cartoon and
the same orientation. Extra domains from the same chain are displayed as grey
traces. Interacting partners are displayed as coloured traces. Interface residues on
the Rossmann domain are coloured black. Sub-figures 2.17a through to 2.17e display
PDB entries 1a7a, 1e3w, 1tt5, 1zud, and 2z1m, respectively. Subfigure 2.17f shows
the representative with residues coloured according to the same colour scheme as
described in Figure 2.12.
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2.3.5 Examining the relationship between structural and
functional diversity
A structurally diverse superfamily is defined here as a superfamily with at least five
SSGs, generated with a cutoff of 5 A˚. Figure 2.18 shows that structurally diverse
superfamilies are more likely to have larger functional site coverage values.
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(a) Protein-protein interface coverage
(b) Small ligand binding site coverage
Figure 2.18: Functional site coverage versus superfamily diversity. Structurally
diverse superfamilies are shown in red, i.e. those with at least five structural clusters,
where a cutoff of 5A˚ was used to generate the clusters.
The distributions of these functional site coverage values in structurally diverse
and structurally coherent superfamilies were found to be significantly different, using
an unpaired, one-sided Wilcoxon Rank-Sum test, with a p-value less than 2.2 x 10−16
(see Figure 2.19).
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(a) Protein-protein interface binding sites coverage
(b) Small ligand binding site coverage
Figure 2.19: Number of superfamilies versus functional site type coverage. The black
line represents superfamilies with less than five structural clusters, and the red line
represents superfamilies with at least five structural clusters.
2.3.6 Making functional family and functional site informa-
tion available on the CATH website
Following the processing and validation of the functional families, the information
was published in Sillitoe et al. (2013) and Lees et al. (2014) and it has also been
made available from the CATH website online. A list of the latest functional families
from CATH version 4.0 (established in June 2014) is provided for each CATH su-
perfamily, together with information on: the number of sequences in their alignment
after filtering the information content of the functional family alignment, the repre-
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sentative domain (which is chosen to be a structural domain where available), and
whether or not there are any functional sites in the PDB domain (see Figure 2.20).
This information content score is defined by the Diversity of Positions (DOPs) score,
which is calculated by Scorecons, and reflects the proportion of diverse sequences in
the alignment and the number of highly conserved positions. A functional family
tree (bottom-left of Figure 2.20) describes the structural relationships between the
functional families by illustrating which SSG cluster they are within.
Figure 2.20: CATH webpage screenshot showing a partial list of the functional
families in the Thiamine diphosphate-dependent superfamily (ID: 3.40.50.970).
Selecting a functional family name from this list, or from the functional fam-
ily tree, takes the user to pages summarising functional annotations for the family,
together with information on species distributions. If the functional family has a rep-
resentative with a PDB structure, this is displayed alongside the multiple sequence
alignment (see Figure 2.21). In the functional family sequence alignment, highly
conserved positions are highlighted in green and displayed on the representative
structure.
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Figure 2.21: CATH webpage screenshot showing the ‘Cysteinyl-tRNA synthetase’
functional family representative domain information. The domain is classified within
the HUPs superfamily (ID: 3.40.50.620). Functional residue sites are listed under
‘PDB Sites’.
2.4 Conclusions and future work
This work identified and quantified functional site diversity in CATH domain su-
perfamilies. Different types of functional sites were identified, ranging from catalytic
sites to different types of ligand binding sites and protein interface sites.
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The removal of sequence fragments from the FunFamGO and FunFamSEQ func-
tional families was shown to increase the family alignment quality. This was val-
idated by an increase in the proportion of conserved CSA and IBIS functional
residues. There are approximately 100 FunFamGOs and FunFamSEQs with no con-
served residues following sequence fragment removal, which suggests that the fam-
ily alignment quality can still be further improved. For example, these FunFams
may contain relatives that use different catalytic residues to catalyse different enzy-
matic reactions and therefore the families should be further divided. Although the
FunFamGOs show significant enrichment in catalytic, nucleic acid binding, and small
ligand binding functional site residues, in the FunFamSEQs, significant enrichment
is seen for all four types of functional site residues. This is likely to be a result
of the FunFamSEQs comprising more functionally related sequences, which is also
reflected in the structural coherence analysis where FunFamSEQ relatives superpose
with lower RMSD values in comparison to FunFamGO relatives. Examples of super-
families with extreme structural and functional site diversity have been identified
and discussed.
Our results show that whilst catalytic sites are generally identified within a small,
restricted number of spatial positions, i.e. they tend to be located in a site common
to all members of the superfamily, most structurally diverse superfamilies are very
flexible in the spatial locations of other functional sites. Protein-protein interfaces
display the most flexibility in spatial location. The locations of small ligand binding
sites are more varied within a superfamily than catalytic sites, however they are not
as diverse as protein-protein interfaces.
This chapter confirmed previous findings of preferred locations for catalytic func-
tional site residues (Dessailly et al., 2010). In enzymes, the active site is usually
found in a large and deep surface cleft (Laskowski et al., 1996). Further analy-
sis would be needed to confirm whether the preferred catalytic residue locations in
this chapter are found in such a cleft. Using a large cleft can be advantageous as
it can: maximise the interactions between the protein and its substrate, the sub-
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strate can optimally position itself for catalysis, and the substrate is buried in a
solvent-free environment which allows it to form the electrostatic forces required for
catalysis (Laskowski et al., 1996).
This chapter also reported that the majority of superfamilies have a small ligand
binding site coverage of less than 50%. The term ‘small ligand’ here refers to small
organic compounds, peptides and ions. The relatively low coverage we observe may
be a result of small ligands being used as substrates to bind in enzyme active sites,
which have shown to be constrained in their functional site location. The other small
ligands not being used as substrates will be less constrained in their binding sites
and most parts of a protein surface may be able to evolve the required properties to
bind these. Relatives in different organisms for example often bind different metal
ions and different cofactors and their protein surfaces clearly evolve to bind these
different molecules in different ways.
Protein-protein interactions (PPI) allow proteins to form multi-protein com-
plexes that perform a number of essential biological processes including translation,
transcription, signal transduction and gene regulation (Thompson et al., 2012). Thomp-
son et al. (2012) report that interfaces are larger and flatter than other types of
functional sites with an average surface area of 1940 +- 760A˚. It would therefore
take relatively few relatives with different PPI interfaces to result in a high coverage
of data on the superfamily representative. These larger sites could help suggest why
we are observing such large superfamily coverage.
This work also supported the previous study of Dessailly et al. (2010) in showing
that structurally diverse superfamilies tend to have a high coverage of interfaces and
suggested that diverse functional relatives have different domain or protein partners.
A hypothesis which is also supported by studies showing that relatives in different
species do not necessarily have the same interaction partners (Reid et al., 2010).
Interestingly however, there is some overlap between different family interfaces in a
majority of superfamilies. Further analysis would be needed to ascertain whether
this overlap is larger than expected by chance. To determine whether this is due to
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some structural characteristic of the surface or a constraint imposed by the location
of the cofactor would require further study.
Protein interactions also exhibit a wide range of affinity values, ranging from
strong picomolar dissociation values in stable complexes through to weak millimolar
dissociation values in transient complexes. As it is difficult to study and crystallise
transient structures, these are under-represented in the PDB (Thompson et al.,
2012) and therefore in this work.
Due to structural diversity within the functional families and superfamilies stud-
ied there may be large insertions, or embellishments, that are not shared across
the members. Functional site residues identified within such embellishments there-
fore may not be mapped onto a representative that does not also have an insertion
at the same place, resulting in potentially missing functional site information. As
the functional family and superfamily representative was chosen as the most struc-
turally similar domain, this method should prevent the chosen representative as
being one with unique embellishments which would minimise the effect of missing
any functional site mappings and therefore under-estimating functional site diver-
sity. Further work would need to be done to examine the extent of any missing
functional site information.
Chapter 3
Understanding the Mechanisms of Func-
tional Diversity in Enzyme Domain Super-
families
3.1 Introduction
3.1.1 Background
Enzymes are powerful, specific, and essential proteins that catalyse chemical trans-
formations. They are used by cells to catalyse the production of molecules required
during growth, repair, maintenance and death. Nearly all enzymes are proteins,
with the exception of some catalytic RNA molecules, and they carry out catalysis
within an active site. There are thousands of enzymes that together provide a wide
diversity of chemical reactions due to their ability to specifically bind and act on a
wide range of substrates (Berg et al., 2002).
Emil Fisher in 1890 first suggested that an enzyme and its substrate fit together
like a lock and a key, i.e. the two are highly specific for each other and have a
one-to-one relationship. This model was updated in 1958 by Daniel Koshland, who
hypothesised that an enzyme is structurally flexible upon binding the substrate and
produced the induced-fit model of enzyme-substrate binding (Koshland, 1958). This
model reflects the fact that the substrate does not have to be an exact fit to the
enzyme’s active site, which is the reason many enzymes can bind more than one
substrate and potentially catalyse a variety of chemical reactions.
Chemical reactions can be greatly accelerated by the presence of an appropriate
enzyme. Carbonic anhydrase catalysing the hydration of carbon dioxide is one of
the fastest known enzymes. This enzyme can hydrate carbon dioxide at rates up
to 1 million times a second, which is over 6 million times faster than without an
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enzyme (Berg et al., 2002).
As well as a substrate, a number of enzymes also require a cofactor to perform
their activity. Cofactors are small molecules that can be divided between metal
or non-organic molecules, and small organic molecule subgroups. They are often
derived from vitamins and bind either tightly or loosely to the enzyme (Berg et
al., 2002). Such data is stored in resources such as the CoFactor database at the
EMBL-EBI, which contains manually-curated data taken from the literature on 27
small organic cofactors, as well as automatically-derived information (Fischer et al.,
2010).
3.1.2 Characterising the enzyme active site
The active site of an enzyme, typically found in a large surface pocket, plays a key
part in catalysis. It allows the ligand to bind in a solvent-free environment, which
stabilises polar transition states through neighbouring charged residues or metal
ions. As the active site is vital for the performance of an enzyme, the structural
location and the amino acid type of the catalytic residues have been shown by a
number of studies to be generally conserved between enzyme relatives performing
the same chemical reaction. A well-known example is the completely conserved
catalytic triad, Asp-His-Ser found in trypsin, chymotrypsin, and elastase, which
are homologues belonging to the serine protease superfamily. All three hydrolyse
a peptide bond, however they bind and act on different substrates (Krem et al.,
2000), and produce different products. More recent studies have shown that it is
not uncommon for catalytic residues to change in location within the active site
or to change in their amino acid type between relatives in a functionally diverse
homologous superfamily (Dellus-Gur et al., 2013).
During the last decade, the amount of active site and catalytic residue data
available in the literature has risen. This data has been collected and published
online through resources such as the Catalytic Site Atlas (CSA). The CSA stores
information on catalytic site residues derived from the literature, and also from ho-
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mology searches, and defines them as either, a residue: 1) with direct involvement
in the catalytic mechanism, 2) effecting another residue or water molecule directly
involved in the catalytic mechanism, 3) that stabilises a transition-state intermedi-
ate, or 4) that exerts an effect on a substrate/cofactor aiding catalysis. Residues
involved in ligand binding are excluded unless they are involved in one of the four
definitions (Bartlett et al., 2002; Porter et al., 2004).
Bartlett et al. (2002) analysed 615 catalytic residues in 178 enzyme active sites
and reported an average of 3.5 catalytic residues per enzyme. They described most
catalytic residues (65%) as being charged (His, Arg, Lys, Glu, Asp), 27% as being
polar (Gln, Thr, Ser, Asn, Cys, Tyr), and 8% as being hydrophobic (Gly, Ala,
Val, Leu, Ile, Phe, Trp, Pro, Met). Charged residues were abundant as they are
required during catalysis to create electrostatic forces, which enable the movement of
protons and electrons between the acceptor and donor, and they also provide charge
stabilisation. Polar residues also play a part in forming this environment. Bartlett et
al. (2002) concluded that there was no correlation between the abundance of a given
residue type and its contribution to catalysis. They also showed that 50% of the
analysed catalytic residues occurred in loop regions, which is more than expected by
chance, and described lower distributions for alpha helices (28%) and beta-strands
(22%).
3.1.3 Divergence of function across protein domain super-
families
Neidhart et al. (1990) was the first study showing that related enzymes did not
necessarily catalyse identical reactions. They solved the structures of mandelate
racemase (MR) and muconate lactonising enzyme (MLE), through X-ray crystal-
lography, to find that despite being homologous enzymes and therefore sharing a
common (TIM-barrel) structural fold, they catalysed completely different chemical
reactions.
Many other pairs of homologous enzymes have since been shown to catalyse
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different chemical reactions using the same or different catalytic machineries. Struc-
tural determination of protein structures through X-ray crystallography has been
particularly important in identifying and understanding how such events occur. The
Triose Phosphate Isomerase (TIM) barrel fold is an example of a structure support-
ing many diverse functions. TIM is the central enzyme in the glycolytic pathway
and it was the first enzyme found to contain the structural motif of eight parallel
beta-strands, each one followed by an alpha-helix. The eight strands of the beta-
sheet form a barrel-like centre and the helices cover the barrel-like structure, and this
scaffold has frequently been used to perform different enzyme chemistries (Petsko et
al., 1993).
3.1.3.1 Divergence of chemistry and substrate specificities in protein
superfamilies
Studies have been carried out to explore the nature of functional divergence within
multiple superfamilies. Babbitt and Gerlt (1997) discuss a small-scale study of
four enzyme superfamilies whose members share the same TIM barrel structural
fold, or scaffold, but that catalyse different chemical reactions: the Enolase, N-
Acetylneuraminate Lyase, Crotonase, and the Vicinal Oxygen Chelate (VOC) Fold
superfamilies. Babbitt and Gerlt (1997) hypothesised that there is a common chem-
ical reaction step to all superfamily members. They discovered a higher number
of catalytic functions that could be supported by a single structural scaffold than
previously determined. They also found evidence to support that adding new cat-
alytic residues to an active site, whilst conserving the catalytic machinery needed to
catalyse the common reaction step, leads to the divergence of enzyme function. It
was suggested that this common reaction step was involved in stabilising chemically-
similar transition states and intermediates (Babbitt and Gerlt, 1997).
Due to the increase in information associated with these superfamilies, for exam-
ple enzyme reaction mechanism data from wild type and mutant studies, sequence
data from genome sequence projects, and structural data, Gerlt and Babbitt (1998)
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went on to characterise the same four superfamilies further. They also wanted to
better understand whether they could assign an enzyme with unknown function to a
superfamily using only reaction mechanism information. They discovered that defin-
ing a common reaction step between members of these four superfamilies was more
complicated than previously described. The shared step was not always involved in
the stabilisation of transition states or intermediates but could instead be involved
in another part of the reaction, as shown in members of the Vicinal Oxygen Chelate
(VOC) fold superfamily. Members of this superfamily did not catalyse an obvious
shared reaction step but instead used a divalent metal ion to stabilise a negative
charge that occurred in a number of different reaction steps. This example required
the use of structural and genetic information as well as reaction mechanism infor-
mation to deduce the common reaction step between superfamily members (Gerlt
and Babbitt, 1998). These results suggested that for large-scale studies and for
very functionally diverse superfamilies, in order to assign an unknown enzyme to
a superfamily one needs to use a number of different methods rather than simply
looking at reaction mechanism steps.
Todd et al. (2001) analysed 28 enzyme superfamilies known to bind substrates
and found a conservation of chemistry but surprising variations in the diversity of
substrates that were acted on by members of the same superfamily. Different sub-
strates were acted on by different superfamily members in all but one superfamily.
In a high proportion of these superfamilies (20 out of the 28) the substrate speci-
ficity was completely diverse. They varied in their size, chemical properties, and/or
in their structure scaffolds (e.g. if they were aromatic versus linear-chain hydro-
carbons). Enzymes in 6 of the 28 superfamilies bound a common substrate type,
for example nucleic acid, sugars, or phosphorylated proteins. The two remaining
superfamilies had little or no variation in their substrate binding. The phosphoenol-
pyruvate binding domains superfamily consist of members that only bind the sub-
strate phosphoenolpyruvate, and the ribulose-phosphate-binding superfamily whose
substrates, and products, had to have a glycerol or ribulose-phosphate group. This
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is because three out of the five superfamily members catalyse sequential steps in the
biosynthesis of tryptophan and the product of one reaction is the substrate of the
next (Todd et al., 2001).
More recent analyses of functional divergence within highly divergent homologous
superfamilies, but on a much larger scale, have shown that some large superfamilies
contain diverse relatives that catalyse completely different chemical reactions (Des-
sailly et al., 2010). Functional divergence within superfamilies can be explored
through the FunTree resource (Furnham et al., 2012). FunTree reconstructs phy-
logenetic trees for selected CATH superfamilies and highlights functional diversity
through publicly available data on enzyme reaction mechanisms from MACiE and
catalytic residue data from the CSA. Furnham et al. (2012) calculated the distribu-
tion of the number of EC terms for each of FunTree’s 276 CATH superfamilies, and
found that while 49 superfamilies (17.75%) only had one associated EC number,
there are some superfamilies that have numerous, for example the NAD(P)-binding
Rossmann-like domain was highly functionally diverse with 223 unique EC num-
bers. When they ordered the superfamilies by the number of associated sequences,
it was discovered that 10% of enzyme superfamilies accounted for 849 unique func-
tions (i.e. EC numbers), with an average of 35 EC numbers per superfamily. The
remaining superfamilies had an average of 6 EC numbers. The fourth hierarchical
level of an EC number was used to gauge promiscuity; 177 superfamilies showed
functional diversity at this fourth level and in 150 superfamilies at least half of their
EC number diversity was due to changes at the fourth level of EC. A change at the
third level of EC is defined here as a proxy for a change in enzyme chemistry; 176
superfamilies (∼ 64%) have at least one member with an EC that is diverse at the
third hierarchical level (Furnham et al., 2012).
3.1.3.2 Mechanisms of functional divergence
Large scale analyses on the mechanisms of functional divergence were carried out by
the Thornton group on 31 enzyme superfamilies classified in the CATH database (Todd
CHAPTER 3. UNDERSTANDING THE MECHANISMS OF FUNCTIONAL
DIVERSITY IN ENZYME DOMAIN SUPERFAMILIES 105
et al., 2001). They reported that new enzyme functions are frequently due to gene
duplication events and incremental mutations. These incremental mutations may
lead to differences in the catalytic machinery of an active site. Other mechanisms of
functional divergence discussed included: oligomerisation, where two or more copies
of the same protein, or at least one copy of two or more different proteins, form
a protein complex; gene fusion; gene recruitment, where the function of the gene
product depends upon the environment in which it is expressed; gene fission; alterna-
tive gene splicing; exon shuﬄing through intronic recombination; post-translational
modifications; and the presence of different metal ions and/or cofactors in the active
site (Todd et al., 1999; Buljan and Bateman, 2009).
Indels and structural embellishments Reeves et al. (2006) described another
method of functional divergence through the insertion or deletion of amino acid
residues (indels). They manually inspected 48 structurally diverse domain superfam-
ilies in CATH and found short secondary structural insertions, or embellishments,
typically less than 15 residues long, that were usually discontiguous at the sequence
level but often co-located in 3D. These insertions often resulted in a modified active
site structure or a modified protein surface that promoted more diverse domain and
protein interactions. As the majority of the indels were found in the loop regions in
between secondary structure elements, these mutations were shown to be tolerated
because they did not affect the stability of the fold. Residue mutations that do fall
in the structural core and involve changes in the size of the amino acid residues are
generally compensated by shifts in the secondary structure to maintain tight residue
packing (Reeves et al., 2006).
Later studies also showed that indels causing large length differences within
domain superfamilies could affect the function of the protein and promote functional
diversity (Sandhya et al., 2009). Out of the 353 domain superfamilies analysed,
those with at least 4 members had 20% of their domains exhibiting large length
variation due to indels, i.e. a domain was over 30% longer than the average domain
size. Sandhya et al. (2009) reported that these longer domains can: confer extra
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thermal stability, influence subunit interactions and therefore affect the quaternary
structure, affect substrate specificity, and generate new interaction interfaces. A
total of 64 (18.13%) superfamilies had at least 75% of their members showing large
length variation and were termed ‘length-deviant’ superfamilies. Within these 64
superfamilies, domain structural repeats were found to be common in 27 of them.
Diverse domain contexts were found where associations were observed with multiple
copies of the same or different domain superfamilies, and functional interactions
were found with large numbers of different protein domains.
3.1.3.3 Balance between maintaining protein stability and mutations
which drive functional change
Dellus-Gur et al. (2013) hypothesised that there are two main factors in the evolution
of protein function: genetic robustness, where mutations are accumulated but do
not affect function; and innovability, the acquisition of new functions that have di-
verged from the original function. Protein stability provides tolerance to amino acid
mutations, which promotes robustness. For example a highly-ordered, well-packed
protein has a high stability threshold, which allows more destabilising mutations to
accumulate (than if the protein structure had a low stability threshold), and this in
turn promotes innovability. However an increase in stability also means a decrease
in conformational plasticity, which is often required by new functionalities.
Dellus-Gur et al. (2013) looked for evidence of a trade-off between the levels of
innovability and stability to better understand the evolution of function. They anal-
ysed single-domain proteins found in the LUCA (Last Universal Common Ancestor)
with a high-resolution crystal structure (i.e. < 2.5A˚). 43 PDB structures, with a
total of 28 different EC numbers, from only eight folds in CATH (i.e. the same
class, Architecture, and Topology classification) had enough representative exam-
ples. The structures belonging to each fold group were structurally aligned using
MUSTANG (Konagurthu et al., 2006) and scaffold positions were defined as > 70%
conservation of secondary structure in the alignment. The scaffold represents the
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secondary structure elements shared by all enzymes with a given fold.
They found that in protein folds that have carried out a single function through-
out evolution, most of the active site residues (e.g. 60% in dihydrofolate reductase)
are found within the highly stable, and therefore rigid, structural scaffold. How-
ever, multi-functional protein folds such as the TIM barrel were found to have only
around 20% of their active site residues in the structural scaffold and the rest were
found in loops that are able to be more plastic. This is an example of a trade-off
between innovability and structural stability as it allows the structural scaffold to
remain robust, whilst the active site residues evolve at a faster rate to promote new
functionality (Dellus-Gur et al., 2013).
3.1.3.4 Multifunctional and promiscuous enzymes
While it was originally thought that one enzyme only binds one substrate, i.e. the
lock and key hypothesis by Fischer (1890), it is now understood, as discussed al-
ready above, that many enzymes have the ability to interact with more than one
substrate. This multiple substrate specificity enables the catalysis of potentially
multiple chemical reactions, as each different substrate that is bound will catalyse a
single, different chemical reaction. This ability of an enzyme to interact with more
than one substrate, can be due to either: enzyme multi-specificity, where an enzyme
has broad specificity and can therefore bind multiple substrates in its active site;
or promiscuity, where an enzyme coincidentally binds a non-native substrate and
catalyses a reaction which it did not evolve to carry out.
The first notion of enzyme promiscuity came in 1976 when Jensen hypothesised
that while modern enzymes tend to specialise in one substrate and one reaction,
ancient enzymes had very broad specificities (Jensen, 1976). Khersonsky and Taw-
fik (2010) describe enzyme promiscuity as the additional activities an enzyme has
evolved to carry out that are not part of the organism’s physiology. By contrast,
enzymes such as glutathione S-transferases (GSTs) and cytochrome P450s, which
evolved to transform a wide range of substrates are multi-specific, or broad-spectrum
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enzymes, and are not promiscuous. Multi-specificity typically involves the same en-
zyme chemistry being carried out with a range of substrates and therefore only
changes at the fourth EC hierarchical, or EC4, level are observed. Promiscuity how-
ever typically leads to changes at the first, second and third EC hierarchical levels as
very different enzyme chemistries can be performed (Khersonsky and Tawfik, 2010).
Promiscuous enzymes have been shown to catalyse different chemical reactions
with the same active site due to a number of influencing factors: 1) the native
and the promiscuous functions are controlled by different active site configurations;
2) interactions with different substrates; 3) catalytic residues can act in different
protonation states in the native and promiscuous functions; 4) different sub-sites
with the same active site can be used; 5) alternative cofactors may be used; 6) water
molecules may assist promiscuity as they can buffer charges between the active site
and substrate residues, as well as acting as an acid, base or a nucleophile (Khersonsky
and Tawfik, 2010).
Many enzymes are known to perform additional functions that are more often re-
lated to structural or regulatory functions rather than catalysis, which is referred to
as moonlighting (Copley, 2003; Jeffery, 1999). Promiscuity is a form of moonlight-
ing, however it only refers to enzymes that can catalyse different types of chemical
reactions. Distinct biological activities are usually seen in proteins that moonlight,
which may be a product of the protein’s active site or the evolution of other func-
tional sites on the protein. The biological context is frequently a factor in a protein’s
ability to moonlight, and the function of a moonlighting protein can change due to:
a change in the protein’s cellular location; a secreted protein losing its enzymatic ac-
tivity and serving as a growth factor; the cell type in which the protein is expressed;
the oligomeric state, e.g. a multimer could have different functional activity to a
monomer; the cellular concentration of a ligand, substrate cofactor or product; some
proteins having different binding sites for different substrates (Jeffery, 1999).
The E. coli PutA protein is an example of a change in cellular location causing
a change in function. PutA has proline dehydrogenase and pyrroline-4-carboxylate
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dehydrogenase activity inside the plasma membrane, however in the cell cytoplasm
it does not have enzymatic activity and binds DNA as a transcriptional repressor (de
Spicer and Maloy, 1993; Muro-Pastor et al., 1997).
3.1.4 Convergence of function across protein domain super-
families
Aside from functional diversity, functional convergence can occur. Functional con-
vergence has most commonly been studied between superfamilies, i.e. in sets of
non-homologous proteins, or protein domains, that carry out the same, or a related,
biological function using the same catalytic machineries in different structural scaf-
folds. For example, early studies by Drenth et al. (1972) and Kraut (1977), found
that the Ser-His-Asp catalytic triad carried out the same reaction mechanism in two
structurally unrelated proteins: chymotrypsin and subtilisin. Zhang et al. (1994)
later discovered functional convergence in the active sites of tyrosine phosphatases.
Gherardini et al. (2007) performed a large-scale analysis to quantify the amount
of functional convergence occurring between non-homologous protein domains in the
Structural Classification of Proteins (SCOP) database. They looked at two different
types of functional convergence, both at the protein domain fold level. They first
studied mechanistic analogues, which were enzymes that used the same mechanism,
or catalytic machinery, to carry out related reactions, classified using the first three
hierarchical levels of the EC number (EC3). They then studied transformational
analogues, which were enzymes catalysing the same chemical reaction (identical EC
numbers) using different catalytic machineries. Catalytic residues were defined using
data from the CSA. They found that the catalytic triad is the most widespread active
site, with variation occurring in 23 superfamilies. 15% of the 169 EC3 groups were
mechanistic analogues, (i.e. enzymes using the same catalytic machinery to catalyse
related chemical reactions) and 4.7% of the 951 EC4 numbers were transformational
analogues (i.e. enzymes using different catalytic machineries to catalyse the same
chemical reaction). This showed that functional convergence between superfamilies
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is not particularly rare and that more often the same catalytic machinery is used.
Since many studies assumed that proteins with the same EC3 classification per-
formed similar reactions, Almonacid et al. (2010), studied 95 pairs of enzymes in
different superfamilies that catalysed similar chemical reactions to find out whether
the EC3 level of annotation is indeed indicative of overall reaction similarity when
comparing pairs of functionally analogous enzymes (i.e. non-homologous enzymes
carrying out the same enzymatic function). The enzymes pairs were extracted using
MACiE entries that had the same EC3 number, and the CATH database was used to
define non-homologous enzymes. Enzymes were taken from all four CATH structural
classes to provide higher coverage of the data. The overall reaction similarity and
the mechanistic similarity (i.e. comparing each step in the reaction mechanism) for
each enzyme pair was calculated, and compared to a background data set. Reaction
similarity was calculated by comparing the sets of bond changes in the transfor-
mations of substrates and products (O’Boyle et al., 2007). They found widespread
convergence of reaction mechanism steps, for example, cases of unrelated enzymes
that carry out similar, or the same, overall reaction mechanisms (i.e. mechanistic
analogues) with similar or different catalytic machineries. However, in contrast to
the Gherardini study, they found that different catalytic machineries were found to
be used more often. Almonacid et al. (2010) concluded that to perform a similar
chemical reaction mechanism, an enzyme does not need to use the same catalytic
machinery or use a similar 3D environment for its active site.
By contrast, functional convergence after evolutionary divergence can also occur
within homologous superfamilies, which is when relatives within the superfamily use
different catalytic machineries to catalyse similar chemical reactions (Todd et al.,
2002). Here, the gene of the common ancestor has been duplicated and it has di-
verged to produce two primordial enzyme genes carrying out two different functions.
These two enzymes then evolve through independent pathways and functionally con-
verge to carry out the same function using different active-site machineries (Todd
et al., 2002).
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Kuriyan et al. (1991) describe an example of functional convergence between
homologues in the pyridine nucleotide disulphide oxidoreductase superfamily. They
studied the structures of E. coli thioredoxin reductase and glutathione reductase and
discovered that they both catalysed the reduction of disulphide bonds, despite us-
ing different active site residues. The Zinc-peptide superfamily is another example
of functional convergence after evolutionary divergence; the two distantly-related
families, Zn-dependent carboxypeptidases (ZnCP) and Zn-dependent aminopepti-
dases (ZnAP), have a conserved structural core and both families contain three
common types of enzyme: 1) proteases, 2) enzymes performing N-deacylation, and
3) enzymes catalysing the N-desuccinylation of amino acids. The ZnCP and ZnAP
families have therefore evolved their own reaction specificities independently of each
other following their divergence from their common ancestor (Makarova and Grishin,
1999).
3.1.5 Measuring similarities between enzyme chemical re-
actions
The similarity between two enzyme chemical reactions is typically compared using
EC terms and observing whether the numbers are the same at each hierarchical
level. The problem with this is that the similarity cannot be quantified using EC
numbers and the numbers at each hierarchical level do not necessarily represent
reaction similarity if they are close in value. The EC-BLAST algorithm overcomes
this issue by automatically calculating the similarity between two enzyme chemical
reactions through their associated IUBMB reactions (Rahman et al., 2014). The
reaction mechanism similarity is calculated in three different ways, using either bond
change, reaction centre, or substructure information. Bond change represents the
bonds formed or cleaved, the order changes, and stereo changes. The reaction centre
incorporates the atoms directly in contact with the bond being acted on. The small
molecular substructures are the small molecule moieties of the reaction (Rahman et
al., 2014). Figure 3.1a highlights these three different types of reaction mechanism
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characteristics, based on the chemical reaction of catechol O-methyltransferase (EC
2.1.1.6).
(a) Catechol O-methyltransferase (EC 2.1.1.6) chemical reaction.
(b) The three different types of bond changes that occur and their symbols.
(c) Atoms forming the reaction centres are highlighted with red circles. Interacting atoms
are marked with green circles.
(d) Atoms forming common substructures are highlighted with the same coloured circles.
Figure 3.1: Example showing the three different types of reaction mechanism char-
acteristic that are compared to quantify chemical reaction mechanism similarity.
Figures have been taken from the KEGG REACTION database (a) and the EC-
BLAST web site (b-d).
The MACiE (Mechanism, Annotation, and Classification in Enzymes) (Holliday
et al., 2011) resource provides information on enzyme reaction mechanisms. It also
provides tool for comparing these reaction mechanisms. The latest version (3.0)
contains 335 annotated enzyme reaction mechanisms, which correspond to 321 EC
numbers and 372 different CATH superfamilies. Each entry comprises the number
of steps in the reaction, the catalytic residues, and the use of any cofactors. The
reaction similarity between entries can be compared pairwise or through a matrix.
Users can easily search for MACiE entries that have the same EC4 number, and for
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CATH domains that share at least one catalytic domain.
Three different characteristics are scored and incorporated to calculate a single
overall reaction similarity score for the compared entries: 1) the bond change in-
formation, which used the same information as described above, 2) the similarity
of the reaction mechanism at each reaction step, where the bond changes across all
reaction steps are compared, and 3) the catalytic machinery similarity, where first
the complementing catalytic residues are compared, and second their 3D coordinates
are compared through the superposition of structures. The catalytic machinery sim-
ilarity score is a weighted (9:1) combination of these two comparisons. The scores
for these three similarities are weighted and summed to give a final overall similarity
score (Holliday et al., 2011).
3.1.6 Aims and objectives
This work examines functional subfamilies from over 100 enzyme superfamilies in the
CATH database and investigates how enzyme chemistries and catalytic machineries
change between the subfamilies across each superfamily. We also examine whether
changes in catalytic machineries correlate with changes in reaction chemistries. The
location of catalytic residues is also investigated to explore whether there is a pref-
erence for a catalytic residue to be within a secondary structure element or a non-
structured region, i.e. a loop region.
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3.2 Methods
Changes in catalytic machineries have been examined between relatives in en-
zyme domain superfamilies with regards to their physicochemical properties and
structural location. A subset of CATH enzyme superfamilies was created containing
all enzyme superfamilies with CSA data for two or more FunFamSEQ functional fam-
ilies. This allowed for comparisons with at least two sets of experimentally-validated
catalytic sites.
3.2.1 Identification and mapping of catalytic residues
Using the FunFamSEQ functional families (see definition in Section 2.2.1, page 59),
we first identified the superfamily members to be compared. A representative do-
main with known 3D structure was chosen for each functional family in each su-
perfamily. This representative was calculated as the domain with the highest struc-
tural similarity to all other domains within a functional family (see Methods in
Section 2.2.5, page 65).
Catalytic residues were identified for each structural domain, within a func-
tional family, with experimentally-identified catalytic residues in the Catalytic Site
Atlas (CSA) (Porter et al., 2004) (see Methods in Section 2.2.5, page 64). Cat-
alytic residues were mapped onto the functional family representative as described
in Methods Section 2.2.5 (page 65).
Choosing one representative for each functional family reduced the number of
domains whose catalytic residues had to be compared, without losing any infor-
mation as all catalytic residue information for each family was mapped onto the
representative. This was thought to be a reasonable protocol as the FunFamSEQs
had been shown to be functionally pure in the majority of cases.
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3.2.2 Comparing catalytic machinery similarity between func-
tional families
To explore whether catalytic machineries change between functional families in a
superfamily, we first mapped catalytic residues between the functional families. This
was done in two ways: 1) ‘the pairwise alignment-based protocol’ by obtaining a
structure-based pairwise sequence alignment of two functional family representative
domains using SSAP (Taylor and Orengo, 1989) and then selecting known catalytic
residues from equivalent positions in the alignment; 2) ‘the 3D superposition-based
protocol’ by superposing pairs of functional family representative structures and
mapping catalytic residues that co-locate in 3D to within 5A˚.
Subsequently, we compared the physicochemical properties of residues found to
be equivalent catalytic residues between the functional family representatives using
the physicochemical similarity matrix from McLachlan (1972).
Steps in the protocol are described in more detail in Figure 3.2.
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Figure 3.2: The general steps used to score catalytic residue similarity between
functional family representative domains across a given superfamily.
CHAPTER 3. UNDERSTANDING THE MECHANISMS OF FUNCTIONAL
DIVERSITY IN ENZYME DOMAIN SUPERFAMILIES 117
3.2.2.1 Comparing catalytic machineries using the pairwise alignment
method
For each pair of functional families in a superfamily, a pairwise structure-based
sequence alignment was obtained using the structure comparison method SSAP.
The pairwise alignment was used to compare aligned residues where at least one of
the aligned residues was a known catalytic residue. Functional families were only
compared if the representatives aligned well (i.e. with an RMSD less than 5A˚).
For each pair of well-aligned functional family representatives, the similarity in
aligned catalytic residues was measured using the physicochemical similarity matrix
(McLachlan, 1972). This scoring matrix provided a measure of amino acid similar-
ity based upon amino acid polarity, size, shape and charge. Depending on these
characteristics, a pair of amino acids was given a similarity score ranging from zero
to six. A score of zero indicated no similarity or a deletion. The score for a pair
of the same amino acid was typically five, but it was sometimes six for the amino
acids considered less common by McLachlan (1972). These less common amino acids
consisted of: phenylalanine, methionine, tyrosine, histidine, cysteine, tryptophan,
arginine, and glycine (McLachlan, 1972). The score was normalised to give a scoring
range of zero to ten, to avoid having two maximum scores.
Two approaches were used: 1) the ’fully-annotated’ approach where the physic-
ochemical similarity of the aligned residues was scored if both were annotated as
catalytic (A in Figure 3.3), 2) the ’partially-annotated’ approach where at least
one residue should be annotated as being catalytic for an equivalent position to be
scored (B and C in Figure 3.3). The latter approach allows for missing annotations
or mis-annotations in the CSA. In both approaches, a catalytic residue aligned to a
gapped position was penalised with the lowest score of zero (D and E in Figure 3.3).
Scores were accumulated across the catalytic residue positions in an alignment and
divided by the number of positions scored.
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Figure 3.3: Similarities in residues at aligned positions are used to calculate the
catalytic residue similarity between two functional family representative domain
sequences.
3.2.2.2 Comparing catalytic machinery similarity using the 3D structure
superposition method
There may be cases where the same catalytic residues in two related, superposed
structural domains align well in 3D space, but do not align well at the sequence level.
To identify these cases, all pairs of functional family representative domains were
superposed within each superfamily and pairs of catalytic residues were identified
that superposed within a distance of 5A˚ (see Figure 3.4).
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Figure 3.4: The steps taken when calculating catalytic residue similarity between a
given pair of functional family representatives using the 3D structure superposition
mapping protocol.
3.2.3 Comparing chemical reaction mechanisms
To compare the similarity of the chemical reaction mechanisms carried out across
a superfamily, the EC-BLAST algorithm was used to automatically calculate the
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similarity between all IUBMB enzyme reactions observed in the superfamily. These
reactions were mapped from the EC numbers found within each superfamily. En-
zyme reaction comparisons were made with respect to bond change, reaction centre,
and small molecule substructure similarity scores (Rahman et al., 2014).
As we only wanted to compare chemical reaction mechanism similarities between
functional families which had a parent-child evolutionary relationship, information
from FunTree (version 1.0) (discussed in Section 3.1.3.1) phylogenetic trees was used
to describe the evolutionary relationships between FineFam functional families in a
superfamily.
Comparisons of chemical reactions were done in collaboration with Nick Furnham
in the Thornton Group at the EBI, who developed the FunTree resource.
3.2.4 Examining the structural preference of catalytic residues
To find the structural location of catalytic residues the secondary structure prop-
erty of each catalytic residue was determined using the DSSP program. The eight
categories from the DSSP program were reduced down to four by the BioPerl DSSP
module (Stajich et al., 2002): 1) ‘H’ represents helix secondary structure elements
and incorporates alpha helix (H in DSSP), 3/10 helix (G), and Pi helix (I) states;
2) ‘B’ represents beta secondary structure elements and incorporates residues in
isolated beta-bridges (B), and extended strands (E); 3) ‘T’ represents turns, which
includes residues involved in H-bonded turns (T) and bends (S); 4) finally, ‘’ repre-
sents no secondary structure assignment, i.e. loop regions.
The turn and no secondary structure assignment categories were merged into
one and are referred to as loop regions in the chapter. The proportion of catalytic
residues in each of the three categories was used to explore any preference in struc-
tural position.
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3.3 Results
3.3.1 Identifying changes in catalytic machinery between
functional families
Changes in catalytic residues, or catalytic machineries, within and between func-
tional families have been identified and quantified within enzyme superfamilies. A
total of 101 enzyme superfamilies were found to have catalytic site data present in
two or more of their functional family representatives, and these superfamilies were
therefore used in the analysis.
Before examining the changes in catalytic residues across functional families in
our superfamily dataset, we first checked whether the FunFamSEQ functional families
were sufficiently functionally coherent to perform this type of analysis.
3.3.1.1 Examining the purity of the functional families
The previous chapter showed that the Funfamer method generated more function-
ally pure families that the DFX method. However, to examine enzyme superfamilies
in more detail, the functional purity of FunFamSEQ functional families was also con-
sidered by examining the number of EC terms within them. Initial analysis showed
that some FunFamSEQ functional families had multiple EC terms. Subsequently,
the functional purity of each functional family was examined through the struc-
tural comparison of relatives, as well as through catalytic residue and EC number
similarity.
Testing functional coherence within functional families by measuring the
structural similarity of relatives As FunFamSEQ functional families ideally
contain sequences that code for a similar biological function, it was assumed that
relatives would have high structural similarity. This is because previous studies
have shown a correlation between structural and functional similarity (Redfern et
al., 2008; Dessailly et al., 2010).
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All domains within the functional families were pairwise structurally aligned with
SSAP. A SSAP score of 80 or greater has been shown to indicate highly similar ho-
mologous structures (Orengo and Taylor, 1996) and functionally similar homologues
tend to have an RMSD value of less than 3 A˚ (Cuff et al., 2009).
Figure 3.5 shows that in the majority of the 101 superfamilies examined, the
median values for the comparison of FunFamSEQ functional family relatives are
within the SSAP and RMSD thresholds. There are some outliers in a number of
superfamilies.
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(a) SSAP score measure.
(b) RMSD measure.
Figure 3.5: The structural comparison of FunFamSEQ functional family relatives in
the enzyme dataset. Lines are drawn to highlight the points above a SSAP score of
80 and below an RMSD value of 5A˚, which are acceptable thresholds for structural
coherence. Functionally similar homologues tend to have an RMSD < 3A˚.
The ‘Ribonucleotide Reductase Subunit A’ CATH superfamily (ID: 1.10.620.20)
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is an example of a superfamily that contains both structurally coherent and struc-
turally diverse FunFamSEQ functional families. It contains three FunFamSEQ func-
tional families. While all of the domains in one family (ID: 1808 in terracotta)
(Figure 3.6) and most of the domains in a second family (ID: 1818 in blue) are
highly structurally similar, many of the domains in the third family (ID: 1817 in
green) are structurally diverse. The presence of outliers in some FunFamSEQ func-
tional families suggested that these families were not sufficiently structurally and
functionally pure, and should be subclassified for our study of changes in catalytic
residues across superfamilies.
Figure 3.6: The level of structural diversity found within FunFamSEQ functional
families in the superfamily 1.10.620.20. The contours represent the areas of highest
density and the black lines represent the RMSD and SSAP score thresholds.
Testing functional coherence within a functional family by measuring
catalytic residue similarity Another way of finding out whether FunFamSEQ
functional families are functionally coherent is to look at the conservation of func-
tional site residues across the family. The method described in Section 3.2.2 was
used to compare the catalytic residue similarity.
An RMSD filter of 5A˚ was applied to ensure that the sequence alignment was
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based upon structures that were not too divergent from each other. Empirical
analyses by CATH curators have shown at this RMSD it is possible to get accurate
structural alignments of homologues. Figure 3.7 shows that even when this RMSD
filter was applied, there are a few families identified with highly variable catalytic
residues based on both approaches. 33 (36.67%) and 22 (24.44%) of superfamilies
using the fully-annotated and the partially-annotated approaches (see definition in
Methods Section 3.2.2.1, page 117), respectively, have a median similarity value less
than ten.
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(a) Scoring aligned pairs using the fully-annotated approach.
(b) Scoring aligned pairs of residues using the partially-annotated approach.
Figure 3.7: The similarity of catalytic residues within FunFamSEQ functional fam-
ily representatives. Catalytic residues were mapped using pairwise structure-based
sequence alignment information. The data are ranked by median similarity score.
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3.3.1.2 Subclassifying the functional families into subfamilies with greater
functional coherence
To improve their functional coherence, the FunFamSEQ functional families from
the 101 enzyme superfamily data set were subclassified on the basis on their EC
annotations, so that a single EC term was associated with each subfamily. Up
to five functional families per superfamily were split using EC information. 29 of
the 101 superfamilies had at least one functional family split, and 9 of the 101
superfamilies had two or more functional families split. The percentage of families
split are shown in Figure 3.8. These split families will now be referred to as FineFams
(see Figure A.1).
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To explore whether the catalytic residue similarities had increased within func-
tional families following splitting into FineFams, both the ‘fully-annotated’ and
‘partially-annotated’ approaches were used (see Figure 3.9). In 85 superfamilies,
FineFam functional families relatives could be compared as they superposed within
5A˚. Using the fully-annotated approach, 71 superfamilies (83.53%) have pairs of
family representatives with a median similarity score of 10 (see Figure 3.9a). Using
the partially-annotated approach, 78 superfamilies (91.76%) have family pairs with
a median score of 10. These results show a very encouraging increase in catalytic
residue similarity from the FunFams to the FineFams. Approximately 15-20% more
superfamilies have FineFam functional family relatives that align well and have a
median similarity score of ten.
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(a) Scoring aligned pairs using the fully-annotated approach.
(b) Scoring aligned pairs of residues using the partially-annotated approach.
Figure 3.9: Catalytic residue similarity within FineFam functional families. Cat-
alytic residues were mapped using pairwise structure-based sequence alignment in-
formation.
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3.3.1.3 Comparing catalytic machinery similarity between FineFam func-
tional families across superfamilies
To explore the extent to which catalytic machineries can change across superfam-
ilies, catalytic residues were compared between FineFam functional families across
all superfamilies in the 101 dataset. The catalytic residue alignment information,
for all the superfamilies, has been made available online at http://www.cathdb.
info/nataliedawson/csashift/list_all_superfamilies. However for the anal-
yses described below, superfamilies were only included in the analyses if all their
functional family representatives could be superposed within 5A˚. This gave a dataset
of 79 superfamilies.
a. Mapping catalytic residues between functional families using the pair-
wise structure-based sequence alignment protocol Surprisingly, only 14
(17.72%) superfamilies have a median similarity score of at least 5 using the fully-
annotated approach and 31 (39.24%) superfamilies using the partially-annotated
approach (see Figure 3.10). Figure 3.10 reports a wide range of different catalytic
machineries used between relatives for the majority of superfamilies analysed. In
addition, there is no clear correlation between the number of FineFam functional
families analysed in a superfamily and the catalytic residue similarity score.
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(a) Scoring aligned pairs using the fully-annotated approach.
(b) Scoring aligned pairs of residues using the partially-annotated approach.
Figure 3.10: Catalytic residue similarity between FineFam functional family rep-
resentatives. Catalytic residues were mapped using the pairwise structure-based
sequence alignment protocol.
b. Mapping catalytic residues between functional families using the 3D
superposition protocol If one uses spatial information to identify equivalent cat-
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alytic residues between functional families, a similar range of similarity scores are
observed between FineFams (see Figure 3.11). In only 16 (20.25%) and 34 (43.04%)
superfamilies, using the fully-annotated and partially-annotated approaches, respec-
tively, a similarity score of at least five is reported. For the majority of families there
is considerable change in the catalytic residues in the active site.
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(a) Scoring aligned pairs using the fully-annotated approach.
(b) Scoring aligned pairs of residues using the partially-annotated approach.
Figure 3.11: Catalytic residue similarity between FineFam functional family repre-
sentatives. Catalytic residues were mapped using the 3D superposition-based pro-
tocol.
Figure 3.12 compares the similarity scores for each FineFam pair obtained using
either the pairwise sequence alignment based protocol to identify equivalent catalytic
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residues (x-axis) or the 3D structure superposition based protocol (y-axis). The
‘partially-annotated’ approach was used to assess catalytic residue similarities.
Figure 3.12: Comparing the pairwise alignment-based catalytic residue similarity
score against the 3D superposition-based catalytic residue similarity score for each
pair of FineFam representative domains. The number of pairs compared is noted in
each quadrant.
Figure 3.12 shows that there is a correlation between the schemes’ scores for some
functional families and that the most populated quadrants are those representing
low pairwise sequence alignment- and low 3D structure superposition-based scores,
and high pairwise sequence alignment- and high 3D structure superposition-based
scores.
Unsurprisingly, a large number (233, 29.68%) of FineFam pairs have a high pair-
wise alignment-based similarity score accompanied with a high 3D superposition-
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based similarity score. As would also be expected, a correlation is seen between low
pairwise alignment-based and low 3D superposition-based scores and the majority
of pairs (476, 60.64%) are in this category. A Pearson’s product-moment correlation
of 0.872 was calculated between all pairs of similarity scores.
Despite this high correlation between the two types of similarity score, variation
can be observed between some pairs. For example, 51 FineFam pairs have catalytic
residues that do not align well when using a pairwise structure-based sequence align-
ment but that closely co-locate in 3D. This may suggest that relatives in different
functional families have evolved to perform similar functions using the same cat-
alytic residues, but these residues are contributed from different positions in the
sequence.
A pair of functional family representatives from the ‘Butyryl-CoA Dehydroge-
nase, subunit A, domain 3’ CATH superfamily (ID: 1.20.140.10) are an example
of two functional families having a catalytic residue similarity scores of 0 and 10
depending on whether they are mapped by the pairwise sequence alignment or the
3D superposition protocol, respectively. Figure 3.13 illustrates the superpositions
of the two representatives and highlights a catalytic glutamic acid residue, which is
not found at the same position in the sequence (see Figure 3.14) but is co-located
to within 5A˚ in the two domain structures.
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Figure 3.13: Two functional family representative domains whose catalytic residues
superpose within 5A˚ but that do not align at the sequence level. The domains
represent subunits of isovaleryl-CoA dehydrogenase (CATH domain ID: 1ivhA03
in light pink) and acyl-CoA dehydrogenase (CATH domain ID: 3mddA03 in light
blue).
Figure 3.14: Pairwise structure-based sequence alignment with SSAP of the two
functional family representatives, 1ivhA03 and 3mddA03, visualised in Jalview (Wa-
terhouse et al., 2009). The single glutamic acid residue used by both domains does
not align and can be found at opposite ends of the alignment (see asterisks).
In the bottom-right quadrant of Figure 3.12, a small number (25) of FineFam
pairs are reported to have high similarity using the pairwise alignment protocol and
a low similarity using the 3D superposition protocol. This may suggest that some
relatives in different functional families have structural embellishments that result
in the catalytic residues being positioned in different spatial position despite being
in a similar sequence position.
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When comparing the conservation of functional residues between two closely re-
lated protein domains via a structure-based sequence alignment, there is no bench-
marked RMSD value that reflects sufficient structural similarity to ensure an accu-
rate alignment. In order to ensure that our protocol gave an accurate alignment
of catalytic residues we have only compared functional family representatives that
superpose within an RMSD of 5 A˚. However even at this threshold relatives may be
too diverse, and this could be the cause of the wide range of catalytic residue similar-
ities reported across superfamilies. A cut-off RMSD of 3A˚ was therefore also used
to examine whether such variation is observed between more structurally-similar
domains. Figure 3.15 shows that the range of catalytic residue similarity is still just
as varied when using the lower RMSD threshold, i.e. a significant proportion of
superfamilies are still showing low similarity in catalytic residue machinery between
functional families.
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(a) Scoring aligned pairs using the fully-annotated approach.
(b) Scoring aligned pairs of residues using the partially-annotated approach.
Figure 3.15: The catalytic residue similarity between FineFam functional family
representatives, which superpose within 3A˚.
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3.3.2 Exploring whether different catalytic machineries used
within enzyme superfamilies are associated with dif-
ferent enzyme chemistries
In the last section, catalytic residue similarity scores were reported across 79 su-
perfamilies. Of these superfamilies, 72 have FineFam functional families which use
different catalytic machineries (see Figure 3.16) where different catalytic machiner-
ies are defined by having a catalytic residue similarity score less than five. We
examined whether changes in catalytic machinery were associated with changes in
enzyme chemistry, which were measured using EC terms. If the relatives have the
same EC number at the third hierarchical level they were assumed to have the same
enzyme chemistry.
Figure 3.16 shows the number of functional families that use different catalytic
machineries in each of the 72 superfamilies. These superfamilies are divided ac-
cording to the number of functional families that perform: 1) different enzyme
chemistries, 2) the same enzyme chemistry but act on different substrates, or 3) the
same enzyme chemistry and act on the same substrate.
In 50 superfamilies there are between 2 and 30 functional families where changes
in catalytic machinery are associated with changes in enzyme chemistry (see red
in Figure 3.16). Not reported previously on this scale, there are 54 superfamilies
with functional families using different catalytic machineries to perform the same
enzyme chemistry. Of these 54, 38 superfamilies have between 2 and 18 functional
families that act on different substrates, i.e. they differ at fourth EC hierarchical
level (see blue in Figure 3.16). While the residues from the CSA do not contain
substrate-binding residues, some of the CSA residues could be involved in roles
associated with the different substrates, for example stabilising the different inter-
mediates. Interestingly, the remaining 16 of these 54 superfamilies each contain two
or three functional families that use different catalytic machineries to perform the
same enzyme chemistry with the same substrate (see yellow in Figure 3.16).
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An example of two relatives that use different catalytic machineries to perform
the same enzyme chemistry comes from the Thiamine diphosphate (TPP)-dependent
domain superfamily (CATH ID: 3.40.50.970). Figure 3.17 shows the superposition
of two TPP domains from pyruvate decarboxylase (PDC) and benzoylformate de-
carboxylase (BFD), which are both carboxy-lyase enzymes but they use different
catalytic residues. Carboxy-lyases, also known as decarboxylases, catalyse the ad-
dition or the removal of a carboxyl group to or from a compound.
Both domains have a common histidine. In BFD, Glu28 is reported to possibly
form a protein relay system with His70, through hydrogen bond formation (Polovnikova
et al., 2003) and as PDC also has a negatively-charged (Asp28) and positively-
charged (His114 / His115), these residues could also form a protein relay system.
Polovnikova et al. (2003) reported that, apart from the residues bound to the TPP
cofactor, there is a general lack of conserved residues in the active site of TPP-
dependent enzymes. A number of studies have reported however, that the histidine
catalytic residues present in both PDC and BFD are positioned similarly with re-
spect to the TPP cofactor (Arjunan et al., 1996; Dyda et al., 1993; Hasson et al.,
1998). Figure 3.18 illustrates the sequence alignment and highlights the differences
in catalytic residue sequence positions between the two domains.
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Figure 3.17: Two functional families from the Thiamine diphosphate (TPP)-
dependent domain superfamily (CATH ID: 3.40.50.970) use different catalytic ma-
chineries to perform the same carboxylyase enzyme chemistry. Domains 1pvdA01 (in
light blue) and 1bfdA02 (in light pink) are from the enzymes pyruvate decarboxylase
(EC 4.1.1.1) and benzoylformate decarboxylase (EC 4.1.1.7), respectively.
Figure 3.18: Pairwise structure-based sequence alignment with SSAP of the two
functional family representatives, 1pvdA01 and 1bfdA02, visualised in Jalview (Wa-
terhouse et al., 2009). The two domains use different catalytic residues that do not
align at the sequence level (see asterisks), however the domains perform the same
reaction mechanism.
Clearly, two functional family representatives with a catalytic residue similarity
score less than 5 still have some similarity in catalytic machinery, as shown here with
the common histidine residue and the common negatively charged residue. Similarly,
the 37 other superfamilies with some changes in catalytic residues and acting on
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different substrates will also show some similarity in catalytic residues in terms of
physicochemical properties conservation or residue location conservation. This is
expected in agreement with the early work of Babbitt and Gerlt (1997) and Todd
et al. (2001), who showed that substrate specificity is more likely to change than
chemistry across a superfamily. They also showed that catalytic residues must be
conserved within the active site to enable the common reaction steps to be preserved
across the superfamily.
3.3.3 Examining the correlation between catalytic machin-
ery and reaction mechanism across a superfamily
To explore these concepts further, we examined how frequently a change in cat-
alytic machinery across a superfamily was accompanied by a change in the enzyme
chemical reaction mechanism. The catalytic residue similarity score between pairs
of FineFam functional families, measured using the McLachlan scoring matrix (see
Methods Section 3.2.2.1, page 119), was used to report a change in catalytic ma-
chineries, and the reaction mechanism similarity score, was measured using EC-
BLAST (see Methods Section 3.2.3, page 119). To ensure the accuracy of the study,
only functional families which had been assigned SwissProt-curated EC4 terms were
used.
Figures 3.19, 3.20, and 3.21 plot the catalytic residue similarity score and the
reaction mechanism similarity score between pairs of functional family representa-
tives. While there is no clear correlation between these two properties there are a
number of functional family pairs (shown in the top-right quadrants) that perform
the same reaction mechanisms using the same catalytic machineries. Also, unsur-
prisingly, there is a greater density of points in each of the bottom-left quadrants, i.e.
changes in catalytic residues accompanied by differences in bond changes, reaction
centres, and substructures.
CHAPTER 3. UNDERSTANDING THE MECHANISMS OF FUNCTIONAL
DIVERSITY IN ENZYME DOMAIN SUPERFAMILIES 145
Figure 3.19: Correlating catalytic residue similarity with similarity in bond change.
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Figure 3.20: Correlating catalytic residue similarity with similarity in reaction cen-
tre.
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Figure 3.21: Correlating catalytic residue similarity with similarity in substructure.
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Reaction mechanism similarity data was not available for all functional family
representative pairs. A total of 228 functional family representative domain pairs
could be assigned a catalytic residue similarity score as well as a bond change sim-
ilarity score. Since similarity in chemistry will be reflected by a similarity in the
bond changes, Figure 3.19 is discussed in more detail below.
Different catalytic machinery, different reaction mechanism (bottom-left
quadrant) In 103 functional family pairs (45.18%), changes in catalytic machiner-
ies are accompanied by differences in bond change. An example of two functional
families within a superfamily which have diverged in both catalytic machinery and
in reaction mechanism (i.e. bond change) is provided by the ‘NAD(P)-binding
Rossmann-like domain’ CATH superfamily (ID: 3.40.50.720). Precorrin-2 dehydro-
genase (P2DH) (EC 1.3.1.76) and adenosylhomocysteinase (AHS) (EC 3.3.1.1) both
have catalytic residues present in loop regions: P2DH has a C-terminal Asp141 while
AHS has a C-terminal His300 and a N-terminal Cys194 (see Figure 3.22 in red and
blue, respectively).
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(a)
(b)
Figure 3.22: Examining two functional family representatives from the ‘NAD(P)-
binding Rossmann-like domain’ superfamily (ID: 3.40.50.720) which have no simi-
larity in either their catalytic residues or in their reaction mechanisms, circled in
Subfigure (a). Subfigure (b) The superposition of the two functional family repre-
sentative domains. They contribute to catalytic activity in adenosylhomocysteinase
(CATH domain ID: 1b3rA01 in light blue) and precorrin-2 dehydrogenase (CATH
domain ID: 1kyqA01 in light pink). Their catalytic residues are shown in blue and
red, respectively.
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(a) Adenosylhomocysteinase (EC 3.3.1.1, reaction ID: R00192): S-Adenosyl-L-
homocysteine + H2O <=> Adenosine + L-Homocysteine
(b) Precorrin-2 dehydrogenase (EC 1.3.1.76, reaction ID: R03947): Precorrin 2 + NAD+
<=> Sirohydrochlorin + NADH + H+
Figure 3.23: Examining two functional family representatives from the ‘NAD(P)-
binding Rossmann-like domain’ superfamily (ID: 3.40.50.720) which have no similar-
ity in either their catalytic residues or in their reaction mechanisms. Subfigure (a)
describes the chemical reaction catalysed by precorrin-2 dehydrogenase. Thick ar-
rows identify the two bonds broken and the two bonds formed. Thick rings identify
the single stereo change. Subfigure (b) describes the chemical reaction catalysed
by adenosylhomocysteinase. Thick arrows identify the bonds cleaved/formed. The
subfigures have been adapted from images taken from the EC-BLAST web site.
Different catalytic machinery, same reaction mechanism (bottom-right
quadrant Surprisingly, and not reported on this scale in previous work, there are
56 pairs of functional families with different catalytic machineries associated with
the same, or highly similar, bond changes. These are possible cases of functional
convergence and we have examined some of the examples from this category below.
Within the CATH ‘Vaccinia Virus protein VP39’ superfamily, domains from the
enzymes caffeate O-methyltransferase and catechol O-methyltransferase use different
catalytic machineries but are associated with the same bond changes during the
two different enzymatic reactions. Both enzymes have methytransferase activity
(EC 2.1.1.-). The caffeate O-methyltransferase has a single catalytic histidine at
position 269 while the catechol O-methyltransferase has a lysine residue at position
144 and a glutamic acid residue at position 199. The His269 and the Lys144 are
at different sequence positions in the pairwise alignment of the functional family
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representatives, but they are similar residue types and they closely co-locate in 3D
space when superposed (see Figure 3.24). The CSA reports that His269 functions
as a base to deprotonate an hydroxyl group on the reactant molecule (Furnham et
al., 2014) and it is likely that the Lys144 would have a similar basic role.
To examine the similarities between the two enzyme reactions further, the bonds
cleaved and formed were identified through EC-BLAST. Figures 3.25a and 3.25b
show the identical bond changes made.
(a)
(b)
Figure 3.24: Examining two functional family representatives from the ‘Vaccinia
Virus protein VP39’ CATH superfamily (ID: 3.40.50.150) which have no catalytic
residue similarity but perform the same bond changes, circled in Subfigure (a).
Subfigure (b) shows the superposition of the two functional family representative
domains. They are responsible for catalytic activity in caffeate O-methyltransferase
(CATH domain ID: 1kywA02 in light pink) and catechol O-methyltransferase
(CATH domain ID: 1vidA00 in light blue). Their catalytic residues are shown in
red and blue, respectively.
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(a) Catechol O-methyltransferase (EC 2.1.1.6, reaction ID: R00827): S-Adenosyl-L-
methionine + Catechol <=> S-Adenosyl-L-homocysteine + o-Methoxyphenol
(b) Caffeate O-methyltransferase (EC 2.1.1.68, reaction ID: R06575): S-Adenosyl-L-
methionine + Caffeyl alcohol <=> S-Adenosyl-L-homocysteine + Coniferyl alcohol
Figure 3.25: Examining two functional family representatives from the ‘Vaccinia
Virus protein VP39’ CATH superfamily (ID: 3.40.50.150) which have no catalytic
residue similarity but perform the same bond changes. Subfigure (a) describes the
chemical reaction catalysed by catechol O-methyltransferase. Thick arrows identify
the two bonds cleaved and the two bonds formed. Subfigure (b) describes the
chemical reaction catalysed by caffeate O-methyltransferase. Thick arrows identify
the same two bonds cleaved and the same two bonds formed. The subfigures have
been adapted from images taken from the EC-BLAST web site.
Same catalytic machinery, different reaction mechanisms (top-left quad-
rant) The top-left quadrant of Figure 3.19 shows that a change in bond change
reaction mechanism is sometimes achieved without a large, or any, change in the
catalytic machinery. There are 38 pairs (16.7%) of homologous functional family
representative domains that use similar, or identical, catalytic machineries to catal-
yse different enzymatic reactions.
Examining two enzymes with the same catalytic machinery in the Class I glu-
tamine amidotransferase CATH superfamily (ID: 3.40.50.880), anthranilate synthase
(AS) (EC 4.1.3.27) and carbamoyl-phosphate synthase (CPS) (EC 6.3.5.5) catal-
yse different chemical reactions with the same catalytic machinery. The partially-
annotated approach found a common catalytic triad of Cys-His-Glu in both domains:
i.e. there is a glutamic acid residue in the domain of CPS that was missing from
the CSA. The presence of this Cys-His-Glu catalytic triad is supported by the work
of Thoden et al. (1997), who found the small subunit of CPS (i.e. 1bxrB02) has
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glutamine amidotransferase activity. This catalytic triad is found to be conserved
in all domains with this enzymatic activity, e.g. the TrpG domain in AS (Spraggon
et al., 2001).
Figure 3.26 shows the identical positions of the catalytic residues between CATH
domains IDs 1i7qB00 (AS) and 1bxrB02 (CPS), which represent subunits of these
two enzymes. 1i7qB00 represents the TrpG subunit from AS; TrpG produces an
intermediate in the formation of ammonia from a bound glutamine (Spraggon et al.,
2001). 1bxrB02 represents the small subunit from CPS that also produces ammonia
by hydrolysing a bound glutamine. The ammonia is then used by the large subunit
to produce carbamate (Thoden et al., 1999).
Whilst both domains are annotated in the literature as catalysing two different
EC enzymatic reactions the domains are actually performing the same function of
converting glutamine to ammonia. Therefore, the fact that this functional family
pair appear in the ‘different reaction mechanisms’ quadrant is the result of the EC
number capturing the functional annotation at the whole-protein level rather than
at the domain level.
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(a)
(b)
Figure 3.26: Examining two functional family representatives from the Class I glu-
tamine amidotransferase CATH superfamily (ID: 3.40.50.880) which have a high
catalytic residue similarity of ten but a low similarity in bond change (0.1790),
circled in Subfigure (a). Subfigure (b) shows the superposition of the two func-
tional family representative domains. They are responsible for catalytic activity in
anthranilate synthase (AS) (CATH domain ID: 1i7qB00 in light pink) from Serra-
tia marcescens and carbamoyl-phosphate synthase (CPS) (glutamine-hydrolysing)
from Escherichia coli (strain K12) (CATH domain ID: 1bxrB02 in light blue). Their
catalytic residues are shown in red and blue, respectively.
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(a) EC 4.1.3.27 (R00986): Chorismate + L-Glutamine <=>Anthranilate + Pyruvate +
L-Glutamate
(b) EC 6.3.5.5 (R00256): L-Glutamine + H2O <=>L-Glutamate + Ammonia
Figure 3.27: Examining two functional family representatives from the Class I glu-
tamine amidotransferase CATH superfamily (ID: 3.40.50.880) which have a high
catalytic residue similarity of ten but a low similarity in bond change (0.1790).
Subfigure (a) describes the chemical reaction catalysed by anthranilate synthase.
Subfigure (b) describes the chemical reaction catalysed by carbamoyl-phosphate
synthase. Thick filled arrows identify the bonds formed/cleaved. Thick white-
headed arrows identify bond order changes. Thick black circles identify bond stereo
changes. The subfigures have been adapted from images taken from the EC-BLAST
web site.
Therefore, to avoid similar problems with other examples from this quadrant, we
took a second example from a different superfamily, the Aldolase Class I superfamily,
where the protein function is associated with a single domain. We selected the
yeast L-lactase dehydrogenase (also known as flavocytochrome b2, or FCB) and
spinach glycolate oxidase (GOX) enzymes. They use the same catalytic residues to
perform different enzymatic reactions: FCB is a dehydrogenase (EC 1.1.2.3) whereas
GOX is an oxidase (EC 1.1.3.15). Both are flavoprotein enzymes that catalyse the
oxidation of different L-alpha-hydroxy acids. The flavoprotein enzyme family is well
characterised with members sharing a number of properties. These enzymes bind
the cofactor flavin and feature six conserved active site residues around this cofactor
binding site in highly similar spatial positions (Macheroux et al., 1993; Maeda-Yorita
et al., 1995). Figure 3.28 shows the superposition of the two domains and the six
catalytic residues.
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Interestingly, the first steps in the two enzymatic reactions (see Figure 3.29) are
similar in that the lactate substrate of FCB and the glycolate substrate of GOX
are both oxidised and the FMN cofactor is reduced. Subsequently the reactions
diverge: in the FCB-catalysed reaction, the electrons from the FMN are transferred
to a haem moiety (through a semiquinone intermediate) and then on to cytochrome
c (Xia et al., 1987). In the GOX-catalysed reaction, the reduced FMN is reoxidised
by oxygen to hydrogen peroxide (Lindqvist, 1989).
(a)
(b)
Figure 3.28: Examining two functional family representatives from the Aldolase
Class I superfamily (ID: 3.20.20.70) which have a high catalytic residue similarity of
ten and a low bond change similarity of 0.357, circled in Subfigure (a). Subfigure (b)
shows the superposition of the two functional family representative domains. They
are responsible for catalytic activity in yeast flavocytochrome b2 (FCB) (EC 1.1.2.3,
CATH domain ID: 1fcbA02 in light blue) and spinach glycolate oxidase (GOX) (EC
1.1.3.15, CATH domain ID: 1goxA00 in light pink). Their catalytic residues are
shown in blue and red, respectively.
CHAPTER 3. UNDERSTANDING THE MECHANISMS OF FUNCTIONAL
DIVERSITY IN ENZYME DOMAIN SUPERFAMILIES 157
(a) EC 1.1.2.3 (R00196): (S)-Lactate + 2 Ferricytochrome c <=>Pyruvate + 2 Ferrocy-
tochrome c + 2 H+
(b) EC 1.1.3.15 (R00475): Glycolate + Oxygen <=>Glyoxylate + Hydrogen peroxide.
Figure 3.29: Examining two functional family representatives from the Aldolase
Class I superfamily (ID: 3.20.20.70) which have a high catalytic residue similar-
ity of ten and a low bond change similarity of 0.357. Subfigure (a) describes the
chemical reaction catalysed by yeast flavocytochrome b2. Subfigure (b) describes
the chemical reaction catalysed by spinach glycolate oxidase. Thick filled arrows
identify the bonds formed/cleaved. Thick black circles identify bond stereo changes.
Thick white-headed arrows identify bond order changes. The subfigures have been
adapted from images taken from the EC-BLAST web site.
3.3.4 Examining whether catalytic residues are preferen-
tially located in loop or secondary structure regions
To examine whether catalytic residues are preferentially located in a particular struc-
tural element, the secondary structure properties of each catalytic residue in each
superfamily were obtained through DSSP file information. Figure 3.30a shows that
the majority of alpha-class superfamilies have > 50% of their catalytic residues in
alpha-helices. On the other hand, the majority of beta-class and alpha-beta class
superfamilies have > 50% of their catalytic residues in loop regions.
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(a) Alpha CATH class.
(b) Beta CATH class.
(c) Alpha-beta CATH class.
Figure 3.30: The location of catalytic residues within different types of secondary
structure elements for superfamilies in different CATH class classifications.
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The Two Sample t-test statistical hypothesis test was used to examine whether
there was a significant difference in the percentage of catalytic residues found in loop
regions, based upon the CATH class or topology of the superfamily data. Beta and
alpha-beta class superfamilies were found to have significantly higher percentage
of catalytic residues in loops than the alpha class, than by chance (t(22)=-2.4038,
p < 0.02509, and t(88)=-2.3084, p < 0.02332, respectively). No significant difference
was found between beta and alpha-beta class superfamilies.
We then examined in closer detail the alpha-beta superfamilies with TIM barrel
or Rossmann folds to investigate the preferential structural elements for catalytic
residues in folds well known to support diverse functions. Almost 40% (29) of the 77
superfamilies with an alpha-beta CATH class classification belong to either the TIM
barrel (CATH ID: 3.20.20) or Rossmann (CATH ID: 3.40.50) fold. The majority of
these superfamilies have at least half of their catalytic residues in loop regions; 6
(out of 9, 67%) superfamilies with a TIM barrel fold have > 50% of their catalytic
residues in loop regions (see Figure 3.31a) and 15 (out of 20, 75%) superfamilies
with a Rossmann fold have > 50% of their catalytic residues in loop regions (see
Figure 3.31b). These results agree with the findings from Bartlett et al. (2002)
and Dellus-Gur et al. (2013), who found that catalytic residues tend to be found in
the loop-regions of a protein structure, particularly if the protein has a highly stable
structural scaffold and innovable fold, such as the TIM barrel fold.
However, the Two Sample t-test did not find the highly innovable TIM barrel
and Rossmann folds to have significantly more catalytic residues in loops than by
chance when compared to other folds in the alpha-beta class.
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(a) TIM barrel fold (CATH Topology: 3.20.20).
(b) Rossmann fold (CATH Topology: 3.40.50).
Figure 3.31: The location of catalytic residues within different types of secondary
structure for the TIM barrel and Rossmann fold groups.
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3.4 Conclusions and future work
In this chapter changes in catalytic machineries have been explored between
functional families in the same homologous superfamily. A total of 101 superfamilies
were found to have CSA residue information in at least two functional families and
were used in the analysis.
While the FunFamSEQ functional families were described in the previous chap-
ter as containing structurally similar domains and being of good functional purity,
further examination has highlighted that some functional families contained fairly
structurally diverse domains and multiple EC terms. The FunFamSEQs were there-
fore split into FineFams, where each FineFam has a single EC number annotation.
Following this splitting process, greater similarity in catalytic machinery was ob-
served within the functional families.
When comparing the catalytic machinery of two functional family representa-
tives, an RMSD cut-off of 5 A˚ was used to ensure that the two superposed domains
were not structurally diverse, as this would affect the sequence alignment. A total of
79 CATH enzyme domain superfamilies had functional family representatives that
could be aligned well to compare their catalytic residues, and these were compared
with regards to their physicochemical properties. Two different approaches were
used, which either scored pairs of catalytic residues that were both annotated by
the CSA (i.e. the ‘fully-annotated’ approach) or that scored pairs where at least
one residue in the pair was annotated by the CSA (i.e. the ‘partially-annotated’
approach). The latter approach was used to identify potential catalytic residues
that are missing from the CSA. Considerable variation in catalytic machineries has
been observed across the majority (> 60%) of superfamilies.
We examined whether a change in catalytic machinery is accompanied by a
change in reaction mechanism. Information on bond change, reaction centre, and
substructure similarity was used to characterise reaction mechanism similarity. No
clear correlation was found. Comparing functional families across a superfamily,
the smallest percentage of comparisons showed the same catalytic residues and the
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same reaction mechanism, whether measured by bond change, reaction centre, or
substructure similarity. Perhaps unsurprisingly, the largest percentage showed dif-
ferences in catalytic residues accompanied by differences in chemistry. Interestingly,
quite a large proportion of functional family comparisons revealed that the same cat-
alytic machineries were supporting different chemistries. Most of the time, changes
are occurring in the substrate, this suggests that the chemistry enabled by a par-
ticular arrangement of catalytic residues has been exploited to operate on different
substrates or in different enzyme complexes/metabolic pathways. It would be inter-
esting to examine these in more detail in the future.
Perhaps most interesting was the observation that in nearly one quarter of func-
tional families, we observed that different catalytic machineries were performing
the same bond changes. For example, we reported two domains in caffeate O-
methyltransferase and catechol O-methyltransferase which have no similarity in
their catalytic machineries, the former uses a single histidine and the latter uses
a glutamic acid and a lysine, yet each cleave/form one O-H hydrogen bond and
cleave/form one sulphur-carbon bond. This observation is on a much larger scale
than reported by previous studies and supports early studies of Babbitt (Babbitt and
Gerlt, 1997) and Thornton (Todd et al., 2001) which reported conservation of one
or more steps in the reaction pathway. A large proportion of these functional family
pairs were associated with changes in substrate and therefore may reflect changes
in residues that are associated with substrate interactions and stabilising transition
states. In other words, the key catalytic residues may be similar in these functional
family pairs but changes of residues (marked as catalytic residues by the CSA) may
be necessary for specific chemical interactions with the different substrates during
the reaction steps. Even more surprising and interesting, was the observation of
quite a significant proportion of pairs of functional families with different catalytic
machineries and the same chemical reaction performed on the same substrate. In
this scenario, it is possible that mutations in residues in the active site are subject
to neutral drift, which can remove catalytic properties, and are then followed by
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further mutations that restore catalytic activity by providing a new arrangement of
catalytic residues which can also perform the same reaction.
To compare the reaction mechanisms of two functional family representatives,
they must have an EC number as this will be associated with at least one IUBMB
enzyme reaction code. EC-BLAST uses the first IUBMB reaction code to calculate
the reaction mechanism similarity. It has not been possible to compare all pairs
of chemical reactions as EC-BLAST requires that a chemical reaction is chemically
balanced and this was not possible with a number of entries.
We also examined whether catalytic residues prefer being located within a par-
ticular structural element. We used the full set 101 CATH superfamilies that have
two or more functional families with CSA residue information. The majority of
superfamilies in each CATH class had at least half of their catalytic residues in loop
regions with 61.54%, 72.73%, and 51.95% of superfamilies in the alpha, beta, and
alpha-beta classes, respectively. The TIM and Rossmann superfamilies make up
40% of the 77 analysed alpha-beta superfamilies and the majority (88.76%) have at
least half of their catalytic residues in loop regions.
Beta and alpha-beta class superfamilies are perhaps more likely to have catalytic
residues in their loop regions, as they are thought to possess stable structural scaf-
folds comprised of beta sandwiches and beta barrels. These scaffolds often support
many different functions and all feature loops clustered around the active site. In
the alpha-beta superfamilies, the active site is generally found at the C-terminal
ends of beta strands, as well as in the loops that link the beta strands with alpha
helices. These loops do not contribute to protein stability (Dellus-Gur et al., 2013)
and therefore insertion of residues at these positions can easily change the geometric
and physicochemical properties of the active site. We are currently analysing the
preference for catalytic residues in loop regions in all superfamilies with structural
scaffolds comprising beta sandwiches or beta barrels.
Chapter 4
Functional Analysis of the Human Oral
Metagenome
4.1 Introduction
4.1.1 Metagenomics and the microbiome
Metagenomics is a relatively new field that analyses DNA extracted from any given
environment to examine the species composition and functional ability of the mi-
crobial community found in that environment. The term ‘metagenomics’ was first
used by Handelsman et al. (1998). The first large-scale metagenomic studies were
carried out in 2004 by Tyson et al. (2004) and Venter et al. (2004) who studied the
genomes of microorganisms within an acid mine drainage biofilm, and within ocean
water samples, respectively.
Before metagenomics, genome sequences could only be studied if the organism
could be cultivated in the laboratory. This provided a biased view of bacterial
life on earth as it is estimated that only approximately 1% of all microbes can be
cultured (Hugenholtz et al., 1998; Foerstner et al., 2006; Kristiansson et al., 2009).
As the species within the sampled environment do not require cultivating in the
laboratory, the new sequencing technologies exploited by metagenome studies can
provide a relatively unbiased view of the community structure, also termed the
microbiome, and its functional repertoire.
Following the large-scale studies from Tyson et al. (2004) and Venter et al. (2004),
whole-genome shotgun sequencing and sequence read assembly has been increasingly
used to sequence and study mixed microbial communities.
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4.1.2 Experimental characterisation of the metagenome
Characterising microbial species Before the 1980s, researchers would char-
acterise a species by publishing summary tables of phenotypic traits, for example
whether the bacterium was gram-positive or gram-negative (Woese, 1987; Clarridge,
2004; Kim et al., 2011). There was frequently no match to the query species and
an educated guess had to be made. Such methods were dependent on being able
to culture the organism in the laboratory, and as more and more organisms were
being discovered, this method proved subjective and unreliable (Clarridge, 2004).
As previously mentioned, there are also few well-characterised microbes.
In 1965, Dubnau et al. discovered that the 16S rRNA gene in Bacillus species
was highly conserved. Pioneering work from Woese (1987) then showed that the 16S
rRNA gene sequence could be used across all kingdoms to identify species through
sequence similarity searches. This was due to the 16S rRNA gene being one of the
few ubiquitous and highly evolutionarily conserved genes. The 16S rRNA gene is a
common housekeeping genetic marker approximately 1,550 bp in length and contains
variable and conserved regions. To create a 16S rRNA profile, amplification primers
are typically used to target three of the nine hypervariable regions in the 16S rRNA
gene: V2, V3, and V6 (Chakravorty et al., 2007).
The Pace group used this gene to construct the first phylogenetic analysis of
a microbial community, a marine picoplankton community (Schmidt et al., 1991).
This led to the development of widespread taxonomic classification through 16S
rRNA gene sequence analysis (Clarridge, 2004).
Characterising microbial protein function When studying genes of functional
interest, there are two types of methodologies traditionally used: function-based and
sequence-based metagenomics. Function-based metagenomics involves cloning en-
vironmental DNA into expression vectors and propagating them into a host. An
activity screen is used to filter for a function of interest. The active clones that per-
form the function of interest are sequenced and the genes and their protein products
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analysed (Chistoserdova, 2010). This is useful when looking for proteins from new,
or poorly characterised, species with a particular function.
4.1.3 Next-generation sequencing
DNA sequencing characterises the sequential order of different nucleotide bases in a
length of DNA. The first techniques to achieve this were based upon the chemical
modifications of DNA, developed by Maxam and Gilbert (1977) and the chain-
termination method developed by Sanger et al. (1977). The latter method, termed
‘Sanger sequencing’, was the first to be automated, which allowed researchers to
sequence large quantities of DNA faster and more cheaply. The technology was de-
veloped over the next two decades and became the first method to sequence the full
human genome in 2001 (Lander et al., 2001). Sanger sequencing is similar to natural
DNA replication as it uses DNA polymerase to elongate complementary strands of
short primers. Different labels are used to identify the four different dideoxynu-
cleotides so that an addition of one can be detected through a detectable chain
termination (Mutz et al., 2013). This method is associated with a low sequencing
error rate of ∼ 2% and read lengths of up to ∼ 2000 bp (Nagarajan and Pop, 2013).
Pyrosequencing, also known as sequencing by synthesis, is a DNA sequencing
technique developed in the late 1990s by Ronaghi et al. (1996). This technique
brought an attractive alternative to Sanger sequencing through its ability to perform
real-time sequencing that was simple, automated and faster than previous methods.
As DNA polymerase moves along an immobilised single stranded template of DNA,
the four different nucleotides are sequentially added in solution, and if incorporated
a flash of light is detected. The pyrophosphate released from the DNA polymerase-
catalysed reaction forms ATP, which is then used in the ATP-dependent conversion
of luciferin to oxyluciferin. The production of oxyluciferin causes a pulse of light,
whose amplitude is directly related to the number of nucleotides incorporated (Ron-
aghi et al., 1996; Petrosino et al., 2009). DNA pyrosequencing is generally only able
to sequence DNA fragments up to 100-200 bases whereas from 2005, 454 Life Sci-
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ences released a high-throughput pyrosequencing technique, which can now sequence
fragments up to approximately 750 bases (Margulies et al., 2005; Glenn, 2011). This
technique is known as 454 sequencing and it was the first next generation sequenc-
ing method. While longer reads are produced with fast run times, the reagent costs
are high and there are high error rates associated with homopolymer repeats and
duplicate reads (Glenn, 2011). Nagarajan and Pop (2013) reported a sequence error
rate of ∼ 4% for this technology.
Illumina next generation sequencing (NGS) (initially developed in 2007 by Solexa)
also uses a sequencing-by-synthesis method and was the first next generation short-
read sequencer (Bentley et al., 2008). The DNA of an amplified library of fragments
is sequenced using reversible dye terminators. In this method, all four nucleotides
can be added at the same time in each cycle as each carries a different fluorescent la-
bel. A nucleotide is added by DNA polymerase, then the unincorporated nucleotides
are washed away and an image is taken to identify the fluorescent signal. The fluo-
rescent group is then cleaved and the 3’-hydroxyl group is chemically de-blocked so
that the next nucleotide can be incorporated. Up to 150 nucleotides can be added
in this way. Most Illumina reads are reported to have an error rate of 0.5%, i.e. 1
error in 200 bases) (Mardis, 2013). Nagarajan and Pop (2013) also reported a low
sequencing error rate of < 2%. These errors can be a result of phasing, which is
where the de-blocking process is incomplete, or where a blocking group is missing.
Errors can also result from fluorescence interference noise, which can occur when a
fluorescent group has not been cleaved from a previous cycle (Mardis, 2013).
Most recently, instruments have been developed that are able to sequence in-
dividual strands of metagenomic DNA in real time. Pacific Biosciences, known as
PacBio, was developed in 2009 (Eid et al., 2009) and made commercially available
in 2010. Starlight is another single-molecule sequencing technique however it is still
under development and is not commercially available. In PacBio, each nucleotide
has a different fluorescent label that is detected as soon as it is cleaved during syn-
thesis (Glenn, 2011). While the reads produced are 964 bases on average, it has the
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highest error rates compared to other NGS techniques of ∼ 18% (Metzker, 2010;
Nagarajan and Pop, 2013).
A number of metagenomic studies have used 454 pyrosequencing since its release
in 2005. A single run of 454 pyrosequencing allowed for the analysis of a 13 Mb
sequence of 28,000-year-old mammoth in 2006 (Poinar et al., 2006). Since then,
projects using 454 technology have investigated the metagenomes of soils (Leininger
et al., 2006), a coral holobiont (Wegley et al., 2007), and nine biomes (Dinsdale et al.,
2008), which include stromatolites, fish gut, fish ponds, mosquito viriome, chicken
gut, bovine gut and marine viriome (Hugenholtz and Tyson, 2008). Recent years
have seen a focus on the sequencing of the human microbiome using next-generation
technologies, with projects such as the HMP as mentioned in Section 4.1.9. Another
recent example used the Illumina sequence reads to establish a human gut microbial
gene catalogue (Qin et al., 2010).
As there are error rates associated with all methods of DNA sequencing a method
was developed to calculate the reliability of each base-call through a quality score.
The program Phred was developed to estimate the probability of error for each
base-call (Ewing and Green, 1998). Log-transformed error probabilities are used to
calculate a quality value (q) (see Equation 4.1).
q = −10 x log10(p) (4.1)
p represents the estimated error probability for a given base-call. A high quality
value corresponds to a low error probability. For example, a Phred quality score of
30 corresponds with a 1 in 1000 chance of an incorrect base call (Ewing and Green,
1998).
4.1.4 Computational methods to classifying microbiome species
The species present within an environment’s bacterial community can be identified
using two different types of sequence data: 16S rRNA gene sequences or whole-
genome shotgun sequences.
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In metagenomics, a whole-genome shotgun sequencing approach is taken to se-
quence whole genomes rather than a single gene. These genomic sequence reads are
typically scanned against a database containing 16S rRNA gene data, such as the
Ribosomal Database Project (RDP) to classify microbial species, though they can
also be scanned against whole protein sequences in resources including UniProtKB,
GenBank and RefSeq.
From these approaches, microbial species can be identified. However if there
are any novel microbial species in a metagenome data set, they cannot be classified
into the species taxonomy. In these cases, sequences can be clustered into groups of
operational taxonomic units (OTUs) based upon their sequence similarities (Wu et
al., 2013). While this is advantageous for examining biodiversity, there are a number
of disadvantages to this approach. There is no phylogeny hierarchy, different algo-
rithms cluster OTUs in different ways, and very short sequences will rarely overlap
with sequences in the database being searched to calculate sequence similarity (Wu
et al., 2013).
4.1.5 Computational methods to predict protein function
As discussed in the previous work chapters, protein function can be predicted in
a number of ways. With metagenome data, we are presented with a large volume
of DNA sequences which are typically annotated using protein sequence homology
approaches.
There are three databases which are frequently mentioned in the literature
when assigning functional annotations to metagenome sequences. KEGG Orthol-
ogy (KO) terms from KEGG, which are manually defined sets of orthologous se-
quences for all proteins and functional RNAs that each represent a node in a KEGG
pathway (Kanehisa et al., 2014). The Cluster of Orthologous Groups (COGs)
database (Tatusov et al., 2003), contains clusters of prokaryotic and eukaryotic
orthologues. The evolutionary genealogy of genes: Non-supervised Orthologous
Groups (eggNOGs) database contains orthologous groups clustered using sequences
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from complete high-quality genome projects. Sequences are clustered using whole-
protein sequence similarity information and orthologous proteins are identified within
the clusters. Functional annotations are then retrieved for these orthologous proteins
using any associated GO terms, membership to KEGG pathways, and the presence
of domains from SMART and Pfam (Jensen et al., 2008; Powell et al., 2014).
CATH superfamilies and functional families, and members of InterPro such as
Pfam, are additional sources of functional annotation, which have been discussed in
more detail in previous chapters.
4.1.6 Web servers providing metagenome analysis protocols
A number of web servers have relatively recently become available which promote
the public availability of metagenomic data and the standardisation of the analysis
workflow. Data can be uploaded to a web server which processes and analyses the
data to predict species in the microbiome and to provide protein function anno-
tations. These resources include: MG-RAST (Metagenome rapid annotation using
Subsystems technology) (Meyer et al., 2008), Galaxy (Kosakovsky Pond et al., 2009),
IMG/M (Integrated microbial genomes and metagenomes) (Markowitz et al., 2012),
and EBI Metagenomics (Hunter et al., 2014).
Following the submission of metagenome sequence data, all four web servers
first perform quality analysis. Sequences can be: clipped to remove bases with low
quality scores at sequence ends, removed if they contain too many ambiguous bases
(i.e. ‘N’s), removed if they are duplicate reads, and removed if they are too short
or too long.
The Galaxy web server has the most flexibility of the four in how the analysis
is performed as the user can pick and chose each step of the analysis from a wide
range of options. However there is also a metagenomics workflow which has been
set up that takes the user through the steps to select high quality sequence reads
and classify microbiome species (Kosakovsky Pond et al., 2009). The other three
web servers pre-define how the sequence data will be filtered and analysed.
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The MG-RAST, EBI Metagenomics, and IMG/M pipelines predict genes in the
filtered sequence reads using FragGeneScan (Rho et al., 2010). IMG/M however
also uses additional methods to predict different classes of genes, including non-
coding RNA genes and protein-coding genes. Non-coding RNA genes here include
tRNA genes and rRNA genes. Aside from FragGeneScan, protein-coding genes
are predicted using ab initio programs: GeneMark v2.6, MetaGene, and Prodi-
gal (Markowitz et al., 2012).
Different methods are used by the web servers to classify the microbial species.
EBI Metagenomics classifies species in the microbiome by scanning 16S rRNA se-
quences against the SILVA (Pruesse et al., 2007) and Greengenes (DeSantis et al.,
2006) 16S rRNA sequence databases in QIIME v1.5 (Quantitative insights into mi-
crobial ecology) (Caporaso et al., 2010). IMG/M classifies the species and cre-
ates a phylogenetic distribution based upon the results of BLASTing the predicted
protein-coding genes against NCBI COGs. MG-RAST on the other hand scans se-
quences against data from the SILVA, Greengenes, and RDP (Wang et al., 2007)
databases, which have been integrated into a single non-redundant database called
‘M5rna’ (Meyer et al., 2008).
The different metagenome pipelines use different combinations of functional re-
sources, described earlier in Section 4.1.5, to functionally annotate the sequences. In
the EBI Metagenomics pipeline, the protein-coding regions are scanned against In-
terProScan to functionally annotate the sequences. Within the InterPro resources,
Gene3D, Pfam, TIGRFAM, PRINTS, and PROSITE patterns are currently used
(Hunter et al., 2014). In the IMG/M, genes are scanned against Pfam, TIGRFAM,
and NCBI COGs. KEGG Orthology (KO) terms and EC numbers are also assigned
through similarity searches (Markowitz et al., 2012). In MG-RAST, sequences are
scanned against their non-redundant database, ‘M5nr’, which incorporates sequences
from GenBank, SEED, IMG, UniProt, KEGG, and eggNOGs databases. Sequences
are assigned to different functional hierarchies using the SEED Subsystems, IMG
terms, COGs, eggNOGs, and ontologies such as KEGG Orthology terms and GO
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terms (Meyer et al., 2008).
4.1.7 Sequence read assembly
As the sequenced reads of DNA are generally short, it can be difficult to reliably
predict species within the microbiome and thereby, also the protein function. As
most of the bacteria in the human gut cannot be cultured and therefore do not have
reference genomes, de novo sequence assembly is used to assemble to sequence reads
into longer contiguous sequences, or contigs, that represent the genomic content of
bacteria in the metagenome.
Sequence assembly is challenging due to a number of factors. First, sequence
reads that share the same repeating sequence can be impossible to distinguish be-
tween. Second, sequence read error is another factor; the algorithm needs to tolerate
imperfect sequences in order to align and assemble sequences, however it must not be
too lenient otherwise an assembly could be formed from sequences originating from
different species, i.e. forming a chimeric sequence assembly. Third, the coverage of
all the species in the metagenome can vary due to biases in sequencing technology,
where low coverage can lead to gaps in assemblies.
An assembly is reported by the size of the contigs produced. Size statistics
include the maximum length, average length, and combined total length of the
contigs. The N50 statistic is also computed, which represents the length of the
smallest contig in a collection of contigs that contain at least 50% of the assembled
bases (Miller et al., 2010). These measures can be used to gauge how well the
assembly protocol performed, however it is very difficult to assess the exact accuracy
unless there are reference genomes to compare against.
4.1.8 Complications with metagenome analysis
There are a number of complications involved with analysing metagenome sequence
data. For example, each member of the microbiome is present at varying levels
of abundance and their respective genome sizes determine how deep the sequence
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coverage is. Therefore sequence reads from uncommon species are under-represented
and it is difficult to obtain information from these species (Gill et al., 2006).
Another issue is that the microbial genes, rather than expressed proteins, are
being studied. This means that the genetic material might not be expressed by the
microbial community, or it may be expressed differently due to post-translational
modifications. The introduction of metatranscriptomics is one way of overcoming
these issues by sequencing the mRNA transcripts produced by the members of the
microbial community. The sequencing of transcripts is performed by next generation
sequencing technology, which has been termed ‘RNA-Seq’.
The comparison of metagenome data also comes with its own complications,
discussed in detail by Raes et al. (2007). They suggest a number of factors to watch
out for, which are based upon the biology of the environment being studied and also
upon the technology being used. Related to the former set of factors, the analysis can
be affected by the number of different species in each sample being compared. For
example, if one sample contains less than ten species and a second sample contains
hundreds of species, the species in the first sample will have much higher coverage of
sequence reads. This would lead to better species and function prediction. Technical
issues to be aware of include the use of different DNA extraction protocols, which
may filter out certain organisms before the analysis can be carried out (Raes et al.,
2007).
4.1.9 The human metagenome
It has been estimated that the microorganisms that live inside and on the human
body are at least ten times greater in number than all of the human somatic and
germ cells in a single body (Turnbaugh and Gordon, 2008). This total number of
human and microbial cells is estimated to be more than 1014 cells (Darveau, 2010).
These microbial symbionts are extremely advantageous to humans as they provide
traits that humans no longer need to maintain (Gill et al., 2006). Examples of these
traits include functional contributions to the human gut such as the harvesting of
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otherwise inaccessible nutrients and/or sources of energy from the host diet, syn-
thesis of vitamins, metabolism of xenobiotics, the renewal of gut epithelial cells and
the development and activity of the immune system. Cardiac size is also affected
by the microbiome (Turnbaugh and Gordon, 2008).
The human microbiome has been the subject of many studies. Perhaps the
largest study carried out was by the Human Microbiome Project (HMP), an in-
ternational collaboration between groups in the United States, Europe and Asia,
which ran from 2007 to 2014 (NIH HMP Working Group et al., 2009; Turnbaugh
et al., 2007). Samples were taken from all over the body, including the: blood,
eye, gastrointestinal (GI) tract, oral cavity, skin, airways, and urogenital area. The
HMP was an experimental extension of the Human Genome Project with three
major goals: 1) to use high-throughput technologies to characterise the human mi-
crobiome through the sampling of multiple body sites from at least 250 healthy
volunteers, 2) to discover any associations between microbiome perturbations and
human health, and 3) to provide a standardised data resource and new technological
approaches for worldwide and large-scale application (NIH HMP Working Group et
al., 2009). The global aim was to investigate and demonstrate how human health
could be improved through the study of the human microbiome.
The human gut metagenome Another human metagenome-based consortium
was the MetaHIT (Metagenomes of the human intestinal tract) project, which ran
from 2008 to 2012, that aimed to understand the link between the gut microbiome
and chronic human diseases. Qin et al. (2010) reported the first large scale study in
association with the MetaHIT project. They extracted the DNA from 124 healthy,
overweight, and obese European adults, as well as inflammatory bowel disease (IBD)
patients from Denmark and Spain. A catalogue of all the microbial genes was pub-
lished, describing between 1,000-1,150 prevalent bacterial species within the entire
cohort. Each individual was reported to contain at least 160 prevalent bacterial
species. The second major study done in collaboration with MetaHIT and the HMP
by Arumugam et al. (2011) found that bacterial species from 33 European samples
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formed three clusters, termed enterotypes, where each was predominant in either
the Bacteroides genera, Prevotella, or Ruminococcus. They repeated the analysis
with large-scale study samples from US and Europe and again identified three dis-
tinct clusters, where the third cluster was prevalent in Clostridia (Arumugam et
al., 2011). Following such studies, the human gut has been described as the most
complex human metagenome with the highest number of bacterial species (Dave et
al., 2012).
The human oral metagenome The presence of bacteria in the human mouth
was first reported by Antonie van Leeuwenhoek (1632-1723), who studied the “white
stuff” between his teeth using his home-made microscopes (Porter, 1976).
The mouth is a warm and moist environment that provides many different types
of surfaces available for bacterial colonisation. It has been shown that bacteria
are found shortly after birth and are thought to be acquired from the child’s par-
ents/carers as very few of the bacteria are free-living (Gibbons and Houte, 1975). A
large change in the bacterial composition is observed when the first teeth emerge,
as more anaerobic bacteria such as Fusobacterium and Bacteroides species are ob-
served (Gibbons and Houte, 1975; Wilson, 2004). Recent studies have suggested
that the oral microbiome is the second most diverse in terms of species, after the
gut microbiome (Wade, 2013).
While many surfaces are kept relatively bacteria-free due to the cleansing action
of swallowing, there are a number of protected surfaces and crevices: the occlusal
surfaces of teeth (i.e. the surface tip of a tooth that comes into contact with a
tooth from the other jaw), between the teeth, and along the gingival margin (i.e.
gum line). While many bacteria are observed on the teeth, there were thought to
be less around the mucosal glands due to the shedding of epithelial cells (Gibbons
and Houte, 1975). It was concluded that the amount, and type, of secretions in
the mouth played a major role in the removal of bacteria, food particles, and other
substances, together with forces from tongue movements and mastication (Gibbons
and Houte, 1975).
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Those bacteria that manage to adhere form thick biofilms, which are aggregates
of microorganisms that use specific adhesins and receptors to interact with the host
organism and numerous other microbes (Foster et al., 2003; Shestakov, 2011). As the
mouth is a hostile environment to microbes (due to rapid changes in temperature,
pH, and clearance from swallowing) only a small proportion of those entering the
oral cavity are able to attach and survive. Bacteria have also evolved to cope
with the innate and adaptive responses of the host defence system. Biofilms allow
the microbes to remain attached to the oral surface and they prevent bacterial
removal during swallowing. Biofilm composition and metabolism has been observed
to change according to temperature, pH, nutrient intake, host genetics and ethnicity,
lifestyle, and host defence mechanisms (Marsh and Devine, 2011).
Before metagenomics techniques were introduced in the 2000s, the oral bacteria
were only characterised by culturing them in the laboratory. As is estimated that
only ∼ 50% of bacteria in the mouth can be cultured (Wade, 2013), many bacteria
could previously not be studied. Gibbons and Houte (1975) summarised 9 genera
characterised at the time, which covered five phyla: Firmicutes, Bacteroidetes, Pro-
teobacteria, Spirochaetes, and Fusobacterium. In more recent years, around 600-700
(mostly commensal, i.e. non-pathogenic) bacterial taxa covering 13 phyla have been
characterised (Chen et al., 2010; Dewhirst et al., 2010; Jenkinson, 2011), with some
studies suggesting that the overall number of species could increase to approximately
1200 due to continuing improvements in technology (Jenkinson, 2011). This high
level of species diversity is likely to be a result of many different microenvironments
within the mouth that are subject to different conditions, e.g. the tongue, palate,
cheeks, mucosal glands, gums and teeth. Metagenomic analyses have even shown
that biofilms on different teeth of the same person can differ in their microbial
composition (Shestakov, 2011).
The bacteria in the human mouth can obtain nutritional substrates from the
host, the diet, and from other bacteria. Nutrients derived from the host include
constituents of saliva, desquamated (i.e. scraped off) epithelial cells, and serum-like
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crevicular fluid, which is secreted from the parotid, submaxillary, and minor glands,
all found in different areas of mouth (Gibbons and Houte, 1975). It is thought that
each gland can exert local selective pressures on bacterial biofilm development.
Ingested food is only available intermittently to bacteria in the mouth, however
insoluble fibres and adhesive foods may be retained in the mouth if they are trapped.
While little is known about the effects of dietary proteins and lipids on oral bacteria,
carbohydrates have been studied due to the link of their breakdown, by Streptococ-
cus mutans, with tooth decay. Both saliva and crevicular fluid contain low levels of
glucose and free amino acids, as well as glycoproteins. Bacterial communities have
been shown to work together to degrade complex glycoproteins as single bacterium
members do not have the capability (Wickstro¨m et al., 2009).
Within the oral microbiome there are a number of bacterial species shown to play
a key role in oral disease, mainly in dental caries and periodontal diseases (Marsh
and Devine, 2011; Wade, 2013). Dental caries, or tooth decay, results from a high-
carbohydrate diet. Acid-producing bacteria, particularly Streptococcus mutans and
Lactobacilli, produce acid more frequently under such conditions, damaging dental
tissue and producing a more acidic environment which promotes the adhesion of
similar tooth decay-related bacteria (Wade, 2013). Periodontal diseases include
gingivitis and periodontis. Both of these diseases are typically caused by anaerobic
Gram-negative bacteria found in subgingival plaque, which is located below the gum
line (Belda-Ferre et al., 2011).
4.1.10 Aims and objectives
The work reported in this chapter uses computational methods to classify bacterial
organisms and provide functional annotations for their proteins, within three human
oral metagenome data sets. These samples have been sourced from the tongue,
dental plaque and mucosal glands in the oral cavity.
The main aims are to: 1) build a protocol that can be used in the analysis of
future metagenomic data sets, 2) annotate the metagenomes with functional infor-
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mation, and 3) compare the functional profiles between different oral environments,
and between the oral and gut microbiomes.
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4.2 Methods
4.2.1 Data sets
Human tongue data set Bacterial DNA sampling, extraction and preparation
for the human tongue metagenome data set was undertaken as described in Easton
(2009). To summarise, 9 volunteers from the Ward Group in University College
London brushed their tongue with a toothbrush for one minute, twice a week for
3 or 4 weeks. The samples were immediately frozen, and the DNA later extracted
and pooled ready for sequencing.
Human dental plaque and mucosal glands data sets Clinical samples were
collected from 27 patients at the Kings College London Dental Institute that pre-
sented various stages of periodontal disease. In each patient, both supra- and sub-
gingival plaque was collected from all teeth in a randomly selected area (Hunter
et al., 2011). Samples were also taken from all oral mucosal glands. The metage-
nomic DNA was extracted from the 27 individual dental plaque and mucosal glands
samples and then pooled in preparation for sequencing.
Human gut data set The healthy gut data set contains faecal samples taken
from 110 individuals across the world (Yatsunenko et al., 2012) including children
and adults of the Amazonas of Venezuela, rural Malawi, and US metropolitan areas.
The whole genome shotgun faecal metagenome data was sequenced using 454 py-
rosequencing and is publicly available from the MG-RAST metagenomics analysis
server (http://metagenomics.anl.gov/linkin.cgi?project=98) (Yatsunenko et
al., 2012).
A representative bacterial genomes data set A total of 1438 representative
bacterial genomes were downloaded from the Representative Proteomes project (Chen
et al., 2011). This set of representatives have been selected by Chen et al. (2011)
from the Protein Information Resource to reduce the bacterial genome sequence
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space as much as possible, whilst maintaining the functional annotation and se-
quence diversity. This data set was used for comparing the functional repertoires
of the metagenomes studied in this chapter, with a background bacterial set of
genomes.
4.2.2 DNA sequencing
The DNA samples for each oral environment were combined to give a pooled sample.
Each of the three pooled samples was then sequenced using 454 pyrosequencing. The
human tongue DNA was sequenced by Tony Brooks at the UCL Eastman Dental
Institute (London, UK). The human dental plaque DNA and the mucosal gland DNA
was sequenced by Alan Walker at the Sanger Institute (Cambridge, UK). All reads
were sequenced using the GS FLX System for DNA sequencing (454 Life Sciences
Corporation).
4.2.3 Generation and processing of metagenome sequence
data
4.2.3.1 Generating FASTA sequence data
Following sequencing, the raw image data was converted into FASTA format through
image processing and signal processing. Image processing generated the Composite
Well Files (CWFs), which contain the normalised signal value for each well over
each flow. Signal processing was then performed to correct for known errors; this
involved data filtering based on signal quality, trimming read ends for low quality
and primer sequences, and the generation of Standard Flowgram Format (SFF) files,
which are used as standard to encode pyrosequencing results from 454 sequencing.
The FASTA files were extracted from these SFF files. These steps were performed
by Tony Brooks for the tongue data set, and by Alan Walker for the dental plaque
and mucosal glands data sets.
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4.2.3.2 Quality assessment of sequence reads
To assess the quality of the sequence reads in each data set, the sequence (FASTA)
and the quality (QUAL) files were first converted into FASTQ format. Sequence
data statistics were generated for sequence length, GC content, quality scores, n-
plicates, complexity, tag sequences, poly-A/T tails and odds ratios. This was done
using the PReprocessing and INformation of SEQuences (PRINSEQ) tool (online
version 0.16.1 beta, http://edwards.sdsu.edu/cgi-bin/prinseq/prinseq.cgi).
This tool is explicitly designed for 454/Roche data. There is a report on the data
quality, which is then used to filter, reformat and trim the sequence data (Schmieder
and Edwards, 2011b).
The data were then stringently filtered using parameters suggested by PRINSEQ
(see Table 4.1). The quality scores for 454 sequences are Phred-based and range from
0 to 40 (Schmieder and Edwards, 2011b). Bases with low Phred quality scores on
the end of sequence reads were trimmed off, and sequence reads with a mean Phred
quality score less than 20 were removed. Reads that are too short or too long
were removed. Very short sequence reads can cause problems. For example when
using them to search for homologous proteins in a database they are more likely
to match a sequence by chance. On the other hand, very long sequence reads are
likely to contain long stretches of homopolymer runs, which is a reported issue of
pyrosequencing technologies (Huse et al., 2007). The presence of ambiguous bases,
‘N’s, in a sequence read can indicate a low quality sequence, therefore any sequences
with more than 1% N content were removed. Low complexity sequence reads are
those containing stretches of bases with little information content, such as di- and
trinucleotide repeats (Schmieder and Edwards, 2011b). An entropy approach was
used to evaluate the entropy of trinucleotides in a sequence; entropy values range
from 0 to 100, where 0 represent a sequence containing a single amino acid and 100
represents a sequence containing no repeats. Finally, the filtering of sequence read
duplicates was performed to remove any PCR amplification bias introduced before
sequencing (Schmieder and Edwards, 2011b).
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Parameters applied
Trim low quality ends Mean ≥ 15, W:2, S:1
Filter too short and/or too long reads Mode ± 2 SD
Filter low quality reads Mean ≥ 20
Filter reads with ambiguous base N ≤ 1% (1 out of 100)
Filter low complexity reads Entropy ≥ 50
Filter read duplicates 5’ and reverse complement
Table 4.1: A description of the parameters defined to filter the human oral
metagenome sequence reads using the PRINSEQ web tool. W = window size, S
= step size.
4.2.3.3 Detection and removal of human contamination
Good-quality sequences were compared against the human reference genome build
37 to detect human contamination. The human reference genome was first down-
loaded from the NCBI FTP server, extracted and filtered using PRINSEQ to re-
move ambiguous bases, short sequences and sequence duplicates. The data was then
converted into database format. This process was carried out as described in the
DeconSeq online manual http://deconseq.sourceforge.net/manual.html.
Sequences were scanned against the human reference genome database with De-
conSeq (Decontamination of sequence data) standalone version 0.4.1 (Schmieder
and Edwards, 2011a). The BWA-SW algorithm which is used by DeconSeq to iden-
tify human contaminant sequences has been reported to be ten times faster than
BLAST (Li and Durbin, 2010). Sequences were identified as contaminants if they
matched a human sequence with > 90% sequence identity and an alignment cover-
age of > 90%. The data was then converted back into FASTA format for analysis.
4.2.4 Characterising bacterial species in the human oral mi-
crobiome
To classify the bacterial species in each data set, each set of filtered sequence reads
were scanned against the 16S rRNA RDP database via the MG-RAST server. An-
notations were only considered with E-values 6 1x10−5, sequence identities > 99%,
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and a minimum alignment length of 50bp.
Bacterial phyla were classified in each data set by scanning the filtered sequence
reads against the 16S rRNA RDP database using the RDP standalone version 2.9.
A confidence threshold of 0.8 was used to accept a classification.
4.2.4.1 Analysing GC content
Metagenome analyses frequently combine the results of multiple methods to examine
the species in the microbiome. Another method of analysing the bacterial species is
through the examination of sequence read GC content. The fractional GC content of
each sequence in the data set was calculated using the program geecee, by EMBOSS
version 6.3.1 (Rice et al., 2000). The normalmixEM function from the R package,
mixtools (Benaglia et al., 2009) was used to estimate whether there was a mixture
of normal distributions present in each data set as it is common for metagenome
data to contain a bimodal distribution (Schmieder and Edwards, 2011b).
4.2.5 Assembling metagenome sequence data
4.2.5.1 Assembly of sequence reads
To generate contiguous sequences, or contigs, the data was assembled de novo using
Mimicking Intelligent Read Assembly (MIRA) version 3.2.1, a whole genome shotgun
and EST sequence assembler for Sanger, 454, Solexa (Illumina), IonTorrent and
PacBio data (Chevreux et al., 2004). There are less de novo assembly tools available
for 454 pyrosequencing data in comparison to Illumina data, and MIRA has been
recommended in the literature (Hooper et al., 2010; Dutilh et al., 2012; Lysholm et
al., 2012; Tse et al., 2012). Muhammadzadeh et al. (2013) found MIRA to perform
slightly better than other comparable de novo assemblers.
Only sequence reads with more than 50 bases were considered for assembly.
Spoiler detection was switched on, which typically prevents chimeric contigs from
joining.
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4.2.5.2 Gene prediction
Genes were predicted within the contigs using the MetaGeneMark standalone pro-
gram (Zhu et al., 2010). The program is based upon GeneMark, which identifies
genes in complete genomes, and has been adapted to predict genes in short frag-
ments. Codon and oligomer frequencies are used to build heuristic models, which
are then used to find genes in the short reads. Trimble et al. (2012) evaluated five
popular ab initio gene prediction algorithms, FragGeneScan, MetaGeneAnnotator,
MetaGeneMark, Orphelia, and Prodigal. They compared the performance of these
methods over different rates of simulated sequencing error and also on metagenomic
datasets. They concluded that MGM offers accurate gene predictions, as long as the
sequence data is error-free, and that it is best-suited for gene prediction in higher-
quality sequences such as assembled contigs. To increase the chances of finding
full-length genes and to provide the most accurate prediction possible, the predic-
tion tool was run using the contig data sets.
4.2.6 Characterising bacterial protein function in the hu-
man microbiomes
Predicting protein function is a difficult task. Multiple methods have therefore been
used in this stage of the analysis to obtain more reliable answers. The metagenome
sequence fragments were first searched against entire protein sequences using the
MG-RAST server. Subsequently, since the fragments are generally shorter than a
full-length protein, in house CATH, domain-based methods, DomainFinder 3 and
FunFHMMER were used as they were more likely to identify domains in the shorter
fragments.
4.2.6.1 Whole protein-based prediction
Sequence reads from the three oral data sets were searched against the SEED
database and categorised into Subsystems functional groups through the MG-RAST
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server. Annotations were only considered if they had E-values 6 1x10−5, sequence
identities > 60%, and a minimum alignment length of 50bp.
4.2.6.2 Domain-based prediction
DomainFinder3 is an algorithm that uses a hidden Markov model (HMM) approach
to detect CATH protein domain families in a query sequence (Yeats et al., 2010). The
filtered 454-sequenced tongue metagenome DNA sequence reads were first converted
into their respective 6-frame translated protein sequence using the tool ‘transeq’
from EMBOSS-6.3.1 (Rice et al., 2000). These protein sequence fragments were
submitted to DomainFinder3, which scanned these sequences against CATH and
Pfam-A HMMs using HMMER3 software (Mistry et al., 2013) to identify CATH
structural domains and Pfam domains. The CATH HMMs were constructed from
the CATH v4.0 library. Pfam-A HMMs were used from version 27.0 of the Pfam
database.
Once a domain had been assigned to a superfamily it was rescanned against all
the functional family HMMs for that superfamily. This retrieved structural and
functional information about each domain. The Pfam functional families were used
to provide annotations for domains which could not be mapped to CATH.
The FunFHMMER method in this chapter is an update to the Funfamer and
DFX methods used in the previous work chapters. All three methods use the
GeMMA method to perform an initial profile-based clustering of protein domain
sequences. FunFHMMER decides whether two clusters should be merged or kept
separate depending on whether there is sufficient similarity in specificity determining
residues (SDPs) between the clusters. This method uses the GroupSim approach
of Capra and Singh (2008) to detect specificity determining residues. FunFHM-
MER is the most recent version of the function prediction method based on CATH
functional families (Figure A.1) and has been shown to outperform FunFamer and
DFX (Sayoni Das, personal communication). It was ranked second for the predic-
tion of GO terms in the Biological Process ontology and fourth for the prediction
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of GO terms in the Molecular Function ontology (out of 110 methods) in the recent
CAFA-2 function prediction method.
4.2.7 Comparing the functional profiles of oral and gut mi-
crobiomes
To explore whether the bacterial communities in the healthy tongue and gut meta-
genome data were significantly abundant in certain types of protein function, they
were first each compared against a set of representative bacterial genomes. This
background was used as, in some cases, two metagenomes may have a number of
enriched genes in common, which would be missed if they were simply compared
against each other. Through the comparison of each metagenome with an average
bacterial background, such enrichments will not be missed.
The tongue and gut metagenome data were also compared against each other to
explore the differences in functional repertoires. Functional family profiles and KO
term profiles have been compared.
4.2.7.1 Protocol to identify significant changes in FunFam abundance
between data
To calculate FunFam enrichment between the tongue and gut metagenomes, and
between each of these two metagenomes and the bacterial background, the number
of sequences assigned to each FunFam was counted together with the number of
sequences not assigned to all other FunFams. The Fisher exact test used these counts
to determine whether there was functional enrichment of a particular FunFam with
a confidence value threshold of 0.95.
4.2.7.2 Identifying enriched metabolic genes and pathways in the tongue
and gut data
To investigate whether there was significant enrichment of metabolic genes in the
tongue and gut metagenomes, sequence reads in both metagenomes were functionally
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annotated with KEGG Orthology (KO) terms through the MG-RAST server (Meyer
et al., 2008).
All KO annotations were downloaded through the MG-RAST API and each
data set was filtered to remove poor quality functional assignments, e.g. possible
misannotations resulting from assignments made to short read lengths. Annotations
were only considered with E-values 6 1x10−5, sequence identities > 75%, and a
minimum alignment length of 50bp.
For each KO term in the tongue and gut filtered data sets, the number of sequence
reads assigned and not assigned was counted. The Fisher exact test used these
counts to calculate functional enrichment of each KO term with a confidence value
threshold of 0.95.
The pathway enrichment score (developed by Enav et al. (2014)) was used to
calculate enrichment of the pathways containing enriched KO terms. The enrichment
score is defined in Equation 4.2:
PES =
N ∗∑1N(−log10(Pn))
T
(4.2)
PES represents the pathway enrichment score, N is the number of enriched KO
terms in a particular pathway for a given data set, Pn is the p-value calculated by
the Fisher exact test for each enriched KO term, and T is the total number of KO
terms in a particular KEGG pathway.
CHAPTER 4. FUNCTIONAL ANALYSIS OF THE HUMAN ORAL
METAGENOME 188
4.3 Results
Whole genome shotgun metagenome data from three human oral data sets (den-
tal plaque, mucosal glands, and tongue) have been processed and characterised using
multiple computational methods to classify the bacterial species and to predict pro-
tein function annotations and enrichments.
Publicly-available metagenome data for a set of 110 healthy children and adults
have been compared with the healthy tongue metagenome data to identify sets of
metabolic pathways differentially enriched in the tongue and the gut microbiomes.
4.3.1 Processing of sequence data
Table 4.2 reports the number of raw 454 metagenome DNA sequence reads produced
from the pooled human oral samples. The three data sets contained a similar number
of sequence reads.
Data set Sequence reads Base pairs Pooled samples
Dental plaque 1,364,333 492,833,154 27
Mucosal glands 1,210,767 384,156,658 27
Tongue 1,182,079 455,966,019 9
Table 4.2: DNA sequence reads sequenced from pooled human oral metagenome
samples using 454 pyrosequencing methods.
4.3.1.1 Quality assessment of sequence reads
Following the filtering and trimming of sequence reads with the PRINSEQ tool,
∼ 10-15% of sequence reads were removed from each data set due to their poor
quality (see Table 4.3). Low quality refers to: sequences with a low average Phred
quality scores, bases with low Phred quality scores, reads that were too short or
too long, reads containing ambiguous bases, reads with long low complexity regions,
and exact duplicates of reads.
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Data set # from original
sample (%)
Dental plaque 1,201,749 (88.08 %)
Mucosal glands 1,046,288 (86.42 %)
Tongue 1,061,991 (89.84 %)
Table 4.3: Good quality DNA sequence reads remaining after filtering.
4.3.1.2 Detection and removal of human contamination
Sequence reads were scanned against the human reference genome build 37 using
BLAST to detect human contamination. Table 4.4 lists the number of sequence
reads remaining in each data set following these quality checks. A high percentage
of the mucosal sequence reads were removed with this step.
Data set # from original
sample (%)
Dental plaque 946,343 (78.75 %)
Mucosal glands 246,758 (23.58 %)
Tongue 985,846 (92.83 %)
Table 4.4: DNA sequence reads remaining after the removal of sequence reads iden-
tified as human contamination.
Figure 4.1 summarises the number of reads filtered out throughout the different
stages of quality processing.
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Figure 4.1: The number of sequence reads remaining after two stages of filtering.
Step 2 represents the filtering performed with the PRINSEQ tool. Step 3 represents
the filtering performed with the DeconSeq tool.
4.3.2 Characterising bacterial species in the human oral mi-
crobiome
Table 4.5 shows the bacterial phyla characterised within each data set. This is the
result of scanning the sequence reads from each data set against the 16S ribosomal
RNA (rRNA) gene sequences in the Ribosomal Data Project (RDP) database. A
total of 1.8% (16,984 out of 946,343), 2.0% (4,903 out of 246,758), and 0.7% (7,006
out of 985,846) of the filtered sequence reads mapped to 16S rRNA genes in the RDP
database from the dental plaque, mucosal glands, and tongue data sets, respectively.
A total of 284, 137, and 195 bacterial strains were identified in the dental plaque,
mucosal glands, and tongue metagenome data, respectively. In comparison with
previous studies that have typically found around 500 different bacterial species
in the mouth, these numbers appear rather low. This may be due to issues with
DNA extraction from some bacterial species or because the 454 sequencing tech-
nique provided low coverage for certain bacterial species. The sequence reads were
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also scanned against the Greengenes rRNA database as well as the large subunit
(LSU) and small subunit (SSU) rRNA databases from SILVA via MG-RAST to de-
termine whether the number of bacterial strains was low because of biases in the
RDP database searched. These additional three databases however provided similar
results. The RDP scan results publicly available through MG-RAST report that the
gut metagenome on the other hand has a total of 1043 different bacterial strains,
which is around the number suggested by the literature.
Table 4.5 reports that a total of 10, 9, and 10 bacterial phyla were classified in
the dental plaque, mucosal glands, and tongue data sets, respectively. The Firmi-
cutes, and Proteobacteria are the two most abundant phyla in all three metagenomes
(highlighted in bold italics), with Firmicutes being most abundant in the mucosal
glands data and Proteobacteria in the dental plaque and tongue data. The Acti-
nobacteria, Bacteroidetes, and Fusobacteria phyla are less abundant, however still
make up approximately % of the sequences classified. The Aquificae and Verrucomi-
crobia, the SR1, and the Spirochaetes and SR1 phyla re the least abundant in the
dental plaque, mucosal glands, and tongue data sets, respectively.
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Phylum Dental plaque Mucosal glands Tongue
Actinobacteria 189 (1.11%) 114 (2.33%) 566 (8.08%)
Aquificae 1 (0.01%) 0 0
Bacteroidetes 433 (2.55%) 88 (1.79%) 443 (6.32%)
Candidatus Sac-
charibacteria
114 (0.67%) 4 (0.08%) 15 (0.21%)
Chloroflexi 0 0 5 (0.07%)
Cyanobacteria/
Chloroplast
2 (0.01%) 2 (0.04%) 2 (0.03%)
Firmicutes 1788 (10.53%) 3743 (76.34%) 1325 (18.91%)
Fusobacteria 456 (2.68%) 14 (0.29%) 72 (1.03%)
Proteobacteria 13925 (81.99%) 937 (19.11%) 4576 (65.32%)
Spirochaetes 75 (0.44%) 0 1 (0.01%)
SR1 0 1 (0.02%) 1 (0.01%)
Verrucomicrobia 1 (0.01%) 0 0
Total 16S rRNA
sequences
16984 4903 7006
Table 4.5: Number of sequence reads classified to bacterial phyla identified in the
three human oral metagenome data sets. Percentages represent the proportion of
metagenome sequences classified to a phyla out of the proportion of all 16S rRNA
metagenome sequences identified (see final row). The most dominant phyla, Firmi-
cutes and Proteobacteria, are highlighted in bold italics.
These results can be compared with species analysis of the human gut previously
undertaken by Kaoutari et al. (2013) who constructed a ‘mini-microbiome’ to rep-
resent the bacterial phyla found in the typical healthy adult gut microbiome. Their
data came from five different metagenomic studies and consisted of 177 genomes
across 12 phyla. As in the oral microbiome data presented in Table 4.5, the Firmi-
cutes phyla was found to be among the most abundant with 104 (out of 177, ∼ 59%)
genomes reported. While Table 4.5 reports that bacteria from the Proteobacteria
are the most abundant in the Dental plaque and Tongue environments,Kaoutari et
al. (2013) only found 22 members (out of 177, ∼ 12%) from this phyla in their
gut metagenome data. Table 4.5 shows that bacteria from the Actinobacteria and
Bacteroidetes phyla are less abundant but still contribute between 1-8% of sequence
reads, depending on the oral environment studied. Kaoutari et al. (2013) also found
the Actinobacteria and Bacteroidetes phyla to be fairly abundant in the gut, with
12 and 29 genomes reported, respectively.
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4.3.2.1 Analysis of sequence GC content
Figure 4.2 describes the GC content distribution of the three oral data sets. All
three data sets have a clear, major peak with mode values of approximately 0.4
(i.e. a 40% GC content), which is probably due to an abundance of Firmicutes and
Bacteroidetes as these two phyla typically have a low GC content.
As the distributions in Figure 4.2 appear to be bimodal, the normalmixEM
function in R was used to examine this. Figure 4.3 shows two distributions that
have been fit separately to the mucosal glands and the tongue data. This suggests a
second, minor peak with mode values at 0.594 and 0.625 in the mucosal glands and
the tongue data, respectively. This corresponds to an abundance of Proteobacteria,
which have genomic GC contents ranging from 30-60% (Hildebrand et al., 2010).
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(a) Dental plaque GC content distribution
(b) Mucosal glands GC content distribution
(c) Tongue GC content distribution
Figure 4.2: Fractional GC content distribution of the human oral metagenomes.
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(a) Mucosal GC content bimodal distribution
(b) Tongue GC content bimodal distribution
Figure 4.3: The distribution of fractional GC content across tongue and mucosal
sequence reads. The normalmixEM function from the R package, mixtools identified
a bimodal distribution in the two data sets. The modes in the tongue data were
calculated as 0.406 and 0.625. The modes in mucosal data were calculated as 0.404
and 0.594.
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4.3.3 Assembling the metagenome sequence reads
4.3.3.1 Assembling the human oral metagenome sequence reads
All three oral data sets were assembled using MIRA software. The general statistics
of the resulting contiguous reads, or contigs, are summarised in Table 4.6.
The mucosal glands data set has had fewer reads assembled compared to the
dental plaque and tongue data sets due to the smaller number of reads remaining
after filtering. The N50 contig size (see definition in Section 4.1.7, page 172) is
largest for the tongue data, which also has the longest contig length.
Data set Sequence
reads as-
sembled
Contigs N50 con-
tig size
(bp)
Longest
contig
length
(bp)
Dental
plaque
421,565 34,842 1,423 31,355
Mucosal 96,067 8,312 1,346 11,691
Tongue 657,898 39,971 2,396 41,967
Table 4.6: General statistics from the contiguous sequences assembled.
4.3.3.2 Gene prediction
Full-length genes have been predicted within the contig data using MetaGeneMark.
Table 4.7 lists the number of predicted genes in each of the data sets.
Data set # Contigs # Genes
Dental plaque 34,842 79,135
Mucosal 8,312 18,227
Tongue 39,971 125,211
Table 4.7: The number of genes predicted from the assembled contigs.
4.3.4 Functional annotation using the MG-RAST web server
The three oral data sets were scanned against the Subsystems database to assign
functional annotations. Subsystems represents four hierarchy levels of annotation,
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Figure 4.4 shows the percentage of sequence read assignments to the top hierar-
chical level. Subsystems functional annotations were assigned to 463,941 plaque
sequence reads (49.02%), 145,187 mucosal sequence reads (58.84%), and 594,344
tongue sequence reads (60.29%). The most populated category is clustering-based
subsystems, which represents groups of protein sequences with unknown function.
Carbohydrate metabolism and protein metabolism are the next most populated cat-
egories, which is likely to be a result of bacteria breaking down carbohydrates and
glycoproteins for nutrients. The least populated category is photosynthesis, which
is likely to be a result of a small number of photosynthetic bacteria present that
have some small amount of exposure to sunlight. All three data sets have similar
percentage assignments to each category.
CHAPTER 4. FUNCTIONAL ANALYSIS OF THE HUMAN ORAL
METAGENOME 198
F
ig
u
re
4.
4:
T
h
e
p
er
ce
n
ta
ge
of
fu
n
ct
io
n
al
ly
-a
n
n
ot
at
ed
or
al
m
et
ag
en
om
e
se
q
u
en
ce
re
ad
s
as
so
ci
at
ed
w
it
h
th
e
28
to
p
-l
ev
el
S
u
b
sy
st
em
s
fu
n
ct
io
n
al
ca
te
go
ri
es
.
CHAPTER 4. FUNCTIONAL ANALYSIS OF THE HUMAN ORAL
METAGENOME 199
4.3.5 Functional annotation using CATH and Pfam func-
tional families
4.3.5.1 Coverage statistics
Metagenome sequences reads, contigs, and genes were assigned to CATH and Pfam
protein domain homologous superfamilies in CATH version 4.0 and Pfam version
27. CATH version 4.0 comprises 2,734 superfamilies and 110,439 functional families.
Pfam version 27 comprises 14,831 superfamilies and 95,027 functional families.
To calculate the coverage attained through mapping metagenome data to CATH
and Pfam superfamilies and functional families, two general statistics were used:
1) the number of different superfamilies and different functional families assigned
to the data, and 2) the number of different sequences (either read, contig, or gene
sequences) that were assigned to superfamilies and functional families (Tables 4.8
and 4.9).
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Tables 4.8 and 4.9 report the number of metagenome sequences assigned to
CATH and Pfam superfamilies and functional families. Almost twice as many CATH
superfamilies have been assigned, compared to Pfam superfamily assignments. How-
ever even so, less than 10% of sequence reads are assigned to a superfamily. This is
likely to be due to the reads being very small (∼ 450bp) and this may mean that
some matches do not meet the threshold for superfamily recognition.
Unsurprisingly, when moving from the short sequence reads, to contigs and genes
(Tables 4.8 and 4.9), a larger amount of the data is assigned to both CATH and
Pfam FunFams.
Pfam FunFams were used to provide additional functional annotations where
CATH could not.
Due to the short nature of the sequence reads, we wanted to investigate the
number of domains mapped to a read and how this number increased when the reads
were assembled into contigs. Figure 4.5 shows that the sequence reads typically
contain matches to one or two CATH or Pfam domains, whereas the contigs are
shown to contain more domains, as expected.
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Figure 4.5: The number of domains identified in the tongue metagenome per read,
per contig, and per predicted gene. Each sequence can have one or more CATH or
Pfam domain identified.
To determine whether metagenome sequences are matching complete domains
or partial domains, the percentage coverage of each domain HMM match to its
query was calculated. Figure 4.6 shows that the percentage coverage of an identified
domain increased with length of the sequence type, i.e. a sequence read had a
median coverage of 42.3%, a gene had a median coverage of 68.9%, and a contig had
a median coverage of 70.8%.
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Figure 4.7 compares the number of functional families assigned to three bacteria
genomes in Gene3D with the number of functional families assigned to the sequence
reads from the oral metagenome data. The three bacterial genomes have around
3-4,000 different functional families and the oral metagenomes have approximately
twice as many functional family assignments.
Figure 4.7: The number of CATH/Pfam functional families identified in protein
domain sequences from three bacteria in Gene3D and in sequence reads from the
three oral metagenomes.
4.3.5.2 Providing an overview of the functional family assignments by
categorising them using broad GO term information
To overcome the issue of low functional family coverage for sequence reads data,
the coverage was increased by combining the functional families assigned to gene
sequences with functional families identified in oral bacterial strains. The oral mi-
crobiomes were identified by determining the bacterial strains present (see Methods
Section 4.2.4) and then extracting the sequences associated with those strains in
Gene3D. These sequences were then mapped to their corresponding functional fam-
ilies using the in-house Gene3D mapping.
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Through the combination of gene- and species-derived FunFams the sequence
data were mapped to 18,149, 12,765, and 22,645 FunFams for the dental plaque,
mucosal glands, and the tongue data, respectively. This increased the functional
family coverage from ∼ 1-3% to ∼ 11-20%.
Figure 4.8 shows the combined set of FunFams grouped into broad GO cate-
gories from the molecular function ontology. Similar numbers of functional family
assignments are categorised into the same broad GO terms for all three oral environ-
ments: dental plaque, mucosal glands, and tongue. The most abundant GO terms
are ‘binding’ and ‘catalytic activity’, which each categorise thousands of functional
families. The term binding is very general and simply refers to any interaction made
by a protein with another molecule at one or more specific sites (Binns et al., 2009).
The bacterial communities in each of these three environments will need to express
proteins that allow them to recognise and attach to a host surface for example, and
work together with other members of the community to form a biofilm. Bacteria will
also bind nutrients before degrading them using various different types of enzymes
including peptidases and glycoside hydrolases. The latter are just a few examples of
the types of catalytic activity that are likely be occurring within each environment.
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4.3.6 Comparing the functional profiles of microbiomes
To explore any significant differences in the functional repertoires of bacteria in
a healthy oral and a healthy gut environments, the functional annotations associ-
ated with the tongue and gut metagenomes were compared. The tongue and gut
metagenomes were also compared against a general bacterial background (consisting
of 1,438 genomes that map to 81,989 CATH and Pfam FunFams) to explore how
the functional abilities of the microbiomes differ from that of typical bacteria.
Comparing FunFam abundance in the tongue metagenome against the
bacterial background Comparing FunFam abundance between the tongue mi-
crobiome and the bacterial background, 1860 FunFams (892 CATH and 968 Pfam)
were enriched in the tongue microbiome, and 1077 FunFams (642 CATH and 435
Pfam) were enriched in the bacterial background. Table 4.10 shows the top ten most
significantly abundant FunFams in the tongue. There is a clear enrichment in bac-
terial proteins involved in cell wall formation (Penicillin binding proteins), cell wall
binding (Putative cell wall binding repeat, Coiled stalk adhesin, PASTA domain,
YSIRK type signal peptide), and in the transport of molecules in and out of the
cell (Outer membrane porin). These abundances could be a result of the harsh oral
environment where bacteria are frequently removed through swallowing.
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CATH/Pfam
FunFam
FunFam Name P-value
2.40.160.10 9688 Outer membrane porin 0
3.40.710.10 4277 Penicillin binding protein 2B 0
3.40.710.10 4880 Penicillin-binding protein 2x (EC
2.4.1.129)
0
PF01473 6147 Putative cell wall binding repeat 0
PF03793 3989 PASTA domain 0
PF04650 542 YSIRK type signal peptide 0
PF05662 2126 Coiled stalk of trimeric autotransporter
adhesin
0
PF07673 202 DUF1602 0
PF08794 68 Lipoprotein GNA1870 C terminal like 0
PF00521 2877 DNA gyrase/topoisomerase IV, sub-
unit A
2.21E-306
Table 4.10: The top ten most significantly abundant CATH and Pfam FunFams in
the tongue microbiome, in comparison with the bacterial background.
Comparing FunFam abundance in the gut metagenome against the bac-
terial background Comparing FunFam abundance between the gut microbiome
and the bacterial background, 3630 (1688 CATH and 1942 Pfam) FunFams were
enriched in the gut microbiome, and 4863 (2485 CATH and 2378 Pfam) FunFams
were enriched in the bacterial background. Table 4.11 shows the top ten most sig-
nificantly abundant FunFams in the gut. These functional annotations are very
different to those found to be enriched in the tongue metagenome and describe a
number of enzymes involved in the reduction of nitrites.
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CATH/Pfam
FunFam
FunFam Name P-value
1.20.1450.10 1 Ammonia monooxygenase subunit A-1 0
1.20.1450.10 11 Particulate methane monooxygenase
beta subunit
0
2.130.10.10 102414 Nitrous oxide reductase 0
2.140.10.20 2738 Nitrite reductase (EC 1.7.2.1) (Cy-
tochrome cd1)
0
2.40.30.10 37387 Elongation factor Tu 0
2.60.40.420 24014 Copper-containing nitrite reductase
NirK (EC 1.7.2.1)
0
2.60.40.420 24056 Nitrous oxide reductase 0
3.20.20.110 826 Ribulose bisphosphate carboxylase
large chain 1
0
3.30.1510.10 800 C-1-tetrahydrofolate synthase, cyto-
plasmic
0
3.30.260.10 2157 60 kDa heat shock protein, mitochon-
drial
0
Table 4.11: The top ten most significantly abundant CATH and Pfam FunFam in
the gut microbiome, in comparison with the bacterial background.
Comparing the tongue metagenome against the gut metagenome In the
comparison of FunFam abundance between the tongue and gut microbiomes, 1300
FunFams (749 CATH and 551 Pfam) were enriched in the tongue microbiome, and
733 FunFams (248 CATH and 485 Pfam) were enriched in the gut microbiome.
Tables 4.12 and 4.13 list the top ten most significantly abundant FunFams in
the tongue and gut microbiome, respectively. The results obtained in comparing the
metagenomes directly are similar as to when comparing the metagenomes against
the bacterial background. One noticeable difference is the presence of the ‘Glycosyl
hydrolase (GH) family 2, sugar binding domain’, which suggests an enrichment of
carbohydrate degradation in the gut metagenome. This is not a surprising result as
other groups have also reported an enrichment in carbohydrate degradation enzymes.
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CATH/Pfam
FunFam
FunFam Name P-value
2.40.160.10 9688 Outer membrane porin 0
PF07673 202 DUF1602 (clan) 0
PF01473 6147 Putative cell wall binding repeat 1.148025E-222
PF05662 2126 Coiled stalk of trimeric autotransporter
adhesin
5.900531E-218
PF13900 908 Putative binding domain 1.879078E-196
3.40.710.10 4880 Penicillin-binding protein 2x (EC
2.4.1.129)
7.441453E-181
PF08794 68 Lipoprotein GNA1870 C terminal like 6.429207E-157
2.60.40.1380 1148 LPXTG cell wall surface protein 5.459921E-150
PF04650 542 YSIRK type signal peptide 4.759559E-146
3.40.710.10 4277 Penicillin binding protein 2B 6.563816E-144
Table 4.12: The top ten most significantly abundant CATH and Pfam FunFams in
the tongue microbiome, in comparison with the gut microbiome.
CATH/Pfam
FunFam
FunFam Name P-value
2.140.10.20 2738 Nitrite reductase (EC 1.7.2.1) 1.320525E-219
3.40.50.300 26153 Nitrogenase iron protein 1 (EC
1.18.6.1)
1.523918E-144
PF02837 3829 Glycosyl hydrolases family 2, sugar
binding domain
8.719111E-140
3.40.50.300 27595 Nitrogenase iron protein (EC 1.18.6.1) 1.579457E-130
PF14310 3137 Fibronectin type III-like domain 7.294723E-126
2.130.10.10 102414 Nitrous oxide reductase 4.692666E-120
PF06541 1134 DUF1113 4.110635E-115
3.20.20.110 826 Ribulose-bisphosphate carboxylase
(EC 4.1.1.39)
2.096357E-100
3.40.50.740 11858 Nitrate reductase 2 (NRZ), alpha sub-
unit
3.489883E-092
PF14198 368 Transposon-encoded protein TnpV 5.245022E-092
Table 4.13: The top ten most significantly abundant CATH and Pfam FunFams in
the gut microbiome, in comparison with the tongue microbiome.
As in previous comparisons against the general bacterial background, we also see
an enrichment in adhesion proteins in the tongue microbiome and an enrichment of
two nitrogenase iron proteins in the gut microbiome, which are components of the
nitrogenase enzyme system (EC 1.18.6.1). This system catalyses the reduction of
dinitrogen to ammonia.
CHAPTER 4. FUNCTIONAL ANALYSIS OF THE HUMAN ORAL
METAGENOME 212
4.3.6.1 Identifying significantly enriched metabolic genes and pathways
in the tongue and gut data
In order to define an enriched set of metabolic genes in the tongue and gut metagenomes,
the two data sets of sequence reads were annotated using the KO database through
the MG-RAST server. This resulted in 1117 unique KO annotations for the tongue
data, and 1931 KO annotations for the gut data.
Using the Fisher exact test described in Methods (see page 186), a total of
122 and 48 KO terms were found to be significantly more abundant in the tongue
metagenome and in the gut metagenome, respectively. These enriched terms were
then used to explore whether their metabolic pathways were also enriched in the
metagenome using Equation 4.2 in Section 4.2.7.2.
The 15 most enriched KEGG pathways are shown in Tables 4.14 and 4.15. It
should be noted that while different KO terms are enriched between the two data
sets, different KO terms may map to the same KEGG pathway.
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There are few studies comparing the functional annotations of the oral and gut
metagenomes. Belda-Ferre et al. (2011) compared their own oral metagenome data
with the Kurokawa et al. (2007) gut data set and concluded that metabolic genes
involved in sugar uptake and assimilation, adhesion proteins, and prophage genes
were enriched in the gut microbiome. Whereas in the oral microbiome, enriched
metabolic genes were involved in oxidative and osmotic stress, or in iron scavenging.
In agreement with Belda-Ferre et al. (2011), a number of enriched metabolic
pathways involved in carbohydrate metabolism have been found in the gut metagenome
used in this work. We have found enriched metabolic enzymes in the gut (relative
to the tongue) that map to 11 carbohydrate metabolism KEGG pathways: Glycol-
ysis / Gluconeogenesis, Citrate cycle (TCA cycle), Galactose metabolism, Starch
and sucrose metabolism, Amino sugar and nucleotide sugar metabolism, Pyruvate
metabolism, Glyoxylate and dicarboxylate metabolism, Propanoate metabolism,
Butanoate meta-bolism, C5-Branched dibasic acid metabolism, and the Pentose
and glucuronate interconversions pathway.
One of the carbohydrate metabolism pathways with the highest pathway enrich-
ment score is the Starch and sucrose metabolism KEGG pathway. Large amounts
of undigested plant polysaccharides (e.g. cellulose, xylan, and pectin) and partially
digested starch reach the gut which cannot be digested by host enzymes. Members
of the gut microbiome however are able to break down such carbohydrates, for ex-
ample members of the Bacteroidetes phyla, through the use of enzymes including
glycoside hydrolases and polysaccharide lyases, which form part of the Starch and
sucrose metabolism pathway. The gut microbiota are also known to produce short
chain fatty acids (SCFAs) from these complex carbohydrates, which could explain
the higher enrichment scores in lipid metabolism pathways in the gut (den Besten
et al., 2013; Devaraj et al., 2013).
Enriched KO terms/genes involved in carbohydrate metabolism have also been
found in the tongue metagenome. Once carbohydrates have been degraded, bacterial
systems are required to uptake the products. There are enriched KO genes in the
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tongue metagenome which map to the Phosphotransferase system (PTS) pathway.
This system is widely used by bacteria to uptake around 20 different carbohydrates
such as hexoses, hexitols, and disaccharides (Kotrba et al., 2001;Kanehisa et al.,
2014).
Enzymes within the denitrification system were found to be enriched in the gut
metagenome using the FunFam annotations. The KO gene analysis reports that
there are enriched genes in the gut as well as the tongue that map to the Nitrogen
metabolism KEGG pathway, which the denitrification system is part of. Despite the
enriched genes from the gut and the tongue mapping to the same KEGG pathway
we can identify different parts of this pathway that are being performed in these two
different environments. Figure 4.9 highlights the enriched enzymes reported from
the FunFam and KO enrichment studies within the nitrogen metabolism pathway.
Figure 4.9: The enriched FunFam and KO terms mapped onto the nitrogen
metabolism KEGG pathway. Enriched terms in the tongue metagenome are high-
lighted in blue and in the gut metagenome in red.
In the tongue metagenome, the three enriched KO terms in this pathway relate
to: 1) nitrate reductase (EC 1.7.99.4), which reduces nitrate to nitrite, 2) glutamate
synthase (EC 1.4.7.1), which reduces L-glutamate to L-glutamine (which is then
reduced to ammonia by a different enzyme), and 3) nitrate reductase alpha subunit
(EC 1.7.99.4), which is part of nitrate reductase (see Figure 4.9). The three enriched
KO terms in the gut metagenome relate to: 1) glutamate synthase (EC 1.4.1.13, EC
1.4.1.14), 2) glutamate dehydrogenase (NADP+) (EC 1.4.1.4), and 3) glutamine
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synthase (EC 6.3.1.2). All these enzymes are highlighted in Figure 4.9.
A specific part of the nitrogen metabolism pathway, the denitrification system
(see Figure 4.10), has previously been shown to be beneficial to human health. The
ingested nitrate is reduced to nitrite by the oral bacteria. The nitrite is taken up
into the host’s bloodstream in the gut and converted into nitric oxide. Nitric oxide
is essential for healthy blood vessels as it helps to keep them supple, which helps
maintain a low blood pressure (Wade, 2013). It is reassuring to observe that our
results reflect this process by showing that the enzymes catalysing the reaction of
nitrate to nitrite is enriched in the tongue metagenome and showing that the enzyme
catalysing nitrite to nitric oxide is enriched in the gut metagenome (see Figure 4.10).
Figure 4.10: The enriched FunFam and KO terms mapped onto the denitrification
system in KEGG. Enriched terms in the tongue metagenome are highlighted in blue
and in the gut metagenome in red.
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4.4 Conclusions and future work
In this chapter, metagenome data from different areas of the oral cavity were
processed and characterised in terms of bacterial species present and protein function
annotations.
The bacterial phyla classified in the three oral metagenome data are consistent
with reports from other studies. Dewhirst et al. (2010) found that the microbiome
of the mouth is dominated by the bacterial phyla (in descending order) Firmicutes,
Bacteroidetes, Proteobacteria, Actinobacteria, Spirochaetes, and Fusobacteria. This
work reports a similar pattern in the three oral metagenomes studied with minor
variations. For example the most predominant phylum in the dental plaque and
tongue metagenomes is the Proteobacteria rather than the Firmicutes. In addi-
tion, the Spirochaetes phylum is only reported in the dental plaque and tongue
metagenomes and with quite low counts of only 87 and 1 sequence read(s), respec-
tively. Therefore there may not have been enough sequence read coverage of these
bacterial genomes in the mucosal glands data set, resulting in an apparent absence
of this phylum.
Functional annotations have been compared between the healthy tongue meta-
genome, a publicly-available healthy gut metagenome, and a general bacterial back-
ground to understand firstly, what is enriched within each metagenome, and sec-
ondly, to investigate what is enriched between the two metagenomes.
Functional family (FunFam) and KEGG Orthology (KO) terms were used in
this analysis to explore whether certain functions are enriched within a particular
metagenome environment. Differences between the tongue and the gut metagenomes
were first analysed using the FunFams. The most enriched FunFams in the tongue
were involved in cell wall formation and binding, whereas in the gut the most en-
riched FunFams, compared to the tongue, were mainly involved in the denitrification
process.
Enriched metabolic genes in the tongue and gut metagenomes both map to
metabolic pathways involved in the fermentation of amino acids into short chain
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fatty acids. Fusobacterium have aminopeptidase activity, which have been found
in small quantities in the tongue metagenome, and they have been reported to
produce short chain fatty acids (SCFA) following fermentation (Wade, 2013). As
previously mentioned, the gut microbiota are able to produce SCFA from complex
carbohydrates such as starch.
In this analysis we have also searched for enriched genes via KEGG Orthology
gene functional annotations and we have mapped these enriched genes to metabolic
pathways. While this analysis is useful for identifying and comparing enriched KO
genes in either the tongue or the gut microbiomes, it is rather difficult to compare
the enrichment of metabolic pathways between metagenomes. This is because the
different enriched genes in each metagenome can be mapped to the same metabolic
pathway. Therefore a given metabolic pathway can potentially be enriched in both
metagenomes and further analysis is needed to determine which parts of the path-
way are enriched in one or the other metagenome, as was done with the nitrogen
metabolism pathway, above. The pathway enrichment score has therefore simply
been used as an indication of how likely it is that a given pathway is present in that
metagenome.
A number of other complications are associated with the study of metagenome
data. In this analysis, the DNA extraction process for all three oral metagenome
data sets was the same, however it is not known whether the process is exactly the
same as the one used to generate the gut dataset as Yatsunenko et al. (2012) simply
states that a common DNA extraction protocol was used. The oral and gut data were
sequenced in different laboratories, which may have also had an impact. However,
although the biodiversity of the compared tongue and gut data are not identical, they
both contain hundreds of species. The complexity of the two samples is therefore not
too dissimilar. It is also reassuring to observe similar enriched functional terms in
the tongue and gut in comparison to other studies such as Belda-Ferre et al. (2011).
Another confounding factor is the issue of unequal genome coverage for all bac-
teria in the data set. As mentioned previously, the Spirochaetes phylum was only
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detected in the dental plaque metagenome, and in small numbers. It could be that
we have not been able to detect a number of bacterial genomes due to low cover-
age and it would be interesting to compile a list of all previously characterised oral
bacterial species in these metagenomes, to compare our results against. However
this would not account for uncharacterised species that may be under-represented
by genomic coverage.
If a dataset has uneven sequence coverage of a metagenome, the length and
quality of the subsequent contigs assembled and the genes predicted from this will
be affected. If one looks at the number of sequence reads assembled for the three
oral metagenome data, we can see that only 39-67% of the data was used. This may
be a result of missing sequence reads due to low genomic coverage or the removal
of reads during the quality assessment. Clearly, this reduces the number of gene
predictions that can be made, which in turn affects the analysis. This is reflected in
Figure 4.11 where we show that the number of different functional families identified
from predicted metagenome genes is similar to the number of functional families
identified in the protein domain sequences of a single bacterial genome, whereas we
would expect a larger number of functional families to be detected in a metagenome.
As in this work, the literature has also reported that there are many hundreds of
bacterial genomes in the oral metagenomes, and therefore there should be many
times more genes predicted within the metagenome data and many more functional
families identified.
We are now testing different assembly methods to find out whether we can as-
semble larger percentages of the data. While it is difficult to assess the quality of
these de novo sequence assemblies, as we do not have reference genomes for all the
bacteria in the oral and gut environments, we could also try mapping the data onto
reference genome sequences. For example, we could download all of the characterised
bacterial genomes from the HMP for these oral environments and map the sequence
reads against them to produce contigs. This would allow us to directly assess their
sequence quality.
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Figure 4.11: The number of CATH/Pfam functional families identified in protein
domain sequences from three bacteria in Gene3D and in gene predictions from the
three oral metagenomes.
While the metagenome data used for this work was sequenced using 454 technol-
ogy, problems can arise in metagenomic analysis from the comparison of data sets
that have used different sequencing technologies. In fact, studies have been pub-
lished that discourage the comparison of datasets that have used different sequencing
technologies or environmental sampling protocols (Mitra et al., 2009). This is due to
the fact that statistically different results obtained from such comparative analysis
may not reflect true differences between the data but instead report false positives
due to these experimental differences.
Approximately 40% of sequence reads from the oral metagenomes could not be
classified into a CATH (or a Pfam) superfamily. These sequences are referred to
as novel sequences due to their lack of annotation and are classified here as not
belonging to either a superfamily or a functional family. It would be interesting
to look at the number of sequence reads that hit a superfamily but that do not
hit a functional family within that superfamily. These sequences would represent
functionally diverse superfamily members. A similar analysis was carried out when
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looking for novel sequences in three large gut metagenomic datasets. Ellrott et al.
(2010) identified ∼ 1980 novel protein families (i.e. homologous sequences that were
clustered based upon whole-protein sequence similarities) from several human gut
metagenomic studies by scanning sequences against Pfam-B families and identifying
sequences that did not match any Pfam A or B family. 1800 were automatically clus-
tered and the remaining 180 were manually curated. These were then added to the
Pfam database (Godzik, 2011). In our analysis we would be using oral metagenome
data instead and would incorporate our findings into the CATH-Gene3D resource.
Finally, as metagenome data provides genomic content that is not necessarily
expressed and translated into a protein product, it would be interesting to apply a
metatranscriptomics approach to the data to look at the transcripts produced. These
transcripts are typically sequenced using Illumina sequencing technology, which has
a lower sequence error rate than the 454 technology used in this work (discussed
in Section 4.1.3) and a higher sequence read coverage. This would help to improve
sequence assembly quality, which should result in more protein domains and genes
being identified and annotated.
Chapter 5
Conclusions
Functional diversity across CATH superfamilies has been characterised and quan-
tified to understand how function evolves. Different classifications of functional
families, which define different functional groups within CATH superfamilies, were
first assessed to determine the most functionally coherent classification of families.
Experimentally-determined functional site residue information on binding and cat-
alytic residues was then used to characterise the functional sites used by different
relatives across functionally diverse superfamilies.
This work shows, on a much larger scale than previous studies, that functionally
diverse relatives tend to have different protein partners and therefore use differ-
ent protein-protein interface binding sites. We have also shown that despite these
differences, there is overlap between regions of these different large interfaces, and
this suggested a preference for a particular interface site or surface in many of the
superfamilies studied. It would be interesting to analyse further the reasons for
this preference in different superfamilies and whether it is a result of a particular
structural characteristic of the surface eg planarity or a constraint imposed by a
cofactor.
We then use functional families to look more specifically at how function (defined
by EC) evolves within enzyme domain superfamilies by examining the relationship
between changes in catalytic machinery and changes in reaction mechanism. Cat-
alytic machineries were studied in over one hundred CATH enzyme superfamilies
and found to exhibit considerable variation across the majority of the superfamilies
studied. Again, this phenomenon has not been previously reported on such a large
scale.
When examining whether a change in catalytic machinery is accompanied by a
change in reaction mechanism, perhaps the most surprising result was that nearly
one-quarter of the functional families compared used different catalytic machineries
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to perform the same reaction mechanisms, measured by bond change similarity.
While a large proportion of these functional families were associated with a change in
substrate, i.e. a change at the fourth EC hierarchical level, a significant proportion of
functional families used the same substrate. It would be interesting to perform more
detailed phylogenetic studies of these cases to examine whether they are examples
of true functional convergence or whether they are due to divergence of one relative,
from a common function, followed by convergence back to that function.
In the second work chapter, we also examined the preference for catalytic residues
to be present in loop regions. Beta and alpha-beta class superfamilies were shown to
have statistically significantly more catalytic residues in loop regions in comparison
with alpha class superfamilies. We also examined whether TIM barrel and Rossmann
fold superfamilies are more likely to have their catalytic residues in loops. Tawfik
and others have suggested that this is the case and that this contributed to their
incredible functional diversity as the loops are detached from the beta-sandwich or
beta-barrel scaffold so that any mutations that promote a new function are less
likely to destabilise the structure. We are currently analysing catalytic residue
preference within all CATH superfamilies that have a beta-sandwich or beta-barrel
topology. Many superfamilies adopting these structural scaffolds are well-known to
support completely different enzymatic functions and therefore different catalytic
machineries, and many feature loops that are clustered around their active sites.
In the final work chapter, we presented the functional families as a new and
powerful method for annotating metagenome data. Functional families were used
to characterise the functions performed by the bacterial communities inside the oral
and gut metagenomes, the two most bacterially species-diverse environments in the
human body. The results illustrated the different ways in which the bacteria have
adapted to their host in order to survive. For example, we found an enrichment
of adhesion proteins in the tongue metagenome and enzymes involved in the den-
itrification system in the gut metagenome. This new functional family annotation
protocol is a valuable tool in the field of comparative metagenomics and can help in
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understanding how certain bacteria adapt to survive within the human body as com-
mensal and symbiotic species. We are currently testing new metagenome sequence
read assembly methods to assemble as much of the sequence data as possible, which
is expected to lead to an improvement in the number of gene predictions and the
number of functional families that can be identified.
Appendix A
Figure A.1: The subclassification of CATH homologous superfamilies into the differ-
ent types of functional families studied: sequences clustered at 60% sequence iden-
tity, referred to as s60 clusters (A), FunFamGOs generated using the DFX method
(B), FunFamSEQs generated using the Funfamer method (C), and FunFams gener-
ated using the FunFHMMER method (D).
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